[{"in_reply_to_user_id":"116716199","lang":"en","id":"562328002755690496","created_at":"2015-02-02T19:13:38.000Z","possibly_sensitive":false,"author_id":"2924307356","referenced_tweets":[{"type":"replied_to","id":"562279071200313344"}],"text":"@EMA_News @agesnews @ECDC_EU @EFSA_EU Thanks for sharing important updates","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"agesnews","id":"223456379"},{"start":20,"end":28,"username":"ECDC_EU","id":"204752573"},{"start":29,"end":37,"username":"EFSA_EU","id":"84582815"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"562279071200313344","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"562232560529735680","created_at":"2015-02-02T12:54:22.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"562180105313988608"}],"text":"@sbird331 Our website is up and running again now. Sorry for the inconvenience.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"sbird331","id":"3011861393"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"561227773461925888","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"562192501797568512","created_at":"2015-02-02T10:15:12.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News launches central repository to facilitate assessment of #medicinesafety reports http://t.co/11HtouY63O","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":90,"end":112,"url":"http://t.co/11HtouY63O","expanded_url":"http://ow.ly/Ikbkk","display_url":"ow.ly/Ikbkk"}],"hashtags":[{"start":66,"end":81,"tag":"medicinesafety"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"562192501797568512","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"562166888000942080","created_at":"2015-02-02T08:33:25.000Z","possibly_sensitive":false,"author_id":"3011861393","referenced_tweets":[{"type":"replied_to","id":"561227773461925888"}],"text":"@EMA_News Can't access website pages since early morning. ??","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"561227773461925888","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"561878130798112768","created_at":"2015-02-01T13:26:00.000Z","possibly_sensitive":false,"author_id":"22080808","referenced_tweets":{},"text":"@EMA_news recommends suspending 100s of drugs tested by #GVK at @Hyderabad site http://t.co/le6lB9DjWD","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":64,"end":74,"username":"hyderabad","id":"2535381"}],"urls":[{"start":80,"end":102,"url":"http://t.co/le6lB9DjWD","expanded_url":"http://buff.ly/1z9mdzY","display_url":"buff.ly/1z9mdzY"}],"hashtags":[{"start":56,"end":60,"tag":"GVK"}],"annotations":{},"cashtags":{}},"source":"Buffer","conversation_id":"561878130798112768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"561521838283849728","created_at":"2015-01-31T13:50:13.000Z","possibly_sensitive":false,"author_id":"533470505","referenced_tweets":{},"text":"@EMA_News emitió un dictamen favorable a la autorización de ramucirumab para el tratamiento del cáncer gástrico. http://t.co/6r0ovFC8MS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/6r0ovFC8MS","expanded_url":"http://ow.ly/HW7QF","display_url":"ow.ly/HW7QF"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"561521838283849728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"561200476281405440","created_at":"2015-01-30T16:33:14.000Z","possibly_sensitive":false,"author_id":"90486281","referenced_tweets":[{"type":"replied_to","id":"561119270210633728"}],"text":"@EMA_News @Groote @Europarl_EN - is it available to read please ?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"Groote","id":"16297777"},{"start":18,"end":30,"username":"Europarl_EN","id":"36329597"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"560846394953850881","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"561130272994099201","created_at":"2015-01-30T11:54:17.000Z","possibly_sensitive":false,"author_id":"408478366","referenced_tweets":{},"text":"@EMA_News compie 20 anni, approvati più di 1000 #farmaci fra uso umano e veterinario","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":48,"end":56,"tag":"farmaci"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"561130272994099201","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"560793259052920833","created_at":"2015-01-29T13:35:06.000Z","possibly_sensitive":false,"author_id":"2507503682","referenced_tweets":{},"text":"@EMA_News recommends pulling medicines after data manipulation is discovered at GVK Biosciences  http://t.co/vs87wlKTEG","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/vs87wlKTEG","expanded_url":"http://buff.ly/1wDoqw8","display_url":"buff.ly/1wDoqw8"}],"hashtags":{},"annotations":[{"start":80,"end":94,"probability":0.8104,"type":"Organization","normalized_text":"GVK Biosciences"}],"cashtags":{}},"source":"Buffer","conversation_id":"560793259052920833","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"560433413581451265","created_at":"2015-01-28T13:45:12.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News adds #EU centralised procedure to international #data-sharing initiative http://t.co/RlC9aM8zPd","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/RlC9aM8zPd","expanded_url":"http://ow.ly/I4svv","display_url":"ow.ly/I4svv"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":58,"end":63,"tag":"data"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"560433413581451265","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"560401479480377344","created_at":"2015-01-28T11:38:19.000Z","possibly_sensitive":false,"author_id":"164835748","referenced_tweets":{},"text":"@EMA_News - GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies http://t.co/zxpBeTiedC","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/zxpBeTiedC","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002256.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":12,"end":26,"probability":0.4859,"type":"Organization","normalized_text":"GVK Biosciences"},{"start":29,"end":53,"probability":0.5848,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"560401479480377344","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"560369330387681280","created_at":"2015-01-28T09:30:34.000Z","possibly_sensitive":false,"author_id":"887285852","referenced_tweets":{},"text":"@EMA_News suspende la comercialización en Europa de genéricos por irregularidades en los estudios de bioequivalencia http://t.co/zULUkb05Kq","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/zULUkb05Kq","expanded_url":"http://politica.elpais.com/politica/2015/01/27/actualidad/1422366658_776909.html","display_url":"politica.elpais.com/politica/2015/…"}],"hashtags":{},"annotations":[{"start":42,"end":47,"probability":0.9755,"type":"Place","normalized_text":"Europa"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"560369330387681280","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"560347498548445185","created_at":"2015-01-28T08:03:49.000Z","possibly_sensitive":false,"author_id":"594078260","referenced_tweets":{},"text":"@EMA_News  Merck violated the False Claims Act with the testing, labeling, marketing of Propecia. PROOF: http://t.co/ahOLypAg7Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/ahOLypAg7Z","expanded_url":"http://i.imgur.com/qKSEtK5.png","display_url":"i.imgur.com/qKSEtK5.png"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"560347498548445185","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"560072851370549248","created_at":"2015-01-27T13:52:28.000Z","possibly_sensitive":false,"author_id":"510730668","referenced_tweets":[{"type":"replied_to","id":"560044392267149312"}],"text":"@EMA_News happy #anniversary ! 20 years #makingadifference","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":16,"end":28,"tag":"anniversary"},{"start":40,"end":58,"tag":"makingadifference"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"560044392267149312","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559793514129940480","created_at":"2015-01-26T19:22:28.000Z","possibly_sensitive":false,"author_id":"1142187697","referenced_tweets":[{"type":"replied_to","id":"559773810858422272"}],"text":"“@EMA_News: 20 years of EMA at a glance. Check it out! #EMA20 http://t.co/7EkCFNxN1O”. Great graphic.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":62,"end":84,"url":"http://t.co/7EkCFNxN1O","expanded_url":"https://twitter.com/EMA_News/status/559773810858422272/photo/1","display_url":"pic.twitter.com/7EkCFNxN1O"}],"hashtags":[{"start":55,"end":61,"tag":"EMA20"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"559773810858422272","attachments":{"media_keys":["3_559773809587150848"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559755613912444928","created_at":"2015-01-26T16:51:52.000Z","possibly_sensitive":false,"author_id":"230762140","referenced_tweets":{},"text":"@EMA_News recommends 7 meds incl. ARVcombo for approval http://t.co/DMyEwEvVsF Good for EU, but will they be accessible in #LMICs? #Pharma","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/DMyEwEvVsF","expanded_url":"http://ow.ly/HXARS","display_url":"ow.ly/HXARS"}],"hashtags":[{"start":123,"end":129,"tag":"LMICs"},{"start":131,"end":138,"tag":"Pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"559755613912444928","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559737815349866496","created_at":"2015-01-26T15:41:09.000Z","possibly_sensitive":false,"author_id":"3722601","referenced_tweets":{},"text":"@EMA_News Congrats to the European Medicines Agency on 20yrs today. @MinRonaAmbrose","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":68,"end":83,"username":"MinRonaAmbrose","id":"3325851135"}],"urls":{},"hashtags":{},"annotations":[{"start":26,"end":50,"probability":0.6219,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"559737815349866496","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559734318558609408","created_at":"2015-01-26T15:27:15.000Z","possibly_sensitive":false,"author_id":"2315763655","referenced_tweets":{},"text":"@EMA_News You've been quoted in my #Storify \"14th EGA Regulatory and Scientific Affairs Conference\" http://t.co/6FBQNy8mce #EGAreg15","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/6FBQNy8mce","expanded_url":"http://sfy.co/h0D5g","display_url":"sfy.co/h0D5g"}],"hashtags":[{"start":35,"end":43,"tag":"Storify"},{"start":123,"end":132,"tag":"EGAreg15"}],"annotations":[{"start":50,"end":97,"probability":0.3451,"type":"Other","normalized_text":"EGA Regulatory and Scientific Affairs Conference"}],"cashtags":{}},"source":"Storify","conversation_id":"559734318558609408","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559722422942056448","created_at":"2015-01-26T14:39:59.000Z","possibly_sensitive":false,"author_id":"28824136","referenced_tweets":{},"text":"@EMA_News Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’ http://t.co/zzQpeL15iq via @WSJ","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":104,"end":108,"username":"WSJ","id":"3108351"}],"urls":[{"start":77,"end":99,"url":"http://t.co/zzQpeL15iq","expanded_url":"http://www.wsj.com/articles/BL-270B-1358","display_url":"wsj.com/articles/BL-27…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"559722422942056448","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"559695953578721280","created_at":"2015-01-26T12:54:48.000Z","possibly_sensitive":false,"author_id":"59722141","referenced_tweets":{},"text":"@EMA_News Happy 20th Birthday to the European Medicines Agency!! http://t.co/anoF10gqDF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":65,"end":87,"url":"http://t.co/anoF10gqDF","expanded_url":"https://twitter.com/kardamyla/status/559695953578721280/photo/1","display_url":"pic.twitter.com/anoF10gqDF"}],"hashtags":{},"annotations":[{"start":37,"end":61,"probability":0.5572,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"559695953578721280","attachments":{"media_keys":["3_559695935085613056"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558997096943349760","created_at":"2015-01-24T14:37:48.000Z","possibly_sensitive":false,"author_id":"229928793","referenced_tweets":{},"text":"@EMA_News What's wrong with your website today?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558997096943349760","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558908814561665024","created_at":"2015-01-24T08:47:00.000Z","possibly_sensitive":false,"author_id":"1222841256","referenced_tweets":[{"type":"replied_to","id":"558596275067957248"}],"text":".@EMA_News Your website is down! Is there a connection with the publication of your list of flawed medications in Europe? #medicationsafety","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":122,"end":139,"tag":"medicationsafety"}],"annotations":[{"start":114,"end":119,"probability":0.997,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"558596275067957248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"de","id":"558659907671842817","created_at":"2015-01-23T16:17:56.000Z","possibly_sensitive":false,"author_id":"2233494522","referenced_tweets":[{"type":"replied_to","id":"558595633633067008"}],"text":"#Generika - Sicherheitsinformation: Kein Medikament der @EMA_News-Suspendierung am AT Markt. Positiv-Liste des #BASG http://t.co/S7rXQfIdBG","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":56,"end":65,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/S7rXQfIdBG","expanded_url":"http://www.basg.gv.at/news-center/news/news-detail/article/-44a9469faa/","display_url":"basg.gv.at/news-center/ne…"}],"hashtags":[{"start":0,"end":9,"tag":"Generika"},{"start":111,"end":116,"tag":"BASG"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558595633633067008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558644924116402177","created_at":"2015-01-23T15:18:23.000Z","possibly_sensitive":false,"author_id":"585944018","referenced_tweets":[{"type":"replied_to","id":"558596275067957248"}],"text":"@EMA_News Unbelievable","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558596275067957248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558644291867017218","created_at":"2015-01-23T15:15:52.000Z","possibly_sensitive":false,"author_id":"2365671608","referenced_tweets":{},"text":"@EMA_News recommends suspension of drugs with Indian data; some 80 products in the UK affected  http://t.co/ajsDtAnm6L","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/ajsDtAnm6L","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/01/WC500180894.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":[{"start":83,"end":84,"probability":0.9519,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558644291867017218","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558630482074955777","created_at":"2015-01-23T14:21:00.000Z","possibly_sensitive":false,"author_id":"392267100","referenced_tweets":{},"text":"@EMA_News have recommended #Saxenda (#liraglutide) for approval in weight management in adults: http://t.co/FiBBbk3tSE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/FiBBbk3tSE","expanded_url":"http://bit.ly/1xIKarR","display_url":"bit.ly/1xIKarR"}],"hashtags":[{"start":27,"end":35,"tag":"Saxenda"},{"start":37,"end":49,"tag":"liraglutide"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"558630482074955777","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"de","id":"558608869573029888","created_at":"2015-01-23T12:55:07.000Z","possibly_sensitive":false,"author_id":"2330637188","referenced_tweets":{},"text":"@EMA_News Entscheidung nach Indien-\"Studien\", #Klartraum @maxplanckpress, Montags-#Asteroid: Meldungen #IQ @bayern2 http://t.co/uPbmTIml9S","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":57,"end":72,"username":"maxplanckpress","id":"205195655"},{"start":107,"end":115,"username":"bayern2","id":"595551879"}],"urls":[{"start":116,"end":138,"url":"http://t.co/uPbmTIml9S","expanded_url":"http://www.br.de/radio/bayern2/wissen/iq-wissenschaft-und-forschung/tschuri-rosetta-arktis-rohstoffe100.html","display_url":"br.de/radio/bayern2/…"}],"hashtags":[{"start":46,"end":56,"tag":"Klartraum"},{"start":82,"end":91,"tag":"Asteroid"},{"start":103,"end":106,"tag":"IQ"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558608869573029888","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558595908045377536","created_at":"2015-01-23T12:03:37.000Z","possibly_sensitive":false,"author_id":"633978297","referenced_tweets":[{"type":"replied_to","id":"558590687785279488"}],"text":"Published assessment report for #Cyramza (#ramucirumab), a #medicine to treat #gastriccancer http://t.co/9HvngyLagp @EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":116,"end":125,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/9HvngyLagp","expanded_url":"http://bit.ly/1up99PF","display_url":"bit.ly/1up99PF"}],"hashtags":[{"start":32,"end":40,"tag":"Cyramza"},{"start":42,"end":54,"tag":"ramucirumab"},{"start":59,"end":68,"tag":"medicine"},{"start":78,"end":92,"tag":"gastriccancer"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"558590687785279488","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558578196380393472","created_at":"2015-01-23T10:53:14.000Z","possibly_sensitive":false,"author_id":"124388308","referenced_tweets":{},"text":"@EMA_News announced R3 effective date of 1-Jul-16 for electronic exchange.We consider preparing for R3 in this video  http://t.co/BSx0bhqkMv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/BSx0bhqkMv","expanded_url":"http://www.synowledge.com/industry-insights-webinars-video.html","display_url":"synowledge.com/industry-insig…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558578196380393472","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558383589940002818","created_at":"2015-01-22T21:59:56.000Z","possibly_sensitive":false,"author_id":"2789795314","referenced_tweets":{},"text":"@EMA_News Please Sign for approval &amp; supply new vertex drugs SPAIN slow down the progression disease https://t.co/GQCedCtlTT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":128,"url":"https://t.co/GQCedCtlTT","expanded_url":"https://www.change.org/p/ministerio-de-sanidad-servicios-sociales-e-igualdad-medicamento-kalydeco-ya-para-las-personas-con-fibrosis-qu%C3%ADstica?just_created=true","display_url":"change.org/p/ministerio-d…"}],"hashtags":{},"annotations":[{"start":61,"end":65,"probability":0.9654,"type":"Place","normalized_text":"SPAIN"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"558383589940002818","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558296042622689280","created_at":"2015-01-22T16:12:03.000Z","possibly_sensitive":false,"author_id":"462839916","referenced_tweets":{},"text":"@EMA_News launches a public consultation on how transparency rules of the Clinical Trial Regulation will affect the clinical trial database","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"558296042622689280","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"558173335147012099","created_at":"2015-01-22T08:04:28.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News accepts MAA for @AstraZeneca gout drug lesinurad from 2012 #Ardea acquisition #pharma","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":38,"username":"AstraZeneca","id":"62465691"}],"urls":{},"hashtags":[{"start":69,"end":75,"tag":"Ardea"},{"start":88,"end":95,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"558173335147012099","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557981247063224320","created_at":"2015-01-21T19:21:10.000Z","possibly_sensitive":false,"author_id":"235222726","referenced_tweets":[{"type":"replied_to","id":"557970665479753728"}],"text":"better definition needed of \"commercially confidential\" ergo top-secret @EMA_News #consultation on #transparency  http://t.co/wphje1LVNVmtax","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":72,"end":81,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":82,"end":95,"tag":"consultation"},{"start":99,"end":112,"tag":"transparency"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"557970665479753728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557900647623036929","created_at":"2015-01-21T14:00:54.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News launches public consultation on application of #transparency rules of EU #clinicaltrials Regulation http://t.co/xlIvvA3yuD","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/xlIvvA3yuD","expanded_url":"http://bit.ly/1BEmtax","display_url":"bit.ly/1BEmtax"}],"hashtags":[{"start":57,"end":70,"tag":"transparency"},{"start":83,"end":98,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"557900647623036929","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557900623338024960","created_at":"2015-01-21T14:00:48.000Z","possibly_sensitive":false,"author_id":"2834291205","referenced_tweets":{},"text":"@EMA_News launches public consultation on application of #transparency rules of EU #clinicaltrials Regulation http://t.co/oqGRFdQTXL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/oqGRFdQTXL","expanded_url":"http://bit.ly/1BEmtax","display_url":"bit.ly/1BEmtax"}],"hashtags":[{"start":57,"end":70,"tag":"transparency"},{"start":83,"end":98,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"557900623338024960","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557847675329314816","created_at":"2015-01-21T10:30:24.000Z","possibly_sensitive":false,"author_id":"2154184841","referenced_tweets":{},"text":"@EMA_News Draft guideline on clinical investigation of recombinant and human #plasma derived factorIX #pharma #health http://t.co/74SnibQXot","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/74SnibQXot","expanded_url":"http://buff.ly/1Ekvd3S","display_url":"buff.ly/1Ekvd3S"}],"hashtags":[{"start":77,"end":84,"tag":"plasma"},{"start":102,"end":109,"tag":"pharma"},{"start":110,"end":117,"tag":"health"}],"annotations":{},"cashtags":{}},"source":"Buffer","conversation_id":"557847675329314816","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"557520730204954625","created_at":"2015-01-20T12:51:14.000Z","possibly_sensitive":false,"author_id":"887285852","referenced_tweets":{},"text":"@EMA_News da luz verde a #Mysimba (naltrexona + bupropion) para tratamiento de la #obesidad en adultos http://t.co/vfhTCh9Vy2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/vfhTCh9Vy2","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002240.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":25,"end":33,"tag":"Mysimba"},{"start":82,"end":91,"tag":"obesidad"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"557520730204954625","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557482779932254208","created_at":"2015-01-20T10:20:26.000Z","possibly_sensitive":false,"author_id":"239975608","referenced_tweets":{},"text":"@EMA_News   Last reminder: win $1,200 in medical humanities contest in Hekint - Deadline 1/31/15 http://t.co/6T9hKZv7Vv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/6T9hKZv7Vv","expanded_url":"http://bit.ly/1wK7eHx","display_url":"bit.ly/1wK7eHx","status":200,"unwound_url":"https://hekint.org/?option=com_content&view=article&id=1316"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"557482779932254208","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557480828423663616","created_at":"2015-01-20T10:12:41.000Z","possibly_sensitive":false,"author_id":"1851060500","referenced_tweets":{},"text":"@EMA_News to share assessments reports for generic medicines with regulators outside the EU http://t.co/6R3lVGjUyz","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/6R3lVGjUyz","expanded_url":"http://goo.gl/ooF2v9","display_url":"goo.gl/ooF2v9"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"557480828423663616","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557445080496078848","created_at":"2015-01-20T07:50:38.000Z","possibly_sensitive":false,"author_id":"2981942862","referenced_tweets":[{"type":"replied_to","id":"546967507119390720"}],"text":"@EMA_News We at Ihaemo are working on a simple but effective method of contact between hospital staff and patients. Website coming soon!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":16,"end":21,"probability":0.4987,"type":"Organization","normalized_text":"Ihaemo"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"546967507119390720","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"557196740492009472","created_at":"2015-01-19T15:23:49.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News publishes pilot to boost international cooperation on #generics  http://t.co/uBEknVs3ZF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/uBEknVs3ZF","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002251.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":64,"end":73,"tag":"generics"}],"annotations":{},"cashtags":{}},"source":"iOS","conversation_id":"557196740492009472","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"556065855512268801","created_at":"2015-01-16T12:30:05.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News weekly #RegulatoryRoundUp - features info on EMA finalising its #biosimilars guidance, plus much more http://t.co/OnuX9d6VQi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/OnuX9d6VQi","expanded_url":"http://ow.ly/HpTNM","display_url":"ow.ly/HpTNM"}],"hashtags":[{"start":17,"end":35,"tag":"RegulatoryRoundUp"},{"start":74,"end":86,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"556065855512268801","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"555757780205076480","created_at":"2015-01-15T16:05:54.000Z","possibly_sensitive":false,"author_id":"21854075","referenced_tweets":{},"text":"@EMA_News EU CHMP is evaluating a #biosimilar version of Amgen's Enbrel (etanercept) http://t.co/VLm3Velhty","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":85,"end":107,"url":"http://t.co/VLm3Velhty","expanded_url":"http://bit.ly/1AUiNi3","display_url":"bit.ly/1AUiNi3"}],"hashtags":[{"start":34,"end":45,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"555757780205076480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"555594071645777920","created_at":"2015-01-15T05:15:23.000Z","possibly_sensitive":false,"author_id":"239975608","referenced_tweets":{},"text":"@EMA_News   Last chance to win glory and $1,200 in medical humanities contest in Hekint - Deadline 1/31/15 http://t.co/6T9hKZv7Vv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/6T9hKZv7Vv","expanded_url":"http://bit.ly/1wK7eHx","display_url":"bit.ly/1wK7eHx"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"555594071645777920","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"555403578270289920","created_at":"2015-01-14T16:38:26.000Z","possibly_sensitive":false,"author_id":"2828136269","referenced_tweets":[{"type":"replied_to","id":"555390675848818688"}],"text":"@EMA_News I meant the ECDC/EFSA/EMA first joint report on the analysis of the consumption of antimicrobial mentioned on the agenda","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"555297228404056064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"555349494062415872","created_at":"2015-01-14T13:03:31.000Z","possibly_sensitive":false,"author_id":"2828136269","referenced_tweets":[{"type":"replied_to","id":"555297228404056064"}],"text":"@EMA_News Thanks for this. When will you publish the report on consumption of antimicrobials? #AMR","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":94,"end":98,"tag":"AMR"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"555297228404056064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"555067061224083456","created_at":"2015-01-13T18:21:14.000Z","possibly_sensitive":false,"author_id":"2416339741","referenced_tweets":{},"text":"@EMA_News Follow me for #HIV &amp; #Hepatitis News #Blog #Polls #Resources #Videos #Infographics #Subscribe http://t.co/ZkE515Z0T2 PRT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/ZkE515Z0T2","expanded_url":"http://www.design-redefined.co.uk","display_url":"design-redefined.co.uk"}],"hashtags":[{"start":24,"end":28,"tag":"HIV"},{"start":35,"end":45,"tag":"Hepatitis"},{"start":51,"end":56,"tag":"Blog"},{"start":57,"end":63,"tag":"Polls"},{"start":64,"end":74,"tag":"Resources"},{"start":75,"end":82,"tag":"Videos"},{"start":83,"end":96,"tag":"Infographics"},{"start":97,"end":107,"tag":"Subscribe"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"555067061224083456","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554968661157756928","created_at":"2015-01-13T11:50:14.000Z","possibly_sensitive":false,"author_id":"2443530930","referenced_tweets":{},"text":"@EMA_News  #guideline on #biosimilar medicines containing biotechnology-derived proteins as active substance: http://t.co/CQDptit6C7","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/CQDptit6C7","expanded_url":"http://bit.ly/1Il9ivQ","display_url":"bit.ly/1Il9ivQ"}],"hashtags":[{"start":11,"end":21,"tag":"guideline"},{"start":25,"end":36,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"554968661157756928","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554911399567425537","created_at":"2015-01-13T08:02:42.000Z","possibly_sensitive":false,"author_id":"239982538","referenced_tweets":{},"text":"@EMA_News formally adopts new clinical/non-clinical #biosimilar guideline; http://t.co/TuMg5EIQgM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/TuMg5EIQgM","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/01/WC500180219.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":52,"end":63,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"554911399567425537","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554772667342262272","created_at":"2015-01-12T22:51:25.000Z","possibly_sensitive":false,"author_id":"2876403948","referenced_tweets":{},"text":"@EMA_News: Great stakeholder platform on Pharmacovigilance aspects (e.g. RMPs, PASS/PAES);open, constructive dialogue http://t.co/nOkt0S0khj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/nOkt0S0khj","expanded_url":"https://twitter.com/sinieskola/status/554772667342262272/photo/1","display_url":"pic.twitter.com/nOkt0S0khj"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"554772667342262272","attachments":{"media_keys":["3_554772654277013506"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554637624640413698","created_at":"2015-01-12T13:54:49.000Z","possibly_sensitive":false,"author_id":"19642657","referenced_tweets":{},"text":"@EMA_News 1 in 2 medicines contains active substance never used in medicines b4 #rarediseases #orphandrugs #biotech4…https://t.co/T4eRAd8UCj","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":140,"url":"https://t.co/T4eRAd8UCj","expanded_url":"https://lnkd.in/dDrDzcg","display_url":"lnkd.in/dDrDzcg"}],"hashtags":[{"start":80,"end":93,"tag":"rarediseases"},{"start":94,"end":106,"tag":"orphandrugs"},{"start":107,"end":116,"tag":"biotech4"}],"annotations":{},"cashtags":{}},"source":"LinkedIn","conversation_id":"554637624640413698","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554637508206526464","created_at":"2015-01-12T13:54:21.000Z","possibly_sensitive":false,"author_id":"19642657","referenced_tweets":{},"text":"@EMA_News 1 in 2 medicines contains active substance never used in medicines b4 #rardiseases #orphandrugs #biotech4l…https://t.co/T4eRAd8UCj","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":140,"url":"https://t.co/T4eRAd8UCj","expanded_url":"https://lnkd.in/dDrDzcg","display_url":"lnkd.in/dDrDzcg"}],"hashtags":[{"start":80,"end":92,"tag":"rardiseases"},{"start":93,"end":105,"tag":"orphandrugs"},{"start":106,"end":116,"tag":"biotech4l"}],"annotations":{},"cashtags":{}},"source":"LinkedIn","conversation_id":"554637508206526464","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554572943049916416","created_at":"2015-01-12T09:37:47.000Z","possibly_sensitive":false,"author_id":"414752636","referenced_tweets":{},"text":"@EMA_News, @theNCI, and #EORTC agree on #IBCD, a first of its kind meeting about #cancer drug development\nhttp://t.co/wzOVktwehx","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":18,"username":"theNCI","id":"38530021"}],"urls":[{"start":106,"end":128,"url":"http://t.co/wzOVktwehx","expanded_url":"http://www.eortc.org/node/1853","display_url":"eortc.org/node/1853"}],"hashtags":[{"start":24,"end":30,"tag":"EORTC"},{"start":40,"end":45,"tag":"IBCD"},{"start":81,"end":88,"tag":"cancer"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"554572943049916416","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"554565725558702080","created_at":"2015-01-12T09:09:06.000Z","possibly_sensitive":false,"author_id":"21854075","referenced_tweets":{},"text":"@EMA_News has published its updated guideline on clinical/non-clinical requirements for biosimilar products http://t.co/EgW6b1moKo","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/EgW6b1moKo","expanded_url":"http://bit.ly/1IiuZfS","display_url":"bit.ly/1IiuZfS"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"554565725558702080","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"553565760149536768","created_at":"2015-01-09T14:55:36.000Z","possibly_sensitive":false,"author_id":"2301430153","referenced_tweets":{},"text":"@EMA_News: Record number of medicines for rare diseases recommended for approval in 2014  #rarecancer http://t.co/Btetg2Ejxm","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/Btetg2Ejxm","expanded_url":"http://bit.ly/1xYCt31","display_url":"bit.ly/1xYCt31"}],"hashtags":[{"start":90,"end":101,"tag":"rarecancer"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"553565760149536768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"553512417733648384","created_at":"2015-01-09T11:23:38.000Z","possibly_sensitive":false,"author_id":"1417727497","referenced_tweets":{},"text":"@EMA_News says record number of meds for rare diseases recommended in 2014 - out of 82 put forward, 17 are orphan drugs #RareDisease","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":120,"end":132,"tag":"RareDisease"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"553512417733648384","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"553115736055746560","created_at":"2015-01-08T09:07:22.000Z","possibly_sensitive":false,"author_id":"441940097","referenced_tweets":{},"text":"@EMA_News pubblica report su #adaptivepathways per nuove modalità di licenza dei farmaci \nhttp://t.co/RX8grbOH5i","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":90,"end":112,"url":"http://t.co/RX8grbOH5i","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/percorsi-adattivi-l%E2%80%99approccio-del-futuro-portare-nuovi-farmaci-ai-pazienti","display_url":"agenziafarmaco.gov.it/it/content/per…"}],"hashtags":[{"start":29,"end":46,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"553115736055746560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"553115257984798720","created_at":"2015-01-08T09:05:28.000Z","possibly_sensitive":false,"author_id":"441940097","referenced_tweets":{},"text":"@EMA_News pubblica report  sul progetto pilota #adaptivepathways per portare nuovi farmaci ai pazienti http://t.co/RX8grbOH5i","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/RX8grbOH5i","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/percorsi-adattivi-l%E2%80%99approccio-del-futuro-portare-nuovi-farmaci-ai-pazienti","display_url":"agenziafarmaco.gov.it/it/content/per…"}],"hashtags":[{"start":47,"end":64,"tag":"adaptivepathways"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"553115257984798720","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"552605488068976640","created_at":"2015-01-06T23:19:49.000Z","possibly_sensitive":false,"author_id":"2485528122","referenced_tweets":[{"type":"replied_to","id":"552542561341300738"}],"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"552542561341300738","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"552514415304912897","created_at":"2015-01-06T17:17:56.000Z","possibly_sensitive":false,"author_id":"1707181112","referenced_tweets":[{"type":"replied_to","id":"552503904748179456"}],"text":"@EMA_News @luca__pani RT to be circulated","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"luca__pani","id":"2176193576"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"552503904748179456","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"552181916313874432","created_at":"2015-01-05T19:16:42.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":[{"type":"replied_to","id":"552044999588986881"}],"text":"@EMA_News the published report is as vague on PI as the one from March 2014 when I asked for it last time...","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":46,"end":47,"probability":0.4243,"type":"Organization","normalized_text":"PI"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"551891985859379201","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"551891985859379201","created_at":"2015-01-05T00:04:37.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":{},"text":"@EMA_News could you please share the AL patient involvement outline as deadline Feb 2015? http://t.co/Zi1TlWTH7I","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":90,"end":112,"url":"http://t.co/Zi1TlWTH7I","expanded_url":"http://goo.gl/a4GcfC","display_url":"goo.gl/a4GcfC"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"551891985859379201","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"551254338686160898","created_at":"2015-01-03T05:50:50.000Z","possibly_sensitive":false,"author_id":"318969583","referenced_tweets":{},"text":"@EMA_News Not enough: selective redaction of trial data by the sponsors undermines transparency drive http://t.co/HOXah1WptF","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/HOXah1WptF","expanded_url":"http://www.pharmaceutical-journal.com/opinion/comment/the-european-medicines-agency-still-has-a-way-to-go-towards-clinical-trial-transparency/20067402.article","display_url":"pharmaceutical-journal.com/opinion/commen…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"551254338686160898","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"549983551077515265","created_at":"2014-12-30T17:41:11.000Z","possibly_sensitive":false,"author_id":"43070633","referenced_tweets":{},"text":"@EMA_News still has a way to go towards clinical trial #transparency. By @ibushfield from @senseaboutsci #Alltrials http://t.co/HmJMxYgwJb","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":84,"username":"ibushfield","id":"20679494"},{"start":90,"end":104,"username":"senseaboutsci","id":"45579282"}],"urls":[{"start":116,"end":138,"url":"http://t.co/HmJMxYgwJb","expanded_url":"http://www.pharmaceutical-journal.com/opinion/comment/the-european-medicines-agency-still-has-a-way-to-go-towards-clinical-trial-transparency/20067402.article","display_url":"pharmaceutical-journal.com/opinion/commen…"}],"hashtags":[{"start":55,"end":68,"tag":"transparency"},{"start":105,"end":115,"tag":"Alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"549983551077515265","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"549331886750048257","created_at":"2014-12-28T22:31:42.000Z","possibly_sensitive":false,"author_id":"2846500047","referenced_tweets":[{"type":"replied_to","id":"546966307443593217"}],"text":"@EMA_News Need a serious threat to human health ? How about 25000 death in Europe ? http://t.co/0n7Tfa6ddi #superbug #antibiotics #livestock","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":84,"end":106,"url":"http://t.co/0n7Tfa6ddi","expanded_url":"http://www.irishtimes.com/news/health/ireland-facing-silent-epidemic-of-superbugs-doctors-told-1.2006979","display_url":"irishtimes.com/news/health/ir…"}],"hashtags":[{"start":107,"end":116,"tag":"superbug"},{"start":117,"end":129,"tag":"antibiotics"},{"start":130,"end":140,"tag":"livestock"}],"annotations":[{"start":75,"end":80,"probability":0.9933,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"546966307443593217","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"549329484613443584","created_at":"2014-12-28T22:22:09.000Z","possibly_sensitive":false,"author_id":"2846500047","referenced_tweets":[{"type":"replied_to","id":"546966307443593217"}],"text":"@EMA_News @Perrin_Cam Time for monitoring long gone, abuse of #antibiotics is a fact in the EU http://t.co/XVMntrvs8t","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"Perrin_Cam","id":"2893273911"}],"urls":[{"start":95,"end":117,"url":"http://t.co/XVMntrvs8t","expanded_url":"http://m.spiegel.de/international/business/a-828289.html#spRedirectedFrom=www&referrrer=http://www.spiegel.de/international/topic/agriculture/archiv-2012233.html","display_url":"m.spiegel.de/international/…"}],"hashtags":[{"start":62,"end":74,"tag":"antibiotics"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"546966307443593217","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"547765592309383168","created_at":"2014-12-24T14:47:48.000Z","possibly_sensitive":false,"author_id":"215336863","referenced_tweets":{},"text":"@EMA_News Merry Christmas and Thank you for your work on valproate teratogenicity PRAC review. http://t.co/EoqdG5D91M","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/EoqdG5D91M","expanded_url":"http://Www.facsaware.net","display_url":"facsaware.net"}],"hashtags":{},"annotations":[{"start":16,"end":24,"probability":0.6444,"type":"Other","normalized_text":"Christmas"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"547765592309383168","attachments":{"media_keys":{}},"geo":{"place_id":"38d67cacb385e69d","coordinates":{"type":"Point","coordinates":[-1.1128,52.6275]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"547155432251588608","created_at":"2014-12-22T22:23:15.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":{},"text":"@EMA_News Good news for EU patients! http://t.co/AR3sdaXiEo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":37,"end":59,"url":"http://t.co/AR3sdaXiEo","expanded_url":"http://goo.gl/EcQdQt","display_url":"goo.gl/EcQdQt"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"547155432251588608","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"546045412227174400","created_at":"2014-12-19T20:52:25.000Z","possibly_sensitive":false,"author_id":"35511598","referenced_tweets":[{"type":"replied_to","id":"545915967176712192"}],"text":"RT @EMA_News: We've recommended the first #stemcell therapy for approval in the European Union: http://t.co/Xir4IvNuQ2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/Xir4IvNuQ2","expanded_url":"http://bit.ly/1v7sg0L","display_url":"bit.ly/1v7sg0L"}],"hashtags":[{"start":42,"end":51,"tag":"stemcell"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"545915967176712192","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"546008669591465984","created_at":"2014-12-19T18:26:25.000Z","possibly_sensitive":false,"author_id":"2789795314","referenced_tweets":{},"text":"@EMA_News @eurordis @vertexpharma @cfawareness @cftrust @CysticLife CYSTIC FIBROSIS spain. What is (cont) http://t.co/QruLulmLf2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"eurordis","id":"26993786"},{"start":20,"end":33,"username":"VertexPharma","id":"17542775"},{"start":34,"end":46,"username":"CFAwareness","id":"54560021"},{"start":47,"end":55,"username":"cftrust","id":"21299778"},{"start":56,"end":67,"username":"CysticLife","id":"40889469"}],"urls":[{"start":106,"end":128,"url":"http://t.co/QruLulmLf2","expanded_url":"http://tl.gd/nhtvii","display_url":"tl.gd/nhtvii"}],"hashtags":{},"annotations":[{"start":68,"end":88,"probability":0.2173,"type":"Other","normalized_text":"CYSTIC FIBROSIS spain"}],"cashtags":{}},"source":"TweetCaster for Android","conversation_id":"546008669591465984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"545996963393859584","created_at":"2014-12-19T17:39:54.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News recommends approval for weight loss drug #Mysimba despite uncertainties on its long term cardiovascular safety #healthydietfirst","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":51,"end":59,"tag":"Mysimba"},{"start":121,"end":138,"tag":"healthydietfirst"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"545996963393859584","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"545385831939452928","created_at":"2014-12-18T01:11:29.000Z","possibly_sensitive":false,"author_id":"70269977","referenced_tweets":[{"type":"replied_to","id":"545275766188294145"}],"text":"@EMA_News Not many know that http://t.co/llRSHC3FTm holds 'first in class' therapies for Veterinary Use $OCAT trials conducted @tuftsvet","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":136,"username":"tuftsvet","id":"31459586"}],"urls":[{"start":29,"end":51,"url":"http://t.co/llRSHC3FTm","expanded_url":"http://Ocata.com","display_url":"Ocata.com"}],"hashtags":{},"annotations":{},"cashtags":[{"start":104,"end":109,"tag":"OCAT"}]},"source":"Twitter for iPhone","conversation_id":"545275766188294145","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"545280753039572993","created_at":"2014-12-17T18:13:57.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":{},"text":"@EMA_News force sanofi to tell truth about #valproateinreg 8000 harmed &amp; no info to mother via drug co @sanofi @guardian @thesundaytimes","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":107,"end":114,"username":"sanofi","id":"35846368"},{"start":115,"end":124,"username":"guardian","id":"87818409"},{"start":125,"end":140,"username":"thesundaytimes","id":"102707504"}],"urls":{},"hashtags":[{"start":43,"end":58,"tag":"valproateinreg"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"545280753039572993","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"545276167247626240","created_at":"2014-12-17T17:55:43.000Z","possibly_sensitive":false,"author_id":"1327474662","referenced_tweets":[{"type":"replied_to","id":"545275505780748288"}],"text":"@EMA_News Please study: R.I.D.D.O.R i.e. Hydrogen Sulphide emissions from water wells etc","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"545275505780748288","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"544539486924066816","created_at":"2014-12-15T17:08:25.000Z","possibly_sensitive":false,"author_id":"261338066","referenced_tweets":{},"text":"@EMA_news supports us, so we now ask for your help, Mr @V_Andriukaitis, to #banvetdiclofenac http://t.co/uW9pjNa63c http://t.co/EJknpBnY0E","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":55,"end":70,"username":"V_Andriukaitis","id":"575269517"}],"urls":[{"start":93,"end":115,"url":"http://t.co/uW9pjNa63c","expanded_url":"http://www.birdlife.org/europe-and-central-asia/news/european-medicines-agency-asks-european-commission-address-vulture","display_url":"birdlife.org/europe-and-cen…"},{"start":116,"end":138,"url":"http://t.co/EJknpBnY0E","expanded_url":"https://twitter.com/_Ivan_Ramirez/status/544539486924066816/photo/1","display_url":"pic.twitter.com/EJknpBnY0E"}],"hashtags":[{"start":75,"end":92,"tag":"banvetdiclofenac"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"544539486924066816","attachments":{"media_keys":["3_544539485564710912"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"544511797366362112","created_at":"2014-12-15T15:18:23.000Z","possibly_sensitive":false,"author_id":"2207681761","referenced_tweets":[{"type":"replied_to","id":"543473014621609984"}],"text":"Thanks @EMA_News and now the @magramagob has to ban #Diclofenac in Spain","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":7,"end":16,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":52,"end":63,"tag":"Diclofenac"}],"annotations":[{"start":67,"end":71,"probability":0.9971,"type":"Place","normalized_text":"Spain"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"543473014621609984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"544489086430740480","created_at":"2014-12-15T13:48:08.000Z","possibly_sensitive":false,"author_id":"860798112","referenced_tweets":{},"text":"@EMA_News https://t.co/i9daHeoeLk @AMX_Officiel ARCHIMEDOX is a global health observatory #bigdata https://t.co/Gi6nNhVxPZ english video","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":34,"end":47,"username":"AMX_Officiel","id":"1057482398"}],"urls":[{"start":10,"end":33,"url":"https://t.co/i9daHeoeLk","expanded_url":"https://www.b2match.eu/icsmeetings2014/participants/233","display_url":"b2match.eu/icsmeetings201…"},{"start":99,"end":122,"url":"https://t.co/Gi6nNhVxPZ","expanded_url":"https://www.youtube.com/watch?v=sZXuX6JVLPI","display_url":"youtube.com/watch?v=sZXuX6…"}],"hashtags":[{"start":90,"end":98,"tag":"bigdata"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"544489086430740480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"544444273333387264","created_at":"2014-12-15T10:50:04.000Z","possibly_sensitive":false,"author_id":"153320217","referenced_tweets":{},"text":"@EMA_News revisa estudios realizados por GVK Biosciences y su impacto en los fármacos http://t.co/qERZe8XZEt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/qERZe8XZEt","expanded_url":"http://ow.ly/FT7Gm","display_url":"ow.ly/FT7Gm"}],"hashtags":{},"annotations":[{"start":41,"end":55,"probability":0.3256,"type":"Organization","normalized_text":"GVK Biosciences"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"544444273333387264","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543649238467350529","created_at":"2014-12-13T06:10:53.000Z","possibly_sensitive":false,"author_id":"2167504026","referenced_tweets":[{"type":"replied_to","id":"543473014621609984"}],"text":"“@EMA_News: #Diclofenac use in animals poses a risk to European #vultures: http://t.co/XPDxE5BGE9” India banned-drastically reduced vultures","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/XPDxE5BGE9","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":12,"end":23,"tag":"Diclofenac"},{"start":64,"end":73,"tag":"vultures"}],"annotations":[{"start":99,"end":103,"probability":0.9328,"type":"Place","normalized_text":"India"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"543473014621609984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543641827786891264","created_at":"2014-12-13T05:41:26.000Z","possibly_sensitive":false,"author_id":"2204516444","referenced_tweets":{},"text":"@EMA_News http://t.co/unVGiV02mn \"Diclofenac use in animals poses a risk to European vultures\" @EU_Commission should #banvetdiclofenac now!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":95,"end":109,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":10,"end":32,"url":"http://t.co/unVGiV02mn","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/12/news_detail_002233.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":117,"end":134,"tag":"banvetdiclofenac"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"543641827786891264","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543494696837054464","created_at":"2014-12-12T19:56:48.000Z","possibly_sensitive":false,"author_id":"1452235320","referenced_tweets":[{"type":"replied_to","id":"543473014621609984"}],"text":"@EMA_News What is the benefit for the Animals?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"543473014621609984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543488588567310336","created_at":"2014-12-12T19:32:31.000Z","possibly_sensitive":false,"author_id":"261338066","referenced_tweets":{},"text":"@EMA_News agrees with us &amp; believes #Diclofenac is a threat to #vultures. We are getting closer to #banvetdiclofenac http://t.co/M2m22Fkfor","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":121,"end":143,"url":"http://t.co/M2m22Fkfor","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":40,"end":51,"tag":"Diclofenac"},{"start":67,"end":76,"tag":"vultures"},{"start":103,"end":120,"tag":"banvetdiclofenac"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"543488588567310336","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543486383290335232","created_at":"2014-12-12T19:23:45.000Z","possibly_sensitive":false,"author_id":"261338066","referenced_tweets":[{"type":"replied_to","id":"543473014621609984"}],"text":"YES! @BirdLifeEurope #banvetdiclofenac “@EMA_News: #Diclofenac use in animals poses a risk to European #vultures: http://t.co/M2m22Fkfor”","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":5,"quote_count":0},"entities":{"mentions":[{"start":5,"end":20,"username":"BirdLifeEurope","id":"755252174"},{"start":40,"end":49,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/M2m22Fkfor","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":21,"end":38,"tag":"banvetdiclofenac"},{"start":51,"end":62,"tag":"Diclofenac"},{"start":103,"end":112,"tag":"vultures"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"543473014621609984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"543486231192281088","created_at":"2014-12-12T19:23:09.000Z","possibly_sensitive":false,"author_id":"261338066","referenced_tweets":[{"type":"replied_to","id":"543473014621609984"}],"text":"YES! @BirdLife_News #banvetdiclofenac “@EMA_News: #Diclofenac use in animals poses a risk to European #vultures: http://t.co/M2m22Fkfor”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":5,"end":19,"username":"BirdLife_News","id":"57043553"},{"start":39,"end":48,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/M2m22Fkfor","expanded_url":"http://bit.ly/1ux49Z2","display_url":"bit.ly/1ux49Z2"}],"hashtags":[{"start":20,"end":37,"tag":"banvetdiclofenac"},{"start":50,"end":61,"tag":"Diclofenac"},{"start":102,"end":111,"tag":"vultures"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"543473014621609984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"542968386574356480","created_at":"2014-12-11T09:05:25.000Z","possibly_sensitive":false,"author_id":"2789795314","referenced_tweets":{},"text":"@EMA_News STOP PASSIVE EUTHANASIA for CYSTICPHIBROSIS in SPAIN.NOgiving new Vertex Medicines STOPS ILLNESS.SHAMELESS. http://t.co/YGIn1CNLCW","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/YGIn1CNLCW","expanded_url":"http://aprobacioncurafq.blogspot.com.es/?m=1","display_url":"aprobacioncurafq.blogspot.com.es/?m=1"}],"hashtags":{},"annotations":[{"start":57,"end":61,"probability":0.9947,"type":"Place","normalized_text":"SPAIN"}],"cashtags":{}},"source":"TweetCaster for Android","conversation_id":"542968386574356480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"542732830414221314","created_at":"2014-12-10T17:29:24.000Z","possibly_sensitive":false,"author_id":"2834833600","referenced_tweets":[{"type":"replied_to","id":"542727665665724416"}],"text":"@EMA_News @_Ivan_Ramirez @MarkAvery Thanks for the information.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"_Ivan_Ramirez","id":"261338066"},{"start":25,"end":35,"username":"MarkAvery","id":"17560522"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android Tablets","conversation_id":"542420213543608320","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"541931065766854657","created_at":"2014-12-08T12:23:29.000Z","possibly_sensitive":false,"author_id":"1098953306","referenced_tweets":[{"type":"replied_to","id":"541914659390226432"}],"text":"“@EMA_News: See the highlights of last week's #pharmacovigilance committee (PRAC) meeting: http://t.co/3xeRxJzgBe”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/3xeRxJzgBe","expanded_url":"http://bit.ly/1tQGJgT","display_url":"bit.ly/1tQGJgT"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"541914659390226432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"541219584674889728","created_at":"2014-12-06T13:16:19.000Z","possibly_sensitive":false,"author_id":"1718379914","referenced_tweets":{},"text":"@EMA_News approval of Lynparza #olaparib for relapsed #ovarian #cancer platinum-sensitive #BRCA mutated \nhttp://t.co/sMbtdfnUIn","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/sMbtdfnUIn","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002196.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":31,"end":40,"tag":"olaparib"},{"start":54,"end":62,"tag":"ovarian"},{"start":63,"end":70,"tag":"cancer"},{"start":90,"end":95,"tag":"BRCA"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"541219584674889728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"540942466707628032","created_at":"2014-12-05T18:55:08.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News reveals some EU member states will suspend marketing of medicines authorised on basis of studies conducted at #GVK #Biosciences","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":120,"end":124,"tag":"GVK"},{"start":125,"end":137,"tag":"Biosciences"}],"annotations":[{"start":23,"end":24,"probability":0.6338,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"540942466707628032","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"540540416828141568","created_at":"2014-12-04T16:17:32.000Z","possibly_sensitive":false,"author_id":"2315763655","referenced_tweets":{},"text":"@EMA_News Thanks again for the RT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"540540416828141568","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"540209422195503106","created_at":"2014-12-03T18:22:17.000Z","possibly_sensitive":false,"author_id":"408478366","referenced_tweets":{},"text":"@EMA_News tranquillizza sui vaccini, nessun legame con le morti sospette @Aifa_ufficiale invita a proseguire campagna","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":73,"end":88,"username":"Aifa_ufficiale","id":"441940097"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"540209422195503106","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"540202833770213376","created_at":"2014-12-03T17:56:06.000Z","possibly_sensitive":false,"author_id":"441940097","referenced_tweets":{},"text":"@EMA_News PRAC concluded that there is no evidence that #Fluad vaccine caused deaths in Italy: http://t.co/a9gp3oKpmK","public_metrics":{"retweet_count":16,"reply_count":2,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/a9gp3oKpmK","expanded_url":"http://bit.ly/1zQKary","display_url":"bit.ly/1zQKary"}],"hashtags":[{"start":56,"end":62,"tag":"Fluad"}],"annotations":[{"start":88,"end":92,"probability":0.9935,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"540202833770213376","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"540071339273359360","created_at":"2014-12-03T09:13:35.000Z","possibly_sensitive":false,"author_id":"59722141","referenced_tweets":{},"text":"@EMA_News The EMA engages with patients in a professional and thorough manner http://t.co/a6DVdEqPo2","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/a6DVdEqPo2","expanded_url":"http://www.rarediseasematters.org/2014/12/regulators-move-patient-engagement-to-the-next-level-benefit-risk-assessment/","display_url":"rarediseasematters.org/2014/12/regula…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"540071339273359360","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"539764713320497153","created_at":"2014-12-02T12:55:10.000Z","possibly_sensitive":false,"author_id":"39364251","referenced_tweets":{},"text":"@EMA_News: Investigation into reports of serious adverse events following use of #Fluad http://t.co/ItZ0uQxpPq","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/ItZ0uQxpPq","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/11/news_detail_002226.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":81,"end":87,"tag":"Fluad"}],"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"539764713320497153","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"539735928684949504","created_at":"2014-12-02T11:00:47.000Z","possibly_sensitive":false,"author_id":"2365671608","referenced_tweets":{},"text":"@EMA_News to advertise for new executive director &amp; mulls how to use Guido Rasi to \"best support the Agency in the coming months\" #pharma","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":134,"end":141,"tag":"pharma"}],"annotations":[{"start":69,"end":78,"probability":0.9678,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"539735928684949504","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"539357213589266432","created_at":"2014-12-01T09:55:55.000Z","possibly_sensitive":false,"author_id":"1024305913","referenced_tweets":[{"type":"replied_to","id":"539356299038040064"}],"text":"“@EMA_News: EU regulatory authorities are following up on suspension of two batches of flu #vaccine #Fluad in Italy: http://t.co/pRL2J3bziY”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/pRL2J3bziY","expanded_url":"http://bit.ly/1zEuQhF","display_url":"bit.ly/1zEuQhF"}],"hashtags":[{"start":91,"end":99,"tag":"vaccine"},{"start":100,"end":106,"tag":"Fluad"}],"annotations":[{"start":110,"end":114,"probability":0.9884,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"539356299038040064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"538654874318417920","created_at":"2014-11-29T11:25:04.000Z","possibly_sensitive":false,"author_id":"214119379","referenced_tweets":{},"text":"@EMA_News about fluad vaccine http://t.co/fyyRPRVIUW","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":30,"end":52,"url":"http://t.co/fyyRPRVIUW","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/11/news_detail_002226.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"538654874318417920","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"538369549297782784","created_at":"2014-11-28T16:31:17.000Z","possibly_sensitive":false,"author_id":"2193059910","referenced_tweets":[{"type":"replied_to","id":"538362648984059904"}],"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"538362648984059904","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"538363345897013248","created_at":"2014-11-28T16:06:38.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News publishes #guidance on access-to-documents http://t.co/UK0EYOLVkP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/UK0EYOLVkP","expanded_url":"http://ow.ly/F2rgw","display_url":"ow.ly/F2rgw"}],"hashtags":[{"start":20,"end":29,"tag":"guidance"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"538363345897013248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"538286306007453696","created_at":"2014-11-28T11:00:30.000Z","possibly_sensitive":false,"author_id":"21448858","referenced_tweets":[{"type":"replied_to","id":"538285848408911872"}],"text":"@EMA_News @egonwillighagen Link broken for me...","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"egonwillighagen","id":"22911650"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"538285848408911872","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"537507861623242752","created_at":"2014-11-26T07:27:15.000Z","possibly_sensitive":false,"author_id":"2547774333","referenced_tweets":{},"text":"@EMA_News: The EPAR for #Imbruvica (#ibrutinib), an orphan #medicine for #lymphoma and #leukaemia is now available: http://t.co/FWrwMKe1NP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/FWrwMKe1NP","expanded_url":"http://bit.ly/15lWIxW","display_url":"bit.ly/15lWIxW"}],"hashtags":[{"start":24,"end":34,"tag":"Imbruvica"},{"start":36,"end":46,"tag":"ibrutinib"},{"start":59,"end":68,"tag":"medicine"},{"start":73,"end":82,"tag":"lymphoma"},{"start":87,"end":97,"tag":"leukaemia"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"537507861623242752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"537268592484814849","created_at":"2014-11-25T15:36:29.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"537267337310011393"}],"text":"@weedee_ For more info,see http://t.co/buacLeTCHc &amp; http://t.co/y0EYTXEiAJ, or contact your national regulator:  http://t.co/tT1SC2Xtog","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":8,"username":"weedee_","id":"2361405143"}],"urls":[{"start":27,"end":49,"url":"http://t.co/buacLeTCHc","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"},{"start":56,"end":78,"url":"http://t.co/y0EYTXEiAJ","expanded_url":"http://bit.ly/133cMvv","display_url":"bit.ly/133cMvv"},{"start":117,"end":139,"url":"http://t.co/tT1SC2Xtog","expanded_url":"http://bit.ly/ZoTtg0","display_url":"bit.ly/ZoTtg0"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"537252250494959616","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"537176514102829056","created_at":"2014-11-25T09:30:35.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News harmonisation of #herbal #medicine #standards – 10 years on http://t.co/ZK0v0AXJQP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":70,"end":92,"url":"http://t.co/ZK0v0AXJQP","expanded_url":"http://ow.ly/ENAX6","display_url":"ow.ly/ENAX6"}],"hashtags":[{"start":27,"end":34,"tag":"herbal"},{"start":35,"end":44,"tag":"medicine"},{"start":45,"end":55,"tag":"standards"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"537176514102829056","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"536128535237492736","created_at":"2014-11-22T12:06:18.000Z","possibly_sensitive":false,"author_id":"215336863","referenced_tweets":[{"type":"replied_to","id":"535769211600371712"}],"text":"Dear @EMA_News @MHRAgovuk @OACSCharity @apesac1 @facsaware Thanks for ensuring warnings of 40% risk of birth defect with valproate. #FACS","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":5,"end":14,"username":"EMA_News","id":"116716199"},{"start":15,"end":25,"username":"MHRAgovuk","id":"330993102"},{"start":26,"end":38,"username":"OACSCharity","id":"2836109170"},{"start":39,"end":47,"username":"apesac1","id":"1379666360"},{"start":48,"end":58,"username":"facsaware","id":"1539712658"}],"urls":{},"hashtags":[{"start":132,"end":137,"tag":"FACS"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"535769211600371712","attachments":{"media_keys":{}},"geo":{"place_id":"38d67cacb385e69d","coordinates":{"type":"Point","coordinates":[-1.1129,52.6275]}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"535890368794226688","created_at":"2014-11-21T20:19:54.000Z","possibly_sensitive":false,"author_id":"2864411333","referenced_tweets":[{"type":"replied_to","id":"535834623688065024"}],"text":"@EMA_News http://t.co/Ctg1mop1hM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":10,"end":32,"url":"http://t.co/Ctg1mop1hM","expanded_url":"http://petrasynkuart.jimdo.com/english/","display_url":"petrasynkuart.jimdo.com/english/"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"535834623688065024","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"535808231059509249","created_at":"2014-11-21T14:53:31.000Z","possibly_sensitive":false,"author_id":"780787122","referenced_tweets":[{"type":"replied_to","id":"535768090551005184"}],"text":"@EMA_News @Aifa_ufficiale Aifa should take action, besides retweeting. Still no levonorgestrel without prescription in Italy.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":{},"hashtags":{},"annotations":[{"start":119,"end":123,"probability":0.9907,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"535768090551005184","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"535797476000006144","created_at":"2014-11-21T14:10:47.000Z","possibly_sensitive":false,"author_id":"2416355760","referenced_tweets":{},"text":"@EMA_News Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014 http://t.co/OyKW3LtSyu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/OyKW3LtSyu","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/11/news_detail_002215.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"535797476000006144","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"535780758841860097","created_at":"2014-11-21T13:04:21.000Z","possibly_sensitive":false,"author_id":"2169504954","referenced_tweets":[{"type":"replied_to","id":"535766348203581441"}],"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Windows Phone","conversation_id":"535766348203581441","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534694436228587520","created_at":"2014-11-18T13:07:42.000Z","possibly_sensitive":false,"author_id":"237222584","referenced_tweets":[{"type":"replied_to","id":"534692970881363968"}],"text":".@EMA_News We regret such crucial info will be missing. Could the project be updated in the future? #EAAD","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":100,"end":105,"tag":"EAAD"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"534683223998365696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534692132997853184","created_at":"2014-11-18T12:58:33.000Z","possibly_sensitive":false,"author_id":"237222584","referenced_tweets":[{"type":"replied_to","id":"534689617652776960"}],"text":"@EMA_News Could you tell us why not? This would help to know whether Abx are used responsibly #EAAD","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":94,"end":99,"tag":"EAAD"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"534683223998365696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534687974127308801","created_at":"2014-11-18T12:42:01.000Z","possibly_sensitive":false,"author_id":"204752573","referenced_tweets":[{"type":"replied_to","id":"534684453055238145"}],"text":"@EMA_News @beuctweet ECDC monitors human #antibiotic consumption. 2013 data just released: http://t.co/j54sP80ksh #EAAD #AntibioticDay","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"beuctweet","id":"3061421219"}],"urls":[{"start":91,"end":113,"url":"http://t.co/j54sP80ksh","expanded_url":"http://bit.ly/1qjdoQc","display_url":"bit.ly/1qjdoQc"}],"hashtags":[{"start":41,"end":52,"tag":"antibiotic"},{"start":114,"end":119,"tag":"EAAD"},{"start":120,"end":134,"tag":"AntibioticDay"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"534683223998365696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534685443443687428","created_at":"2014-11-18T12:31:58.000Z","possibly_sensitive":false,"author_id":"237222584","referenced_tweets":[{"type":"replied_to","id":"534684453055238145"}],"text":"@EMA_News Indeed, and we praise you for that. But if we want a clearer picture we need to know treatment indications. Will it be included?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"534683223998365696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534651177762582528","created_at":"2014-11-18T10:15:48.000Z","possibly_sensitive":false,"author_id":"2240486136","referenced_tweets":[{"type":"replied_to","id":"534643047443992577"}],"text":"@EMA_News @EU_Health @ECDC_EU @EFSA_EU @EAAD_EU @WHO_Europe that will be interesting!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":29,"username":"ECDC_EU","id":"204752573"},{"start":30,"end":38,"username":"EFSA_EU","id":"84582815"},{"start":39,"end":47,"username":"EAAD_EU","id":"1725283578"},{"start":48,"end":59,"username":"WHO_Europe","id":"125403342"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"534643047443992577","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534641763672403968","created_at":"2014-11-18T09:38:24.000Z","possibly_sensitive":false,"author_id":"1024305913","referenced_tweets":[{"type":"replied_to","id":"534641507861803008"}],"text":"“@EMA_News: RT @Aifa_ufficiale: First rule: only use #antibiotics when necessary. http://t.co/8LVaiCPulJ http://t.co/DFSeKcwOBS”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":30,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":82,"end":104,"url":"http://t.co/8LVaiCPulJ","expanded_url":"http://bit.ly/1xzeZ6M","display_url":"bit.ly/1xzeZ6M"},{"start":105,"end":127,"url":"http://t.co/DFSeKcwOBS","expanded_url":"http://bit.ly/1EUTwUM","display_url":"bit.ly/1EUTwUM"}],"hashtags":[{"start":53,"end":65,"tag":"antibiotics"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"534641507861803008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"534367949038321666","created_at":"2014-11-17T15:30:21.000Z","possibly_sensitive":false,"author_id":"600871466","referenced_tweets":{},"text":"@EMA_News #EMA reitera que ella decide qué información comercial sobre fármacos es confidencial http://t.co/R4z7sKtvKi vía @redaccionmedica","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":123,"end":139,"username":"redaccionmedica","id":"229001251"}],"urls":[{"start":96,"end":118,"url":"http://t.co/R4z7sKtvKi","expanded_url":"http://go.shr.lc/1wN9iN8","display_url":"go.shr.lc/1wN9iN8"}],"hashtags":[{"start":10,"end":14,"tag":"EMA"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"534367949038321666","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534300293228691456","created_at":"2014-11-17T11:01:31.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News SMO Hans-Georg Eichler tells #FTPharma agency is talking to HTAs to collaborate &amp; improve comparative effectiveness considerations","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":39,"end":48,"tag":"FTPharma"}],"annotations":[{"start":10,"end":17,"probability":0.7742,"type":"Person","normalized_text":"SMO Hans"},{"start":19,"end":31,"probability":0.709,"type":"Person","normalized_text":"Georg Eichler"},{"start":70,"end":73,"probability":0.4058,"type":"Organization","normalized_text":"HTAs"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"534300293228691456","attachments":{"media_keys":{}},"geo":{"place_id":"457b4814b4240d87","coordinates":{"type":"Point","coordinates":[-0.151,51.5126]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534298272811454464","created_at":"2014-11-17T10:53:29.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News SMO Hans-Georg Eichler tells #FTPharma audience that breakthrough designation has been a success for accelerating development","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":39,"end":48,"tag":"FTPharma"}],"annotations":[{"start":10,"end":17,"probability":0.7634,"type":"Person","normalized_text":"SMO Hans"},{"start":19,"end":31,"probability":0.7262,"type":"Person","normalized_text":"Georg Eichler"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"534298272811454464","attachments":{"media_keys":{}},"geo":{"place_id":"457b4814b4240d87","coordinates":{"type":"Point","coordinates":[-0.151,51.5126]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"534297477542080512","created_at":"2014-11-17T10:50:20.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News SMO Hans-Georg Eichler tells #FTPharma audience that regulators are looking to make safe products available as early as possible","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":39,"end":48,"tag":"FTPharma"}],"annotations":[{"start":10,"end":17,"probability":0.7192,"type":"Person","normalized_text":"SMO Hans"},{"start":19,"end":31,"probability":0.6701,"type":"Person","normalized_text":"Georg Eichler"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"534297477542080512","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533369294785359872","created_at":"2014-11-14T21:22:04.000Z","possibly_sensitive":false,"author_id":"554667907","referenced_tweets":{},"text":"@EMA_News Can you acknowledge you have read our frustration RT\nhttp://t.co/RQIsFE1MNf","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":85,"url":"http://t.co/RQIsFE1MNf","expanded_url":"http://www.joiningjack.org/the-situation/parents-diaries/frustration-is-building/","display_url":"joiningjack.org/the-situation/…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"533369294785359872","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533320248167256064","created_at":"2014-11-14T18:07:10.000Z","possibly_sensitive":false,"author_id":"372901187","referenced_tweets":[{"type":"replied_to","id":"533319907296182272"}],"text":"@EMA_News Thanks a lot :)","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"533312657861144576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533318273442799617","created_at":"2014-11-14T17:59:19.000Z","possibly_sensitive":false,"author_id":"372901187","referenced_tweets":[{"type":"replied_to","id":"533316938001571840"}],"text":"@EMA_News are there any traineship for young pharmacist from outside Eu , exactly Egypt? Thanks","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":69,"end":70,"probability":0.3687,"type":"Place","normalized_text":"Eu"},{"start":82,"end":86,"probability":0.8199,"type":"Place","normalized_text":"Egypt"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"533312657861144576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533316411167637504","created_at":"2014-11-14T17:51:55.000Z","possibly_sensitive":false,"author_id":"372901187","referenced_tweets":[{"type":"replied_to","id":"533312657861144576"}],"text":"@EMA_News should the applicant be from EU citizens?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":39,"end":40,"probability":0.5868,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"533312657861144576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533261982422827008","created_at":"2014-11-14T14:15:38.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News launches #newtool to assist completion of #information on #medicines http://t.co/lV0yI5vQ6q","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/lV0yI5vQ6q","expanded_url":"http://ow.ly/Ealw9","display_url":"ow.ly/Ealw9"}],"hashtags":[{"start":19,"end":27,"tag":"newtool"},{"start":52,"end":64,"tag":"information"},{"start":68,"end":78,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"533261982422827008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533250458869960704","created_at":"2014-11-14T13:29:51.000Z","possibly_sensitive":false,"author_id":"2539969778","referenced_tweets":{},"text":"@EMA_News for the latest information on drugs &amp; pharmaceuticals, visit http://t.co/52mD1qxJ3m\nNew post is on 1st Testosterone Nasal Gel","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":75,"end":97,"url":"http://t.co/52mD1qxJ3m","expanded_url":"http://alaleeshba.wordpress.com","display_url":"alaleeshba.wordpress.com"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android Tablets","conversation_id":"533250458869960704","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533241975986982912","created_at":"2014-11-14T12:56:08.000Z","possibly_sensitive":false,"author_id":"31353538","referenced_tweets":[{"type":"replied_to","id":"533233882242764800"}],"text":"Want to comment on @EMA_News's paper on #patientreportedoutcome measures in #cancer studies? 2 weeks left! http://t.co/YRrbNr27Kg #PRO","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":19,"end":28,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/YRrbNr27Kg","expanded_url":"http://bit.ly/1qomEAO","display_url":"bit.ly/1qomEAO"}],"hashtags":[{"start":40,"end":63,"tag":"patientreportedoutcome"},{"start":76,"end":83,"tag":"cancer"},{"start":130,"end":134,"tag":"PRO"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"533233882242764800","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"533181348358656000","created_at":"2014-11-14T08:55:14.000Z","possibly_sensitive":false,"author_id":"2407513628","referenced_tweets":{},"text":"@EMA_News #medicalwriting Open-access: EMWA-led review &amp; rec'dation project - ICHE3 &amp; CSP guidance; progress update: http://t.co/YbOXGrrrCu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":125,"end":147,"url":"http://t.co/YbOXGrrrCu","expanded_url":"http://www.maneyonline.com/doi/full/10.1179/2047480614Z.000000000254","display_url":"maneyonline.com/doi/full/10.11…"}],"hashtags":[{"start":10,"end":25,"tag":"medicalwriting"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"533181348358656000","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"532944589687357440","created_at":"2014-11-13T17:14:26.000Z","possibly_sensitive":false,"author_id":"298217417","referenced_tweets":{},"text":"@EMA_News @WHO Sistema VAERS es muy sensible, ¡cualquiera notifica cualquier efecto que atribuya a vacunas! #aev2014 http://t.co/XP34HYZFB7","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"}],"urls":[{"start":117,"end":139,"url":"http://t.co/XP34HYZFB7","expanded_url":"https://twitter.com/AEV_Vacunas/status/532944589687357440/photo/1","display_url":"pic.twitter.com/XP34HYZFB7"}],"hashtags":[{"start":108,"end":116,"tag":"aev2014"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"532944589687357440","attachments":{"media_keys":["3_532944583643389952"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"in","id":"532885577017094144","created_at":"2014-11-13T13:19:56.000Z","possibly_sensitive":false,"author_id":"226603998","referenced_tweets":{},"text":"@EMA_News info slide at #wodc2014 #dmd\ncc @BushbyKate http://t.co/MDETbx4OVk","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":42,"end":53,"username":"BushbyKate","id":"1216228962"}],"urls":[{"start":54,"end":76,"url":"http://t.co/MDETbx4OVk","expanded_url":"https://twitter.com/alanROYGBIV/status/532885577017094144/photo/1","display_url":"pic.twitter.com/MDETbx4OVk"}],"hashtags":[{"start":24,"end":33,"tag":"wodc2014"},{"start":34,"end":38,"tag":"dmd"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"532885577017094144","attachments":{"media_keys":["3_532885576148844544"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"532880956437590016","created_at":"2014-11-13T13:01:35.000Z","possibly_sensitive":false,"author_id":"324431980","referenced_tweets":{},"text":"@EMA_News ha dato l’ok al primo farmaco per il trattamento della Protoporfiria eritropoietica http://t.co/Gg60yZBTil","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/Gg60yZBTil","expanded_url":"http://bit.ly/1xQioe8","display_url":"bit.ly/1xQioe8"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"532880956437590016","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"532515241926864896","created_at":"2014-11-12T12:48:21.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News will send a detailed reply to the @EUombudsman's letter on redaction of commercially confidential info: http://t.co/cHaOlzuJ8p","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":44,"end":56,"username":"EUombudsman","id":"873777758"}],"urls":[{"start":114,"end":136,"url":"http://t.co/cHaOlzuJ8p","expanded_url":"http://bit.ly/1wSobl5","display_url":"bit.ly/1wSobl5"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"532515241926864896","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"532484472177172480","created_at":"2014-11-12T10:46:05.000Z","possibly_sensitive":false,"author_id":"2669842430","referenced_tweets":{},"text":"@EMA_News advise doctors to inform #multiplesclerosis patients about fatality using dimethyl fumarate. http://t.co/lroc8yeFFF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/lroc8yeFFF","expanded_url":"http://bit.ly/1qDC5l0","display_url":"bit.ly/1qDC5l0"}],"hashtags":[{"start":35,"end":53,"tag":"multiplesclerosis"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"532484472177172480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"530454042284421120","created_at":"2014-11-06T20:17:53.000Z","possibly_sensitive":false,"author_id":"2789795314","referenced_tweets":{},"text":"@EMA_News People dying.we cannot wait 1year4burocrathic issues in EMA.first medication cansave http://t.co/hbYFQNuE2K http://t.co/NPs3zS4PTd","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/hbYFQNuE2K","expanded_url":"http://investors.vrtx.com/releasedetail.cfm?ReleaseID=880537","display_url":"investors.vrtx.com/releasedetail.…"},{"start":118,"end":140,"url":"http://t.co/NPs3zS4PTd","expanded_url":"http://aprobacioncurafq.blogspot.com.es","display_url":"aprobacioncurafq.blogspot.com.es"}],"hashtags":{},"annotations":[{"start":38,"end":54,"probability":0.5201,"type":"Person","normalized_text":"1year4burocrathic"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"530454042284421120","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"530368826786193408","created_at":"2014-11-06T14:39:16.000Z","possibly_sensitive":false,"author_id":"2834291205","referenced_tweets":{},"text":"@EMA_News Thxs for the RT!!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"530368826786193408","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"530064782993682432","created_at":"2014-11-05T18:31:07.000Z","possibly_sensitive":false,"author_id":"215336863","referenced_tweets":[{"type":"replied_to","id":"530047601136369665"}],"text":"@EMA_News Thank you. I hope this will be useful for @AlzheimerEurope and others interested in causes of #dementia","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":68,"username":"AlzheimerEurope","id":"1536274003"}],"urls":{},"hashtags":[{"start":104,"end":113,"tag":"dementia"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"530029560528928768","attachments":{"media_keys":{}},"geo":{"place_id":"38d67cacb385e69d","coordinates":{"type":"Point","coordinates":[-1.1168,52.6184]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"529491245370847233","created_at":"2014-11-04T04:32:05.000Z","possibly_sensitive":false,"author_id":"1424464910","referenced_tweets":[{"type":"replied_to","id":"526716148633841664"}],"text":"“@EMA_News: EMA reco for ways to minimize the risk of cardiotoxicity with #Iclusig (#ponatinib): #cardioonc http://t.co/uRKUnQRerd”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/uRKUnQRerd","expanded_url":"http://bit.ly/1rsOCHk","display_url":"bit.ly/1rsOCHk"}],"hashtags":[{"start":74,"end":82,"tag":"Iclusig"},{"start":84,"end":94,"tag":"ponatinib"},{"start":97,"end":107,"tag":"cardioonc"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"526716148633841664","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"529345886942674945","created_at":"2014-11-03T18:54:28.000Z","possibly_sensitive":false,"author_id":"43524728","referenced_tweets":[{"type":"replied_to","id":"529312451998023681"}],"text":"@EMA_News @SanofiFR @SanofiUS @sanofi Why the delay in this warning? How long have you known?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"SanofiFR","id":"771517543"},{"start":20,"end":29,"username":"SanofiUS","id":"183033795"},{"start":30,"end":37,"username":"sanofi","id":"35846368"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"529288896019185664","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"529222442502619136","created_at":"2014-11-03T10:43:57.000Z","possibly_sensitive":false,"author_id":"1262320285","referenced_tweets":{},"text":"@EMA_News G. Rasi @ita2014eu vacc conference \"historical #vaccines: the more they succeed, the more the memory of what they achieve is lost\"","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":18,"end":28,"username":"ita2014eu","id":"2383876290"}],"urls":{},"hashtags":[{"start":57,"end":66,"tag":"vaccines"}],"annotations":[{"start":10,"end":16,"probability":0.6546,"type":"Person","normalized_text":"G. Rasi"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"529222442502619136","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"ro","id":"528977890176929792","created_at":"2014-11-02T18:32:11.000Z","possibly_sensitive":false,"author_id":"2247210554","referenced_tweets":{},"text":"@EMA_News Nueva guía #biosimilares #EMA Facilitating global development of #biosimilars http://t.co/T1tJHg0bBb","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/T1tJHg0bBb","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002201.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":21,"end":34,"tag":"biosimilares"},{"start":35,"end":39,"tag":"EMA"},{"start":75,"end":87,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"528977890176929792","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"527823159450669056","created_at":"2014-10-30T14:03:42.000Z","possibly_sensitive":false,"author_id":"633978297","referenced_tweets":[{"type":"replied_to","id":"527769233577771008"}],"text":"We've issued a revised #guideline to facilitate global development of #biosimilar medicines: http://t.co/CjPDiIUb6b @EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":116,"end":125,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/CjPDiIUb6b","expanded_url":"http://bit.ly/1yHUqT1","display_url":"bit.ly/1yHUqT1"}],"hashtags":[{"start":23,"end":33,"tag":"guideline"},{"start":70,"end":81,"tag":"biosimilar"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"527769233577771008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"527754455400611840","created_at":"2014-10-30T09:30:42.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News revises #guidelines on development of #biosimilars http://t.co/ywWEzhMR3C","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":61,"end":83,"url":"http://t.co/ywWEzhMR3C","expanded_url":"http://ow.ly/DwlYi","display_url":"ow.ly/DwlYi"}],"hashtags":[{"start":18,"end":29,"tag":"guidelines"},{"start":48,"end":60,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"527754455400611840","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"527753113126846464","created_at":"2014-10-30T09:25:22.000Z","possibly_sensitive":false,"author_id":"2459735132","referenced_tweets":{},"text":"@EMA_News Guido Rasi: nothing is more powerful than an idea whose time has come! Great speech! #HTA2014Rome http://t.co/wVjDrmHuuV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/wVjDrmHuuV","expanded_url":"https://twitter.com/Simone_EUnetHTA/status/527753113126846464/photo/1","display_url":"pic.twitter.com/wVjDrmHuuV"}],"hashtags":[{"start":95,"end":107,"tag":"HTA2014Rome"}],"annotations":[{"start":10,"end":19,"probability":0.9748,"type":"Person","normalized_text":"Guido Rasi"}],"cashtags":{}},"source":"iOS","conversation_id":"527753113126846464","attachments":{"media_keys":["3_527753112929705984"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"527748430677176320","created_at":"2014-10-30T09:06:45.000Z","possibly_sensitive":false,"author_id":"1851060500","referenced_tweets":{},"text":"@EMA_News has published revised guidelines on how to bring #biosimilars to market in the EU http://t.co/iTjWpDhop5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/iTjWpDhop5","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":59,"end":71,"tag":"biosimilars"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"527748430677176320","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"527428027345821696","created_at":"2014-10-29T11:53:35.000Z","possibly_sensitive":false,"author_id":"552617924","referenced_tweets":{},"text":"@EMA_News is looking at class waivers for PIPs that are \"not 100% appropriate\" http://t.co/ExowpEvHK5 #pharma #change","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/ExowpEvHK5","expanded_url":"http://bit.ly/1tL53p0","display_url":"bit.ly/1tL53p0"}],"hashtags":[{"start":102,"end":109,"tag":"pharma"},{"start":110,"end":117,"tag":"change"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"527428027345821696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"526771683684675584","created_at":"2014-10-27T16:25:30.000Z","possibly_sensitive":false,"author_id":"2801181403","referenced_tweets":[{"type":"replied_to","id":"526717209167806465"}],"text":"“@drharshvardhan @EMA_News: Last week we recommended authorisation of #Lynparza (#olaparib) for #ovarian #cancer: http://t.co/CjbJ2KjC6D”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":1,"end":16,"username":"drharshvardhan","id":"77732185"},{"start":17,"end":26,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/CjbJ2KjC6D","expanded_url":"http://bit.ly/1DHTHnE","display_url":"bit.ly/1DHTHnE"}],"hashtags":[{"start":70,"end":79,"tag":"Lynparza"},{"start":81,"end":90,"tag":"olaparib"},{"start":96,"end":104,"tag":"ovarian"},{"start":105,"end":112,"tag":"cancer"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"526717209167806465","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"526750580136763392","created_at":"2014-10-27T15:01:39.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News publishes new #Ebola microsite on its actions since the outbreak, including R&amp;D support for new treatments  http://t.co/kPxKLmHTZ8","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":122,"end":144,"url":"http://t.co/kPxKLmHTZ8","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000624.jsp&mid=WC0b01ac0580841e30","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":24,"end":30,"tag":"Ebola"}],"annotations":{},"cashtags":{}},"source":"iOS","conversation_id":"526750580136763392","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"pt","id":"526713718261170176","created_at":"2014-10-27T12:35:10.000Z","possibly_sensitive":false,"author_id":"2219915250","referenced_tweets":{},"text":"@EMA_News  \" está preparada para iniciar a avaliação dos tratamentos e vacinas para o #Ébola \" http://t.co/EPTsJpJyaD","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/EPTsJpJyaD","expanded_url":"http://ow.ly/DnNvF","display_url":"ow.ly/DnNvF"}],"hashtags":[{"start":86,"end":92,"tag":"Ébola"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"526713718261170176","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525701366430568448","created_at":"2014-10-24T17:32:27.000Z","possibly_sensitive":false,"author_id":"2795931064","referenced_tweets":[{"type":"replied_to","id":"524188031230943233"}],"text":"@EMA_News #Absent2032 is a story about a global pandemic, mandatory vaccines,1st Grade at Freedom Elementary http://t.co/2Nrl9PouCo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/2Nrl9PouCo","expanded_url":"http://Absent2032.com","display_url":"Absent2032.com","status":200,"unwound_url":"http://Absent2032.com"}],"hashtags":[{"start":10,"end":21,"tag":"Absent2032"}],"annotations":[{"start":90,"end":107,"probability":0.6122,"type":"Organization","normalized_text":"Freedom Elementary"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"524188031230943233","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"525696567937105920","created_at":"2014-10-24T17:13:23.000Z","possibly_sensitive":false,"author_id":"982666808","referenced_tweets":[{"type":"replied_to","id":"525684833000095744"}],"text":"@EMA_News True data?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"525684833000095744","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525608145646018560","created_at":"2014-10-24T11:22:01.000Z","possibly_sensitive":false,"author_id":"1851060500","referenced_tweets":{},"text":"@EMA_News The CHMP October meeting highlights are out! http://t.co/E7IqXmFNrU","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/E7IqXmFNrU","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002191.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"525608145646018560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525606573109166080","created_at":"2014-10-24T11:15:46.000Z","possibly_sensitive":false,"author_id":"594516236","referenced_tweets":{},"text":"@EMA_News backs 4 new drugs including Scenesse and Lynparza http://t.co/mfYc2vYdS7 #pharma #health","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":60,"end":82,"url":"http://t.co/mfYc2vYdS7","expanded_url":"http://bit.ly/241014PT","display_url":"bit.ly/241014PT"}],"hashtags":[{"start":83,"end":90,"tag":"pharma"},{"start":91,"end":98,"tag":"health"}],"annotations":[{"start":38,"end":45,"probability":0.3538,"type":"Person","normalized_text":"Scenesse"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"525606573109166080","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525570958850281472","created_at":"2014-10-24T08:54:15.000Z","possibly_sensitive":false,"author_id":"16947313","referenced_tweets":[{"type":"replied_to","id":"525570295730831360"}],"text":"RT “@EMA_News: 1 week to comment on draft functional spec to be audited for clinical trials EU portal and database: http://t.co/2qbTaeLIpv”","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/2qbTaeLIpv","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"525570295730831360","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525562118545113088","created_at":"2014-10-24T08:19:08.000Z","possibly_sensitive":false,"author_id":"85821578","referenced_tweets":{},"text":"@EMA_News Reflection Paper on API Starting Materials: \n\nhttp://t.co/ZjG9NnBZoz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/ZjG9NnBZoz","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500175228.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"525562118545113088","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"525184452126072832","created_at":"2014-10-23T07:18:25.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News sets up 'rolling review' process to assess #Ebola vaccines &amp; treatments as soon as data are made available http://t.co/GWqb8HTBDR","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":121,"end":143,"url":"http://t.co/GWqb8HTBDR","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002192.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":53,"end":59,"tag":"Ebola"}],"annotations":{},"cashtags":{}},"source":"iOS","conversation_id":"525184452126072832","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"de","id":"524246314583068674","created_at":"2014-10-20T17:10:36.000Z","possibly_sensitive":false,"author_id":"2233494522","referenced_tweets":[{"type":"replied_to","id":"524188031230943233"}],"text":"#Ebola - EU-#Arzneimittel-Behörde @EMA_News will Medikamententwicklung vorantreiben - Anreiz = \"Orphan Drug\"-Status http://t.co/405NqS1CXv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":34,"end":43,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/405NqS1CXv","expanded_url":"http://bit.ly/1wjBdWn","display_url":"bit.ly/1wjBdWn"}],"hashtags":[{"start":0,"end":6,"tag":"Ebola"},{"start":12,"end":25,"tag":"Arzneimittel"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"524188031230943233","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"524223130886500352","created_at":"2014-10-20T15:38:28.000Z","possibly_sensitive":false,"author_id":"1851060500","referenced_tweets":{},"text":"@EMA_News has just published the Agenda for this week's CHMP meeting http://t.co/EjLfrcDDry","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":69,"end":91,"url":"http://t.co/EjLfrcDDry","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Agenda/2014/10/WC500176187.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"524223130886500352","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"524149401271689216","created_at":"2014-10-20T10:45:30.000Z","possibly_sensitive":false,"author_id":"1244094438","referenced_tweets":{},"text":"@EMA_News to investigate reports that software issue may have affected accuracy of #clinicaltrials... http://t.co/DMM5E9VEjz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/DMM5E9VEjz","expanded_url":"http://fb.me/2L2ZocBWZ","display_url":"fb.me/2L2ZocBWZ"}],"hashtags":[{"start":83,"end":98,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"source":"Facebook","conversation_id":"524149401271689216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"524144201458798592","created_at":"2014-10-20T10:24:50.000Z","possibly_sensitive":false,"author_id":"2827925840","referenced_tweets":{},"text":"@EMA_News has launched a public consultation on draft rules of procedures for public hearings held by its PRAC","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"524144201458798592","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"523707859436331009","created_at":"2014-10-19T05:30:58.000Z","possibly_sensitive":false,"author_id":"2652738587","referenced_tweets":[{"type":"replied_to","id":"523074876224331776"}],"text":"RT \"@EMA_News  Two more weeks to comment on our reflection paper on classification of #advancedtherapy medicines: http://t.co/WwEKr36Je5  \"","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/WwEKr36Je5","expanded_url":"http://bit.ly/1tzbzQb","display_url":"bit.ly/1tzbzQb"}],"hashtags":[{"start":86,"end":102,"tag":"advancedtherapy"}],"annotations":{},"cashtags":{}},"source":"erased6663842_RN4PdmjiRB","conversation_id":"523074876224331776","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"523252722108489728","created_at":"2014-10-17T23:22:25.000Z","possibly_sensitive":false,"author_id":"214119379","referenced_tweets":{},"text":"@EMA_News about ebola http://t.co/bnc5pVcJnF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":22,"end":44,"url":"http://t.co/bnc5pVcJnF","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/09/news_detail_002176.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"523252722108489728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"523108597581246464","created_at":"2014-10-17T13:49:43.000Z","possibly_sensitive":false,"author_id":"545343465","referenced_tweets":{},"text":"@EMA_News published its 2013 report on interaction with patients, consumers, and healthcare professionals http://t.co/UzLXetgwGc","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/UzLXetgwGc","expanded_url":"http://bit.ly/1ughjJ2","display_url":"bit.ly/1ughjJ2"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"523108597581246464","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"523100138257260544","created_at":"2014-10-17T13:16:06.000Z","possibly_sensitive":false,"author_id":"2605730638","referenced_tweets":[{"type":"replied_to","id":"523070653461962752"}],"text":"“@EMA_News: Two more weeks to comment on EU clinical trials portal &amp; database: http://t.co/9AjAoSxXKn  #consultation” #HEPPP 4 #MarketAccess","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/9AjAoSxXKn","expanded_url":"http://bit.ly/1sYX7A6","display_url":"bit.ly/1sYX7A6"}],"hashtags":[{"start":107,"end":120,"tag":"consultation"},{"start":122,"end":128,"tag":"HEPPP"},{"start":131,"end":144,"tag":"MarketAccess"}],"annotations":[{"start":41,"end":42,"probability":0.4055,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"523070653461962752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"522407798194585602","created_at":"2014-10-15T15:24:59.000Z","possibly_sensitive":false,"author_id":"2830257207","referenced_tweets":{},"text":"@EMA_News You write that the new patient pilot is for drugs \"likely to be refused.\" Isn't that a de facto refusal in public prior to CHMP?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"522407798194585602","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"522005216770924544","created_at":"2014-10-14T12:45:16.000Z","possibly_sensitive":false,"author_id":"713848298","referenced_tweets":{},"text":"@EMA_News keeps Ariad’s #cancer drug on the market despite safety worries - http://t.co/v04o0AFVHm #pharma #regulations @PharmaNews","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":131,"username":"PharmaNews","id":"738922748123045888"}],"urls":[{"start":76,"end":98,"url":"http://t.co/v04o0AFVHm","expanded_url":"http://bit.ly/1ESrCLV","display_url":"bit.ly/1ESrCLV"}],"hashtags":[{"start":24,"end":31,"tag":"cancer"},{"start":99,"end":106,"tag":"pharma"},{"start":107,"end":119,"tag":"regulations"}],"annotations":[{"start":16,"end":20,"probability":0.4234,"type":"Person","normalized_text":"Ariad"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"522005216770924544","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520582464490971136","created_at":"2014-10-10T14:31:46.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News: #pharmacovig. comm. recommends further measures to minimise risk of blood vessel blockage with #Iclusig: http://t.co/wx8096oAEz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/wx8096oAEz","expanded_url":"http://bit.ly/1q7AGCR","display_url":"bit.ly/1q7AGCR"}],"hashtags":[{"start":11,"end":23,"tag":"pharmacovig"},{"start":106,"end":114,"tag":"Iclusig"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"520582464490971136","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520582288829317120","created_at":"2014-10-10T14:31:04.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News #Pharmacovig. committee review does not confirm increase in heart problems with #testosterone #medicines: http://t.co/6EBs8rEbtf","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/6EBs8rEbtf","expanded_url":"http://bit.ly/1vQWkzM","display_url":"bit.ly/1vQWkzM"}],"hashtags":[{"start":10,"end":22,"tag":"Pharmacovig"},{"start":90,"end":103,"tag":"testosterone"},{"start":104,"end":114,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"520582288829317120","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520582104300937216","created_at":"2014-10-10T14:30:20.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News #pharmacovigilance committee recommends strengthening restrictions on use of #valproate in women and girls: http://t.co/z3UmDL1E3r","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/z3UmDL1E3r","expanded_url":"http://bit.ly/10ZQpy1","display_url":"bit.ly/10ZQpy1"}],"hashtags":[{"start":10,"end":28,"tag":"pharmacovigilance"},{"start":87,"end":97,"tag":"valproate"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"520582104300937216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520552780143271936","created_at":"2014-10-10T12:33:48.000Z","possibly_sensitive":false,"author_id":"215336863","referenced_tweets":[{"type":"replied_to","id":"520547662211592192"}],"text":"Dear @EMA_News Thank you to PRAC and MHRA. VALPROATE CAUSES BIRTH DEFECTS in 30-40% of babies exposed in the womb. @MHRAgovuk @TUCNHS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":5,"end":14,"username":"EMA_News","id":"116716199"},{"start":115,"end":125,"username":"MHRAgovuk","id":"330993102"},{"start":126,"end":133,"username":"TUCNHS","id":"240674882"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"520547662211592192","attachments":{"media_keys":{}},"geo":{"place_id":"38d67cacb385e69d","coordinates":{"type":"Point","coordinates":[-1.1128,52.6276]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520533136053399552","created_at":"2014-10-10T11:15:45.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_news #PRAC recommends strengthening restrictions on the use of #valproate in women and girls #pharma http://t.co/v6xdXS9Cnr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/v6xdXS9Cnr","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Valproate_and_related_substances_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500175214.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":68,"end":78,"tag":"valproate"},{"start":98,"end":105,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Safari on iOS","conversation_id":"520533136053399552","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520532789276717056","created_at":"2014-10-10T11:14:22.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_news #PRAC recommends further measures to minimise risk of blood vessel blockage with #Iclusig #pharma http://t.co/SXjViZg8Ab","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/SXjViZg8Ab","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Iclusig_20/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500175212.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":91,"end":99,"tag":"Iclusig"},{"start":100,"end":107,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Safari on iOS","conversation_id":"520532789276717056","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520532562532642816","created_at":"2014-10-10T11:13:28.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_news PRAC review does not confirm increase in heart problems with testosterone medicines #pharma  http://t.co/5oJY2GA7AN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/5oJY2GA7AN","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Testosterone_31/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500175213.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":94,"end":101,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Safari on iOS","conversation_id":"520532562532642816","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520532089075425280","created_at":"2014-10-10T11:11:35.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News #PRAC recommends further measures to minimise risk of blood vessel blockage with #Iclusig #pharmacovigilance #pharma #biotech","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":91,"end":99,"tag":"Iclusig"},{"start":100,"end":118,"tag":"pharmacovigilance"},{"start":119,"end":126,"tag":"pharma"},{"start":127,"end":135,"tag":"biotech"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"520532089075425280","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520386132325199873","created_at":"2014-10-10T01:31:36.000Z","possibly_sensitive":false,"author_id":"1613140274","referenced_tweets":{},"text":"@EMA_News launches pilot to involve patients in benefit/discussions #patientcentric #PatientEngagement http://t.co/dDfz0SaUUB","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/dDfz0SaUUB","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/09/WC500173509.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":68,"end":83,"tag":"patientcentric"},{"start":84,"end":102,"tag":"PatientEngagement"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"520386132325199873","attachments":{"media_keys":{}},"geo":{"place_id":"a64cfaa1b1bfe4da","coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520283462142820353","created_at":"2014-10-09T18:43:38.000Z","possibly_sensitive":false,"author_id":"1223273226","referenced_tweets":[{"type":"replied_to","id":"520218512523268096"}],"text":"@EMA_News @URPLWMiPB Thanks but since this is just an MD in Liberia having alleged success with Lamivudine I dont expect him to contact EMA.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":[{"start":60,"end":66,"probability":0.9589,"type":"Place","normalized_text":"Liberia"},{"start":96,"end":105,"probability":0.6424,"type":"Person","normalized_text":"Lamivudine"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"520156358734516224","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520216733127561216","created_at":"2014-10-09T14:18:28.000Z","possibly_sensitive":false,"author_id":"2559531679","referenced_tweets":{},"text":"@EMA_News -we'll not know how transparent this policy is'til it has been used for some time- TJefferson http://t.co/WTIk2NNnUi @bengoldacre","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":139,"username":"bengoldacre","id":"6705042"}],"urls":[{"start":104,"end":126,"url":"http://t.co/WTIk2NNnUi","expanded_url":"http://ow.ly/Cv5m9","display_url":"ow.ly/Cv5m9"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"520216733127561216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520190775045660672","created_at":"2014-10-09T12:35:20.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News to publish #clinicalreports http://t.co/oI36ZQ8f0s","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":38,"end":60,"url":"http://t.co/oI36ZQ8f0s","expanded_url":"http://ow.ly/Cu6aS","display_url":"ow.ly/Cu6aS"}],"hashtags":[{"start":21,"end":37,"tag":"clinicalreports"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"520190775045660672","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"520173838819393537","created_at":"2014-10-09T11:28:02.000Z","possibly_sensitive":false,"author_id":"1223273226","referenced_tweets":[{"type":"replied_to","id":"520156358734516224"}],"text":"@EMA_News @URPLWMiPB what about Lamivudine anedoctal evidence of efficacy? Will EMA look into that?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"URPLWMiPB","id":"556679074"}],"urls":{},"hashtags":{},"annotations":[{"start":32,"end":41,"probability":0.5977,"type":"Person","normalized_text":"Lamivudine"}],"cashtags":{}},"source":"Twitter for Android","conversation_id":"520156358734516224","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519861232304939008","created_at":"2014-10-08T14:45:51.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News says SMEs are driving #innovation in #medicine development http://t.co/6LwnBn6x5g","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":69,"end":91,"url":"http://t.co/6LwnBn6x5g","expanded_url":"http://ow.ly/CeOGk","display_url":"ow.ly/CeOGk"}],"hashtags":[{"start":32,"end":43,"tag":"innovation"},{"start":47,"end":56,"tag":"medicine"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"519861232304939008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519828694714814464","created_at":"2014-10-08T12:36:33.000Z","possibly_sensitive":false,"author_id":"31353538","referenced_tweets":[{"type":"replied_to","id":"519827845456330752"}],"text":"Check out the @EMA_News comment on a draft inventory of pediatric therapeutic needs in #childhoodcancer: http://t.co/akst5vL65T","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":14,"end":23,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/akst5vL65T","expanded_url":"http://bit.ly/1nZn1CC","display_url":"bit.ly/1nZn1CC"}],"hashtags":[{"start":87,"end":103,"tag":"childhoodcancer"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"519827845456330752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519772189948514304","created_at":"2014-10-08T08:52:01.000Z","possibly_sensitive":false,"author_id":"1244094438","referenced_tweets":{},"text":"@EMA_News reduces #clinicaltrial secrecy\n@senseaboutsci #AllTrials... http://t.co/s6ZCRFBHVS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":41,"end":55,"username":"senseaboutsci","id":"45579282"}],"urls":[{"start":70,"end":92,"url":"http://t.co/s6ZCRFBHVS","expanded_url":"http://fb.me/1BmXu9cou","display_url":"fb.me/1BmXu9cou"}],"hashtags":[{"start":18,"end":32,"tag":"clinicaltrial"},{"start":56,"end":66,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Facebook","conversation_id":"519772189948514304","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"519540274414886913","created_at":"2014-10-07T17:30:28.000Z","possibly_sensitive":false,"author_id":"587728022","referenced_tweets":[{"type":"replied_to","id":"519436247736254464"}],"text":"più semplici da monitorare segnalazioni reazioni avverse per le #medicine nei paesi europei. Grazie a @EMA_News: http://t.co/jrpcHcAolM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":102,"end":111,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/jrpcHcAolM","expanded_url":"http://bit.ly/Z8Gbdg","display_url":"bit.ly/Z8Gbdg"}],"hashtags":[{"start":64,"end":73,"tag":"medicine"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"519436247736254464","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519533491545841665","created_at":"2014-10-07T17:03:31.000Z","possibly_sensitive":false,"author_id":"28824136","referenced_tweets":{},"text":"@EMA_News release of regulatory data—trust but verify http://t.co/ygDz15NC2G via @Shareaholic","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":81,"end":93,"username":"Shareaholic","id":"791635"}],"urls":[{"start":54,"end":76,"url":"http://t.co/ygDz15NC2G","expanded_url":"http://go.shr.lc/1vODhoC","display_url":"go.shr.lc/1vODhoC"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"519533491545841665","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519480925802221568","created_at":"2014-10-07T13:34:38.000Z","possibly_sensitive":false,"author_id":"1546974816","referenced_tweets":{},"text":"@EMA_News moving towards policy of #ClinicalTrials data transparency. Healthy debate between pros &amp; cons. http://t.co/q38lqpKOqn #pharma","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/q38lqpKOqn","expanded_url":"http://reut.rs/1vNfC7T","display_url":"reut.rs/1vNfC7T"}],"hashtags":[{"start":35,"end":50,"tag":"ClinicalTrials"},{"start":133,"end":140,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519480925802221568","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519429292644925440","created_at":"2014-10-07T10:09:28.000Z","possibly_sensitive":false,"author_id":"552617924","referenced_tweets":{},"text":"@EMA_News sees requests from #pharma for joint scientific advice with HTA bodies go from 1 in H1 2013 to 6 in H1 2014 http://t.co/PlqatEDxKz","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/PlqatEDxKz","expanded_url":"http://bit.ly/1vGg2go","display_url":"bit.ly/1vGg2go"}],"hashtags":[{"start":29,"end":36,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519429292644925440","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519428992131399680","created_at":"2014-10-07T10:08:16.000Z","possibly_sensitive":false,"author_id":"552617924","referenced_tweets":[{"type":"replied_to","id":"519101889708064768"}],"text":"@EMA_News Makes sense that scientific advice and protocol assistance requests keep going up if SA \"proven to increase MAA success rate\"","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519101889708064768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"519425720326844416","created_at":"2014-10-07T09:55:16.000Z","possibly_sensitive":false,"author_id":"1003782248","referenced_tweets":{},"text":"@EMA_News inicia piloto para incluir a #pacientes en evaluación del beneficio-riesgo de #medicamentos @AGPacientes http://t.co/gcLcACmAF4","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":102,"end":114,"username":"AGPacientes","id":"905430276"}],"urls":[{"start":115,"end":137,"url":"http://t.co/gcLcACmAF4","expanded_url":"http://www.elglobal.net/noticias-medicamento/2014-10-03/industria-farmaceutica/la-ema-inicia-un-piloto-para-incorporar-la-voz-de-los-pacientes-en-las-evaluaciones-del-chmp/pagina.aspx?idart=865116","display_url":"elglobal.net/noticias-medic…"}],"hashtags":[{"start":39,"end":49,"tag":"pacientes"},{"start":88,"end":101,"tag":"medicamentos"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519425720326844416","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519286343277764608","created_at":"2014-10-07T00:41:26.000Z","possibly_sensitive":false,"author_id":"232144061","referenced_tweets":[{"type":"replied_to","id":"519103548702064640"}],"text":"@EMA_News v useful...I've had to have cataract surgeries because of serif induced opacities and was wonder  how to report this.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"519103548702064640","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519206909526933505","created_at":"2014-10-06T19:25:48.000Z","possibly_sensitive":false,"author_id":"2789795314","referenced_tweets":{},"text":"@EMA_News Our fight to get quick aproval in Spain LUMACAFTOR+IVACAFTOR  CYSTICFIBROSIS.Time,days,can save life or die http://t.co/POImUWzEKZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/POImUWzEKZ","expanded_url":"http://aprobacioncurafq.blogspot.com.es/","display_url":"aprobacioncurafq.blogspot.com.es"}],"hashtags":{},"annotations":[{"start":44,"end":48,"probability":0.9935,"type":"Place","normalized_text":"Spain"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519206909526933505","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"519158810481786880","created_at":"2014-10-06T16:14:40.000Z","possibly_sensitive":false,"author_id":"449985670","referenced_tweets":{},"text":"@EMA_News  Folleto informativo para implicar al paciente en notificación de RAM.  http://t.co/UFglPdt06J","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/UFglPdt06J","expanded_url":"http://bit.ly/1BIs6jq","display_url":"bit.ly/1BIs6jq"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519158810481786880","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519149387269046272","created_at":"2014-10-06T15:37:13.000Z","possibly_sensitive":false,"author_id":"187453356","referenced_tweets":{},"text":"@EMA_News encourages patients to report suspected side effects http://t.co/LHL1OyYF2A @esmart_eu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":86,"end":96,"username":"esmart_eu","id":"2472092443"}],"urls":[{"start":63,"end":85,"url":"http://t.co/LHL1OyYF2A","expanded_url":"http://www.adrreports.eu","display_url":"adrreports.eu"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"519149387269046272","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519121928867442689","created_at":"2014-10-06T13:48:07.000Z","possibly_sensitive":false,"author_id":"28824136","referenced_tweets":{},"text":"@EMA_News hands victory to advocates of trial data sharing http://t.co/uulo7Vq85v via @taniarabes","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":59,"end":81,"url":"http://t.co/uulo7Vq85v","expanded_url":"http://news.sciencemag.org/europe/2014/10/e-u-medicines-agency-hands-victory-advocates-trial-data-sharing","display_url":"news.sciencemag.org/europe/2014/10…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"519121928867442689","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"519120391466668032","created_at":"2014-10-06T13:42:00.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News published a leaflet for #patients and #carers on how to report a suspected side effect with a #medicine: http://t.co/XNfYXOMFT7","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/XNfYXOMFT7","expanded_url":"http://bit.ly/1BIs6jq","display_url":"bit.ly/1BIs6jq"}],"hashtags":[{"start":34,"end":43,"tag":"patients"},{"start":48,"end":55,"tag":"carers"},{"start":104,"end":113,"tag":"medicine"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"519120391466668032","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"519087216728211456","created_at":"2014-10-06T11:30:11.000Z","possibly_sensitive":false,"author_id":"441940097","referenced_tweets":{},"text":"@EMA_News pubblicherà i resoconti delle sperimentazioni cliniche dal 1° gennaio 2015 #AIFA http://t.co/qCFX4aMe3J","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/qCFX4aMe3J","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-pubblicher%C3%A0-i-resoconti-delle-sperimentazioni-cliniche-dal-1%C2%B0-gennaio-2015","display_url":"agenziafarmaco.gov.it/it/content/ema…"}],"hashtags":[{"start":85,"end":90,"tag":"AIFA"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"519087216728211456","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518756625537314816","created_at":"2014-10-05T13:36:32.000Z","possibly_sensitive":false,"author_id":"2161796839","referenced_tweets":{},"text":"@EMA_News all Clinical data to be made public by 1st Jan 2015. Good news?  or is it opening Pandora's box?  http://t.co/LvkjY5m39H","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/LvkjY5m39H","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/10/WC500174767.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":[{"start":92,"end":98,"probability":0.617,"type":"Organization","normalized_text":"Pandora"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"518756625537314816","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518691589448024064","created_at":"2014-10-05T09:18:06.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News refuses change to mkting auth. for Vinflunine re ext. of indic. to add treatment of #breastcancer http://t.co/rSPYF7x7mz","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/rSPYF7x7mz","expanded_url":"http://ow.ly/Ci5cQ","display_url":"ow.ly/Ci5cQ"}],"hashtags":[{"start":94,"end":107,"tag":"breastcancer"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"518691589448024064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518485860325810176","created_at":"2014-10-04T19:40:36.000Z","possibly_sensitive":false,"author_id":"187453356","referenced_tweets":{},"text":"@EMA_News has decided to publish the clinical reports that underpin the decision-making on #medicines #opnhealth","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":91,"end":101,"tag":"medicines"},{"start":102,"end":112,"tag":"opnhealth"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"518485860325810176","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518415339336396800","created_at":"2014-10-04T15:00:23.000Z","possibly_sensitive":false,"author_id":"760144436","referenced_tweets":{},"text":"@EMA_news listened to us! They’ve made less difficult for researchers to do their jobs. #AllTrials http://t.co/Ww8KStNySK Still work to do!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/Ww8KStNySK","expanded_url":"http://bit.ly/1E5eFO","display_url":"bit.ly/1E5eFO"}],"hashtags":[{"start":88,"end":98,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"518415339336396800","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518145664610738176","created_at":"2014-10-03T21:08:47.000Z","possibly_sensitive":false,"author_id":"416095845","referenced_tweets":{},"text":"@EMA_News expands clinical data access but questions remain: http://t.co/thUpt7BZ8y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":61,"end":83,"url":"http://t.co/thUpt7BZ8y","expanded_url":"http://bit.ly/1xKOURN","display_url":"bit.ly/1xKOURN"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"518145664610738176","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518098349052801024","created_at":"2014-10-03T18:00:46.000Z","possibly_sensitive":false,"author_id":"187453356","referenced_tweets":{},"text":"@EMA_news removes some restrictions from its data sharing policy http://t.co/RwMXwY8VrP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":65,"end":87,"url":"http://t.co/RwMXwY8VrP","expanded_url":"http://www.alltrials.net/news/ema-removes-some-restrictions-from-its-data-sharing-policy/","display_url":"alltrials.net/news/ema-remov…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"518098349052801024","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518075321216548864","created_at":"2014-10-03T16:29:16.000Z","possibly_sensitive":false,"author_id":"1242034844","referenced_tweets":{},"text":"@EMA_news listened to us! They’ve made it easier for researchers to do their jobs. #reproducibleresearch #AllTrials http://t.co/tKaLSwMb6R","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/tKaLSwMb6R","expanded_url":"http://bit.ly/1E5eFO","display_url":"bit.ly/1E5eFO"}],"hashtags":[{"start":83,"end":104,"tag":"reproducibleresearch"},{"start":105,"end":115,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"518075321216548864","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518034116068245504","created_at":"2014-10-03T13:45:32.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News involve #patients in #assessment of #medicines http://t.co/8UnjpWq1MX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":57,"end":79,"url":"http://t.co/8UnjpWq1MX","expanded_url":"http://ow.ly/CeNPu","display_url":"ow.ly/CeNPu"}],"hashtags":[{"start":18,"end":27,"tag":"patients"},{"start":31,"end":42,"tag":"assessment"},{"start":46,"end":56,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"518034116068245504","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518030432001335296","created_at":"2014-10-03T13:30:54.000Z","possibly_sensitive":false,"author_id":"207525510","referenced_tweets":{},"text":"@EMA_News future policy on access to clinical reports should increase transparency &amp; trust. Good step-fw http://t.co/vqqRVeNKYK","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/vqqRVeNKYK","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/10/news_detail_002181.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"518030432001335296","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518025590944071680","created_at":"2014-10-03T13:11:39.000Z","possibly_sensitive":false,"author_id":"243015736","referenced_tweets":{},"text":"@EMA_News $AHZ:ASX pos P1 for herpes vax \"company's vaccine has the potential to open up a massive market that has not being tapped.\"","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":[{"start":10,"end":14,"tag":"AHZ"}]},"source":"Twitter Web Client","conversation_id":"518025590944071680","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"518024970828791808","created_at":"2014-10-03T13:09:12.000Z","possibly_sensitive":false,"author_id":"243015736","referenced_tweets":{},"text":"@EMA_News $AHZ:asx CardioCel® scaffold stem cell substrate for cell propagation and new tissue formation http://t.co/yybKeEWiYJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/yybKeEWiYJ","expanded_url":"http://www.ncbi.nlm.nih.gov/pubmed/25266083","display_url":"ncbi.nlm.nih.gov/pubmed/25266083"}],"hashtags":{},"annotations":{},"cashtags":[{"start":10,"end":14,"tag":"AHZ"}]},"source":"Twitter Web Client","conversation_id":"518024970828791808","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517983783312949248","created_at":"2014-10-03T10:25:32.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News removes on-screen restrictions from #clinicaltrials data sharing policy, but commercial confidentiality a big worry. #alltrials","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":46,"end":61,"tag":"clinicaltrials"},{"start":127,"end":137,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"517983783312949248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517971224526594048","created_at":"2014-10-03T09:35:38.000Z","possibly_sensitive":false,"author_id":"154544589","referenced_tweets":{},"text":"@EMA_News: landmark policy to take effect on 1/01/ 2015 on Publication of clinical reports #alltrials @bengoldacre http://t.co/ItSESmtMu1","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":102,"end":114,"username":"bengoldacre","id":"6705042"}],"urls":[{"start":115,"end":137,"url":"http://t.co/ItSESmtMu1","expanded_url":"http://bit.ly/1vB99OB","display_url":"bit.ly/1vB99OB"}],"hashtags":[{"start":91,"end":101,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"517971224526594048","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517966772654592000","created_at":"2014-10-03T09:17:56.000Z","possibly_sensitive":false,"author_id":"154544589","referenced_tweets":{},"text":"@EMA_News votes on trials #transparency. Here 3 problems:http://t.co/9D0AAaHYp3   #AllTrials #CT @bengoldacre","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":97,"end":109,"username":"bengoldacre","id":"6705042"}],"urls":[{"start":57,"end":79,"url":"http://t.co/9D0AAaHYp3","expanded_url":"http://bit.ly/1w4iQsl","display_url":"bit.ly/1w4iQsl"}],"hashtags":[{"start":26,"end":39,"tag":"transparency"},{"start":82,"end":92,"tag":"AllTrials"},{"start":93,"end":96,"tag":"CT"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"517966772654592000","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517956602616639488","created_at":"2014-10-03T08:37:31.000Z","possibly_sensitive":false,"author_id":"22911650","referenced_tweets":[{"type":"replied_to","id":"517954714395480064"}],"text":"@EMA_News how do you specify \"commercial use\"? what about all those EU SMEs that want to use this data in H2020 projects? \"commercial\"?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"517954714395480064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517939044287000576","created_at":"2014-10-03T07:27:45.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News #alltrials policy http://t.co/xzvVeBENsR : an important step fwd but a way too generous on what can be commercially confidential","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":28,"end":50,"url":"http://t.co/xzvVeBENsR","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"hashtags":[{"start":10,"end":20,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"517939044287000576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517786486427885568","created_at":"2014-10-02T21:21:33.000Z","possibly_sensitive":false,"author_id":"308356449","referenced_tweets":{},"text":"@EMA_News: EMA is going to publish clinical reports; landmark #Ctdata policy sets new standards for #transparency: http://t.co/Zc7IJUKExR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/Zc7IJUKExR","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"hashtags":[{"start":62,"end":69,"tag":"Ctdata"},{"start":100,"end":113,"tag":"transparency"}],"annotations":[{"start":11,"end":13,"probability":0.3107,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"517786486427885568","attachments":{"media_keys":{}},"geo":{"place_id":"c3a6437e1b1a726d","coordinates":{"type":"Point","coordinates":[6.1308,46.2251]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517738985477931008","created_at":"2014-10-02T18:12:47.000Z","possibly_sensitive":false,"author_id":"769373400","referenced_tweets":{},"text":"@EMA_News is going to publish clinical reports; landmark #Ctdata policy sets new standards for #transparency: http://t.co/TkYHZUn7i6","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/TkYHZUn7i6","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"hashtags":[{"start":57,"end":64,"tag":"Ctdata"},{"start":95,"end":108,"tag":"transparency"}],"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"517738985477931008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517726064509194240","created_at":"2014-10-02T17:21:27.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News adopted key #Ctdata publication policy today. Data to be open for anybody to look download print or save http://t.co/7spgLS1UbF","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/7spgLS1UbF","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"hashtags":[{"start":22,"end":29,"tag":"Ctdata"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"517726064509194240","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517723519145488384","created_at":"2014-10-02T17:11:20.000Z","possibly_sensitive":false,"author_id":"2830197740","referenced_tweets":[{"type":"replied_to","id":"517722125378260992"}],"text":"“@EMA_News: #CTdata policy: access to data builds trust in our work: http://t.co/1tn2gnf2di” let's hope for #transparency not abuse of data","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":69,"end":91,"url":"http://t.co/1tn2gnf2di","expanded_url":"http://bit.ly/1tkm5Vz","display_url":"bit.ly/1tkm5Vz"}],"hashtags":[{"start":12,"end":19,"tag":"CTdata"},{"start":108,"end":121,"tag":"transparency"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"517722125378260992","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517586631629750273","created_at":"2014-10-02T08:07:23.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News Board about to adopt a new policy on access to #alltrials. Will it live up to the expectations of patients, doctors &amp; researchers?","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":57,"end":67,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"517586631629750273","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"517578502208774145","created_at":"2014-10-02T07:35:05.000Z","possibly_sensitive":false,"author_id":"433349430","referenced_tweets":{},"text":"@EMA_News @bengoldacre Jake McGill Lynch RIP  dead Age 14 . #Prozac off label #anxiety. Will EMA step up re access to CT data? @EUombudsman","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"bengoldacre","id":"6705042"},{"start":127,"end":139,"username":"EUombudsman","id":"873777758"}],"urls":{},"hashtags":[{"start":60,"end":67,"tag":"Prozac"},{"start":78,"end":86,"tag":"anxiety"}],"annotations":[{"start":23,"end":39,"probability":0.6236,"type":"Person","normalized_text":"Jake McGill Lynch"}],"cashtags":{}},"source":"Twitter Web App","conversation_id":"517578502208774145","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"516948753321066496","created_at":"2014-09-30T13:52:41.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News to review experimental #medicines to support #treatment of #ebola http://t.co/duo9jx0Fqx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":76,"end":98,"url":"http://t.co/duo9jx0Fqx","expanded_url":"http://ow.ly/C4xFJ","display_url":"ow.ly/C4xFJ"}],"hashtags":[{"start":33,"end":43,"tag":"medicines"},{"start":55,"end":65,"tag":"treatment"},{"start":69,"end":75,"tag":"ebola"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"516948753321066496","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"516876560805421056","created_at":"2014-09-30T09:05:49.000Z","possibly_sensitive":false,"author_id":"14525315","referenced_tweets":{},"text":"@EMA_News I would be honoured if you would follow me back","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"516876560805421056","attachments":{"media_keys":{}},"geo":{"place_id":"60160252aeb7e3e5","coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"516805156118085633","created_at":"2014-09-30T04:22:05.000Z","possibly_sensitive":false,"author_id":"2250188430","referenced_tweets":{},"text":"@EMA_News recommends @GileadSciences ’s #Harvoni, a combination of #Sovaldi with #ledipasvir for chronic #HCV cure\nhttp://t.co/saX6CETXl4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":21,"end":36,"username":"GileadSciences","id":"309728693"}],"urls":[{"start":115,"end":137,"url":"http://t.co/saX6CETXl4","expanded_url":"http://www.bloomberg.com/news/2014-09-26/gilead-s-hepatitis-c-combination-wins-eu-agency-backing.html","display_url":"bloomberg.com/news/2014-09-2…"}],"hashtags":[{"start":40,"end":48,"tag":"Harvoni"},{"start":67,"end":75,"tag":"Sovaldi"},{"start":81,"end":92,"tag":"ledipasvir"},{"start":105,"end":109,"tag":"HCV"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"516805156118085633","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"516649351561871360","created_at":"2014-09-29T18:02:58.000Z","possibly_sensitive":false,"author_id":"77694098","referenced_tweets":[{"type":"replied_to","id":"516648722852478976"}],"text":"@EMA_News #Agenda #herbal #medicines #HMPC frankly I'm rather nettled by all this herbal medicine palaver. It may be sage but is it wise?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":17,"tag":"Agenda"},{"start":18,"end":25,"tag":"herbal"},{"start":26,"end":36,"tag":"medicines"},{"start":37,"end":42,"tag":"HMPC"}],"annotations":{},"cashtags":{}},"source":"Twitter for BlackBerry®","conversation_id":"516648722852478976","attachments":{"media_keys":{}},"geo":{"place_id":"ae6b7c4568a3e506","coordinates":{"type":"Point","coordinates":[6.0757,49.6192]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"516591595429576704","created_at":"2014-09-29T14:13:28.000Z","possibly_sensitive":false,"author_id":"2618269101","referenced_tweets":{},"text":"@EMA_News #CHMP pilot project involves people living with the #RareDisease #porphyria http://t.co/ldmlo2gPQ0\"","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/ldmlo2gPQ0","expanded_url":"http://ow.ly/C3HvM","display_url":"ow.ly/C3HvM"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":62,"end":74,"tag":"RareDisease"},{"start":75,"end":85,"tag":"porphyria"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"516591595429576704","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"515544439859986432","created_at":"2014-09-26T16:52:27.000Z","possibly_sensitive":false,"author_id":"2803457276","referenced_tweets":{},"text":"@EMA_News Solving Medication Non-compliance and Counterfeit Medicine with a Smartphone, pl RT\nhttps://t.co/hi4gksEwfF\nhttp://t.co/tx0j13wRCW","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":117,"url":"https://t.co/hi4gksEwfF","expanded_url":"https://www.youtube.com/watch?v=5yNBGXBSqLY","display_url":"youtube.com/watch?v=5yNBGX…"},{"start":118,"end":140,"url":"http://t.co/tx0j13wRCW","expanded_url":"http://www.intemed.net","display_url":"intemed.net"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"515544439859986432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"de","id":"515516712025075712","created_at":"2014-09-26T15:02:16.000Z","possibly_sensitive":false,"author_id":"2749316330","referenced_tweets":{},"text":"@EMA_News' CHMP recommends @GileadSciences' Harvoni (sofosbuvir/ledipasvir) for treatment of #hepatitisC #pharma http://t.co/2yhNG06X6X","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":27,"end":42,"username":"GileadSciences","id":"309728693"}],"urls":[{"start":113,"end":135,"url":"http://t.co/2yhNG06X6X","expanded_url":"http://tinyurl.com/pxfsmn9","display_url":"tinyurl.com/pxfsmn9"}],"hashtags":[{"start":93,"end":104,"tag":"hepatitisC"},{"start":105,"end":112,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"515516712025075712","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"515464702411800576","created_at":"2014-09-26T11:35:36.000Z","possibly_sensitive":false,"author_id":"193335215","referenced_tweets":[{"type":"replied_to","id":"515461018026532864"}],"text":"Hoping it works “@EMA_News: We're starting to review experimental #medicines for #Ebola to support treatment: http://t.co/CFh7cLxcTo”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":17,"end":26,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/CFh7cLxcTo","expanded_url":"http://bit.ly/1uti0UB","display_url":"bit.ly/1uti0UB"}],"hashtags":[{"start":66,"end":76,"tag":"medicines"},{"start":81,"end":87,"tag":"Ebola"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"515461018026532864","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"514751729179844608","created_at":"2014-09-24T12:22:30.000Z","possibly_sensitive":false,"author_id":"1227483301","referenced_tweets":{},"text":"@EMA_News #recruitment Agencia Europea del Medicamento: contratación #empleo http://t.co/vFp5gTg5E5 http://t.co/cxbKNPI7E9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":77,"end":99,"url":"http://t.co/vFp5gTg5E5","expanded_url":"http://eur-lex.europa.eu/legal-content/ES/TXT/?uri=OJ:C:2014:332A:TOC","display_url":"eur-lex.europa.eu/legal-content/…"},{"start":100,"end":122,"url":"http://t.co/cxbKNPI7E9","expanded_url":"https://twitter.com/EuropeDirectMur/status/514751729179844608/photo/1","display_url":"pic.twitter.com/cxbKNPI7E9"}],"hashtags":[{"start":10,"end":22,"tag":"recruitment"},{"start":69,"end":76,"tag":"empleo"}],"annotations":[{"start":23,"end":53,"probability":0.5574,"type":"Organization","normalized_text":"Agencia Europea del Medicamento"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"514751729179844608","attachments":{"media_keys":["3_514751728051179520"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"514082147418660865","created_at":"2014-09-22T16:01:49.000Z","possibly_sensitive":false,"author_id":"1049587548","referenced_tweets":{},"text":"@EMA_News: We welcome th revised #veterinary #medicines legislation from the @EU_Commission to support animal health: http://t.co/V5wAYzARV2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":77,"end":91,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":118,"end":140,"url":"http://t.co/V5wAYzARV2","expanded_url":"http://bit.ly/1rW8oBi","display_url":"bit.ly/1rW8oBi"}],"hashtags":[{"start":33,"end":44,"tag":"veterinary"},{"start":45,"end":55,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"514082147418660865","attachments":{"media_keys":{}},"geo":{"place_id":"0a063651d547b2b9","coordinates":{"type":"Point","coordinates":[73.7729,18.6523]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"512882865017982977","created_at":"2014-09-19T08:36:18.000Z","possibly_sensitive":false,"author_id":"2148565617","referenced_tweets":[{"type":"replied_to","id":"512882099159060480"}],"text":"@EMA_News Thank you for the swift reply!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"511451331165712384","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"512873730335600640","created_at":"2014-09-19T08:00:00.000Z","possibly_sensitive":false,"author_id":"2148565617","referenced_tweets":[{"type":"replied_to","id":"511451331165712384"}],"text":"@EMA_News Could you please tell us when the July PRAC minutes will be available?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"511451331165712384","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511911495127826434","created_at":"2014-09-16T16:16:25.000Z","possibly_sensitive":false,"author_id":"1366697215","referenced_tweets":{},"text":"@EMA_News  \"EPIGENomics and Health Care Policy: Challenges and Opportunities\"\nhttp://t.co/fBeMvJu2pH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":78,"end":100,"url":"http://t.co/fBeMvJu2pH","expanded_url":"http://www.semm.it/epigenconference2014/","display_url":"semm.it/epigenconferen…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"511911495127826434","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511905002315841536","created_at":"2014-09-16T15:50:37.000Z","possibly_sensitive":false,"author_id":"2615562036","referenced_tweets":{},"text":"@EMA_News \nguideline on  #pharmacovigilance inspections comes into effect for more info see http://t.co/UX1tZYpHMh","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/UX1tZYpHMh","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/09/WC500172403.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":25,"end":43,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"511905002315841536","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511839981221212160","created_at":"2014-09-16T11:32:15.000Z","possibly_sensitive":false,"author_id":"25107934","referenced_tweets":[{"type":"replied_to","id":"511831011798548480"}],"text":"RT @EMA_News: We've just published the #minutes from the August meeting of our #Paediatric Committee (PDCO): http://t.co/S4pu1gV4y4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/S4pu1gV4y4","expanded_url":"http://bit.ly/1uQChjx","display_url":"bit.ly/1uQChjx"}],"hashtags":[{"start":39,"end":47,"tag":"minutes"},{"start":79,"end":90,"tag":"Paediatric"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"511831011798548480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511528032277135360","created_at":"2014-09-15T14:52:41.000Z","possibly_sensitive":false,"author_id":"26476395","referenced_tweets":{},"text":"@EMA_News have published an FAQ guide to their adaptive licensing pilot project - take a look here http://t.co/OJ6euvMPyR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/OJ6euvMPyR","expanded_url":"http://bia.me/1q7xLZB","display_url":"bia.me/1q7xLZB"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"511528032277135360","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511291318040268802","created_at":"2014-09-14T23:12:04.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/eKNZ0F5pJC #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/eKNZ0F5pJC","expanded_url":"http://okt.to/xe20lJ","display_url":"okt.to/xe20lJ"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"511291318040268802","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"511185627996762112","created_at":"2014-09-14T16:12:05.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/OfacbW54IS #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/OfacbW54IS","expanded_url":"http://okt.to/WSD3Lg","display_url":"okt.to/WSD3Lg"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"511185627996762112","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510793038311215104","created_at":"2014-09-13T14:12:05.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/HaFKIo9pk9 #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/HaFKIo9pk9","expanded_url":"http://okt.to/BXP0PL","display_url":"okt.to/BXP0PL"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"510793038311215104","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510717541338329088","created_at":"2014-09-13T09:12:05.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/M8rdMYzU6w #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/M8rdMYzU6w","expanded_url":"http://okt.to/O6g1fT","display_url":"okt.to/O6g1fT"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"510717541338329088","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510445781384704000","created_at":"2014-09-12T15:12:12.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/5rHbate9mY #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/5rHbate9mY","expanded_url":"http://okt.to/p51uNN","display_url":"okt.to/p51uNN"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"510445781384704000","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510370249007710209","created_at":"2014-09-12T10:12:04.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/wgyNGmKKGl #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/wgyNGmKKGl","expanded_url":"http://okt.to/y9n9Cz","display_url":"okt.to/y9n9Cz"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"510370249007710209","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510173960164896768","created_at":"2014-09-11T21:12:05.000Z","possibly_sensitive":false,"author_id":"46546693","referenced_tweets":{},"text":"@EMA_News, NICE, EC News Roundup: @Allergan, @AlexionPharma, Innate Pharma, And More http://t.co/fByEnsZJCf #DrugApproval #OrphanDrug","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":59,"username":"AlexionPharma","id":"246664765"}],"urls":[{"start":85,"end":107,"url":"http://t.co/fByEnsZJCf","expanded_url":"http://okt.to/96UT49","display_url":"okt.to/96UT49"}],"hashtags":[{"start":108,"end":121,"tag":"DrugApproval"},{"start":122,"end":133,"tag":"OrphanDrug"}],"annotations":{},"cashtags":{}},"source":"Oktopost","conversation_id":"510173960164896768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"510008703962333185","created_at":"2014-09-11T10:15:25.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News publishes booklet on #EU #regulatory system for #medicines http://t.co/zkyt9SLRdu","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":69,"end":91,"url":"http://t.co/zkyt9SLRdu","expanded_url":"http://goo.gl/UGgnWU","display_url":"goo.gl/UGgnWU"}],"hashtags":[{"start":31,"end":34,"tag":"EU"},{"start":35,"end":46,"tag":"regulatory"},{"start":58,"end":68,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"510008703962333185","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"ru","id":"509208331488337920","created_at":"2014-09-09T05:15:01.000Z","possibly_sensitive":false,"author_id":"471899753","referenced_tweets":{},"text":"@EMA_News: EMA сообщает о выявлении фальсифицированного препарата Pegasys http://t.co/3TrKEWLsXH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":74,"end":96,"url":"http://t.co/3TrKEWLsXH","expanded_url":"http://bit.ly/1lQXqL7","display_url":"bit.ly/1lQXqL7"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"509208331488337920","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"508901164340215808","created_at":"2014-09-08T08:54:27.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News working with international medicines regulators to find solutions to develop new drugs to tackle #Ebola http://t.co/NnaeXHZYwl","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/NnaeXHZYwl","expanded_url":"http://goo.gl/kIQlqV","display_url":"goo.gl/kIQlqV"}],"hashtags":[{"start":107,"end":113,"tag":"Ebola"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"508901164340215808","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"507889243629555712","created_at":"2014-09-05T13:53:26.000Z","possibly_sensitive":false,"author_id":"102690943","referenced_tweets":{},"text":"@EMA_News raccomanda di modificare info su #farmaci contro l’#insonnia,relative a effetti di ridotta capacità di guida e prontezza mentale","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":43,"end":51,"tag":"farmaci"},{"start":61,"end":70,"tag":"insonnia"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507889243629555712","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"507889124494573568","created_at":"2014-09-05T13:52:58.000Z","possibly_sensitive":false,"author_id":"102690943","referenced_tweets":{},"text":"@EMA_News raccomanda più attenzione a chi usa farmaci contro l’#insonnia #equivalenti http://t.co/eS7RE7n0EY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/eS7RE7n0EY","expanded_url":"http://bit.ly/1o68lM3","display_url":"bit.ly/1o68lM3"}],"hashtags":[{"start":63,"end":72,"tag":"insonnia"},{"start":73,"end":85,"tag":"equivalenti"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507889124494573568","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"507787810015686656","created_at":"2014-09-05T07:10:22.000Z","possibly_sensitive":false,"author_id":"914462377","referenced_tweets":{},"text":"@EMA_News publica el EPAR de #Translarna (ataluren), un medicamento para la distrofia muscular de #Duchenne : http://t.co/EUXt3h8DIV","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/EUXt3h8DIV","expanded_url":"http://bit.ly/1nxVQsK","display_url":"bit.ly/1nxVQsK"}],"hashtags":[{"start":29,"end":40,"tag":"Translarna"},{"start":98,"end":107,"tag":"Duchenne"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507787810015686656","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"507786730624131072","created_at":"2014-09-05T07:06:05.000Z","possibly_sensitive":false,"author_id":"914462377","referenced_tweets":{},"text":"@EMA_News publica el EPAR de #Translarna, un #medicamento para la distrofia muscular de #Duchenne : http://t.co/EUXt3h8DIV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":100,"end":122,"url":"http://t.co/EUXt3h8DIV","expanded_url":"http://bit.ly/1nxVQsK","display_url":"bit.ly/1nxVQsK"}],"hashtags":[{"start":29,"end":40,"tag":"Translarna"},{"start":45,"end":57,"tag":"medicamento"},{"start":88,"end":97,"tag":"Duchenne"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507786730624131072","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"507588082846027777","created_at":"2014-09-04T17:56:44.000Z","possibly_sensitive":false,"author_id":"236935864","referenced_tweets":[{"type":"replied_to","id":"507580415532879872"}],"text":"@EMA_News Thank you for your reply , we are waiting for treatments for patients that don't have the nonsense mutation #exon51","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":118,"end":125,"tag":"exon51"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"507558741429202945","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"507577113046556673","created_at":"2014-09-04T17:13:08.000Z","possibly_sensitive":false,"author_id":"236935864","referenced_tweets":[{"type":"replied_to","id":"507558741429202945"}],"text":"@EMA_News how about access to medicines for Duchenne","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":44,"end":51,"probability":0.2721,"type":"Person","normalized_text":"Duchenne"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"507558741429202945","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"507173913240285185","created_at":"2014-09-03T14:30:58.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News updates EU #PSUR procedural guidance http://t.co/HqIdxIlUaP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":47,"end":69,"url":"http://t.co/HqIdxIlUaP","expanded_url":"http://goo.gl/7dYosV","display_url":"goo.gl/7dYosV"}],"hashtags":[{"start":21,"end":26,"tag":"PSUR"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"507173913240285185","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"507136944485445633","created_at":"2014-09-03T12:04:04.000Z","possibly_sensitive":false,"author_id":"199283172","referenced_tweets":{},"text":"@EMA_News Full aprueba it aprobación para la venta de los del appetite suppressants con amphetamines \nhttp://t.co/GN8ae7P3XJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/GN8ae7P3XJ","expanded_url":"http://www12.senado.gov.br/noticias/materias/2014/09/02/plenario-aprova-liberacao-da-venda-de-inibidores-de-apetite-com-anfetaminas","display_url":"www12.senado.gov.br/noticias/mater…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507136944485445633","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"507133919943479296","created_at":"2014-09-03T11:52:03.000Z","possibly_sensitive":false,"author_id":"199283172","referenced_tweets":{},"text":"@EMA_News Pleno aprueba la aprobación para la venta de los supresores del apetito con anfetaminas\nhttp://t.co/GN8ae7P3XJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/GN8ae7P3XJ","expanded_url":"http://www12.senado.gov.br/noticias/materias/2014/09/02/plenario-aprova-liberacao-da-venda-de-inibidores-de-apetite-com-anfetaminas","display_url":"www12.senado.gov.br/noticias/mater…","status":200,"unwound_url":"https://www12.senado.leg.br/noticias/materias/2014/09/02/plenario-aprova-liberacao-da-venda-de-inibidores-de-apetite-com-anfetaminas"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507133919943479296","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"507132195551866880","created_at":"2014-09-03T11:45:12.000Z","possibly_sensitive":false,"author_id":"199283172","referenced_tweets":{},"text":"@EMA_News Plenary approves approval for selling appetite suppressants with amphetamines\nhttp://t.co/GN8ae7P3XJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/GN8ae7P3XJ","expanded_url":"http://www12.senado.gov.br/noticias/materias/2014/09/02/plenario-aprova-liberacao-da-venda-de-inibidores-de-apetite-com-anfetaminas","display_url":"www12.senado.gov.br/noticias/mater…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"507132195551866880","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"506741786312998913","created_at":"2014-09-02T09:53:51.000Z","possibly_sensitive":false,"author_id":"2354558196","referenced_tweets":{},"text":"@EMA_News \nBarcelona: network on Primary Care to the EMA \n\nIsabelle Moulon (EMA) and Walter Marrocco (FIMMG) at http://t.co/lgNNdyQe7Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/lgNNdyQe7Z","expanded_url":"https://twitter.com/fimmgnotizie/status/506741786312998913/photo/1","display_url":"pic.twitter.com/lgNNdyQe7Z"},{"start":112,"end":134,"url":"http://t.co/lgNNdyQe7Z","expanded_url":"https://twitter.com/fimmgnotizie/status/506741786312998913/photo/1","display_url":"pic.twitter.com/lgNNdyQe7Z"},{"start":112,"end":134,"url":"http://t.co/lgNNdyQe7Z","expanded_url":"https://twitter.com/fimmgnotizie/status/506741786312998913/photo/1","display_url":"pic.twitter.com/lgNNdyQe7Z"}],"hashtags":{},"annotations":[{"start":59,"end":73,"probability":0.9759,"type":"Person","normalized_text":"Isabelle Moulon"},{"start":85,"end":99,"probability":0.9759,"type":"Person","normalized_text":"Walter Marrocco"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"506741786312998913","attachments":{"media_keys":["3_506740998366851072","3_506740990842257408","3_506740990204735489"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"506738445927346176","created_at":"2014-09-02T09:40:34.000Z","possibly_sensitive":false,"author_id":"2354558196","referenced_tweets":{},"text":"@EMA_News Isabelle Moulon and Walter Marrocco:\nNetwork on PC to the EMA http://t.co/R2K63vgoPi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":72,"end":94,"url":"http://t.co/R2K63vgoPi","expanded_url":"https://twitter.com/fimmgnotizie/status/506738445927346176/photo/1","display_url":"pic.twitter.com/R2K63vgoPi"}],"hashtags":{},"annotations":[{"start":10,"end":24,"probability":0.9834,"type":"Person","normalized_text":"Isabelle Moulon"},{"start":30,"end":44,"probability":0.9787,"type":"Person","normalized_text":"Walter Marrocco"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"506738445927346176","attachments":{"media_keys":["3_506738442806779904"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"504607498608082945","created_at":"2014-08-27T12:32:57.000Z","possibly_sensitive":false,"author_id":"19642657","referenced_tweets":{},"text":"@EMA_News publishes booklet on #European regulatory system for #medicines http://t.co/nePkWxxOWt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":74,"end":96,"url":"http://t.co/nePkWxxOWt","expanded_url":"http://bit.ly/1qvDdKh","display_url":"bit.ly/1qvDdKh"}],"hashtags":[{"start":31,"end":40,"tag":"European"},{"start":63,"end":73,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"504607498608082945","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"fr","id":"502392543775305728","created_at":"2014-08-21T09:51:31.000Z","possibly_sensitive":false,"author_id":"1339508364","referenced_tweets":{},"text":"@EMA_News: les restrictions d'utilisation de la #bromocriptine dans l'inhibition de la #lactation sont approuvées http://t.co/fizYbYL4VK","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":114,"end":136,"url":"http://t.co/fizYbYL4VK","expanded_url":"http://bit.ly/VG14eo","display_url":"bit.ly/VG14eo"}],"hashtags":[{"start":48,"end":62,"tag":"bromocriptine"},{"start":87,"end":97,"tag":"lactation"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"502392543775305728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"502386425544052739","created_at":"2014-08-21T09:27:12.000Z","possibly_sensitive":false,"author_id":"134450541","referenced_tweets":{},"text":"@EMA_News #pharmacovigilance #Interferon what’s about communication about  #SEP #and thrombotic microangiopathy? Info on BfArM website?","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":28,"tag":"pharmacovigilance"},{"start":29,"end":40,"tag":"Interferon"},{"start":75,"end":79,"tag":"SEP"},{"start":80,"end":84,"tag":"and"}],"annotations":[{"start":121,"end":125,"probability":0.4378,"type":"Organization","normalized_text":"BfArM"}],"cashtags":{}},"source":"TweetDeck","conversation_id":"502386425544052739","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"500310859223404544","created_at":"2014-08-15T15:59:38.000Z","possibly_sensitive":false,"author_id":"1606025952","referenced_tweets":{},"text":"@EMA_News Thanks for all the RTs!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"500310859223404544","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"498896506574090240","created_at":"2014-08-11T18:19:30.000Z","possibly_sensitive":false,"author_id":"534807798","referenced_tweets":{},"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"498896506574090240","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"498787637004861440","created_at":"2014-08-11T11:06:54.000Z","possibly_sensitive":false,"author_id":"135868803","referenced_tweets":{},"text":"@EMA_News proposal to vet drug research that uses its data is “outdated,” say critics (eg @bengoldacre) - BMJ http://t.co/rbfH16Zpki #NHS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":90,"end":102,"username":"bengoldacre","id":"6705042"}],"urls":[{"start":110,"end":132,"url":"http://t.co/rbfH16Zpki","expanded_url":"http://buff.ly/1oWu4JW","display_url":"buff.ly/1oWu4JW"}],"hashtags":[{"start":133,"end":137,"tag":"NHS"}],"annotations":{},"cashtags":{}},"source":"Buffer","conversation_id":"498787637004861440","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"497779706687926272","created_at":"2014-08-08T16:21:45.000Z","possibly_sensitive":false,"author_id":"514653528","referenced_tweets":{},"text":"@EMA_News if there are flawed analyses or overinterpretation of risk signals, let it be matter for public debate not censorship #AllTrials","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":128,"end":138,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"497779706687926272","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"497758487049302016","created_at":"2014-08-08T14:57:25.000Z","possibly_sensitive":false,"author_id":"357492014","referenced_tweets":[{"type":"replied_to","id":"497743841928417281"}],"text":"Thanks @EMA_News I'll take a look, and thanks for suggestion @CDeRede! #e4pMMC","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":7,"end":16,"username":"EMA_News","id":"116716199"},{"start":61,"end":69,"username":"CDeRede","id":"2254792730"}],"urls":{},"hashtags":[{"start":71,"end":78,"tag":"e4pMMC"}],"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"497714456127107072","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"497748807262543873","created_at":"2014-08-08T14:18:58.000Z","possibly_sensitive":false,"author_id":"16503906","referenced_tweets":[{"type":"replied_to","id":"497743841928417281"}],"text":"@EMA_News many thanks! Nice to see the EMA interacting through multiple channels!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"497714456127107072","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"497672615679770624","created_at":"2014-08-08T09:16:12.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News updates #Eudravigilance access policy http://t.co/RaowdHnEuE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":48,"end":70,"url":"http://t.co/RaowdHnEuE","expanded_url":"http://goo.gl/eCKbS6","display_url":"goo.gl/eCKbS6"}],"hashtags":[{"start":18,"end":33,"tag":"Eudravigilance"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"497672615679770624","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"496679410805002240","created_at":"2014-08-05T15:29:34.000Z","possibly_sensitive":false,"author_id":"1894504674","referenced_tweets":{},"text":"@EMA_News publica un borrador de guía para la investigación con inmunoglobulina humana intravenosa http://t.co/rLcd1QmPzH\"","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/rLcd1QmPzH","expanded_url":"http://bit.ly/UQeunm","display_url":"bit.ly/UQeunm"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"496679410805002240","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"495169038440361984","created_at":"2014-08-01T11:27:53.000Z","possibly_sensitive":false,"author_id":"31353538","referenced_tweets":[{"type":"replied_to","id":"495149832072617986"}],"text":"MT @EMA_News: #EMA publishes evaluation of #paediatric investigation plan http://t.co/J5m6SfdgzW #PIPs #pediatrics","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":74,"end":96,"url":"http://t.co/J5m6SfdgzW","expanded_url":"http://bit.ly/1lg2KSr","display_url":"bit.ly/1lg2KSr"}],"hashtags":[{"start":14,"end":18,"tag":"EMA"},{"start":43,"end":54,"tag":"paediatric"},{"start":97,"end":102,"tag":"PIPs"},{"start":103,"end":114,"tag":"pediatrics"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"495149832072617986","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494910665900175361","created_at":"2014-07-31T18:21:12.000Z","possibly_sensitive":false,"author_id":"2652738587","referenced_tweets":{},"text":"@EMA_news #EMA publishes first public summaries of Paediatric Committee evaluations of paediatric investigation plans","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":14,"tag":"EMA"}],"annotations":[{"start":51,"end":70,"probability":0.7704,"type":"Organization","normalized_text":"Paediatric Committee"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"494910665900175361","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494866169724030976","created_at":"2014-07-31T15:24:23.000Z","possibly_sensitive":false,"author_id":"25107934","referenced_tweets":[{"type":"replied_to","id":"494801533541031937"}],"text":"RT @EMA_News: We've published the assessment report for #Plegridy, a #medicine for #multiplesclerosis: http://t.co/GbyAqmlCgt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/GbyAqmlCgt","expanded_url":"http://bit.ly/1zyGefS","display_url":"bit.ly/1zyGefS"}],"hashtags":[{"start":56,"end":65,"tag":"Plegridy"},{"start":69,"end":78,"tag":"medicine"},{"start":83,"end":101,"tag":"multiplesclerosis"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"494801533541031937","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494864495391412224","created_at":"2014-07-31T15:17:44.000Z","possibly_sensitive":false,"author_id":"25107934","referenced_tweets":[{"type":"replied_to","id":"494837382769033216"}],"text":"RT @EMA_News: We've published the second module of our draft #guidance on the development of #influenza #vaccines: http://t.co/llYE9OLxL1","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/llYE9OLxL1","expanded_url":"http://bit.ly/1u3jmSs","display_url":"bit.ly/1u3jmSs"}],"hashtags":[{"start":61,"end":70,"tag":"guidance"},{"start":93,"end":103,"tag":"influenza"},{"start":104,"end":113,"tag":"vaccines"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"494837382769033216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494858460065193985","created_at":"2014-07-31T14:53:45.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News recommends ext. of indications for denosumab: treatmt of patients w/ giant cell tumour of bone http://t.co/rjTpYdfH7N","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":105,"end":127,"url":"http://t.co/rjTpYdfH7N","expanded_url":"http://ow.ly/zNptg","display_url":"ow.ly/zNptg"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"494858460065193985","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494841090693152768","created_at":"2014-07-31T13:44:44.000Z","possibly_sensitive":false,"author_id":"1617240518","referenced_tweets":{},"text":"@EMA_News recommends approval of 2 new treatment options for rare cancers of the blood http://t.co/RxaTM6hOG5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":87,"end":109,"url":"http://t.co/RxaTM6hOG5","expanded_url":"http://goo.gl/GHS9l5","display_url":"goo.gl/GHS9l5"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"494841090693152768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"494759568585805824","created_at":"2014-07-31T08:20:48.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News #PRAC rules for public hearings open to comment http://t.co/DbJjplgp0w","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":58,"end":80,"url":"http://t.co/DbJjplgp0w","expanded_url":"http://goo.gl/4bVmsN","display_url":"goo.gl/4bVmsN"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"494759568585805824","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"493766665977737216","created_at":"2014-07-28T14:35:21.000Z","possibly_sensitive":false,"author_id":"539894768","referenced_tweets":{},"text":"@EMA_News Here’s why regulators should support multi-arm trials, to #getresultsfaster http://t.co/uay4uTxsAM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/uay4uTxsAM","expanded_url":"http://bit.ly/multiarm","display_url":"bit.ly/multiarm"}],"hashtags":[{"start":68,"end":85,"tag":"getresultsfaster"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"493766665977737216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"493653314928517120","created_at":"2014-07-28T07:04:56.000Z","possibly_sensitive":false,"author_id":"19642657","referenced_tweets":{},"text":"@EMA_News uses #regulatory tools to facilitate #patient access to #innovative #medicines http://t.co/UgKELJaqLY #WorldHepatitisDay","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/UgKELJaqLY","expanded_url":"http://bit.ly/1rKbM1l","display_url":"bit.ly/1rKbM1l"}],"hashtags":[{"start":15,"end":26,"tag":"regulatory"},{"start":47,"end":55,"tag":"patient"},{"start":66,"end":77,"tag":"innovative"},{"start":78,"end":88,"tag":"medicines"},{"start":112,"end":130,"tag":"WorldHepatitisDay"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"493653314928517120","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492641052625743872","created_at":"2014-07-25T12:02:34.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News #CHMP recommends EU OK of @JanssenUK Imbruvica (ibrutinib) &amp; @GileadSciences Zydelig (idelalisib) to treat certain #CLL patients","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":36,"end":46,"username":"JanssenUK","id":"104573125"},{"start":75,"end":90,"username":"GileadSciences","id":"309728693"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":129,"end":133,"tag":"CLL"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"492641052625743872","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492637585752489984","created_at":"2014-07-25T11:48:47.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News #CHMP recommends EU marketing authorisation for @JanssenUK @JNJCares #Imbruvica (ibrutinib) for blood #cancer #MCL &amp; #CLL #pharma","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":58,"end":68,"username":"JanssenUK","id":"104573125"},{"start":69,"end":78,"username":"JNJCares","id":"138845026"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":79,"end":89,"tag":"Imbruvica"},{"start":112,"end":119,"tag":"cancer"},{"start":120,"end":124,"tag":"MCL"},{"start":131,"end":135,"tag":"CLL"},{"start":136,"end":143,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"492637585752489984","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492630548809252864","created_at":"2014-07-25T11:20:50.000Z","possibly_sensitive":false,"author_id":"594516236","referenced_tweets":{},"text":"@EMA_News backs 5 new meds, inc Imbruvica, Zydelig and Xultophy (nice name...) http://t.co/3GJ7t7nqFE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/3GJ7t7nqFE","expanded_url":"http://bit.ly/1nG7tlS","display_url":"bit.ly/1nG7tlS"}],"hashtags":{},"annotations":[{"start":32,"end":40,"probability":0.5233,"type":"Person","normalized_text":"Imbruvica"},{"start":43,"end":49,"probability":0.4793,"type":"Person","normalized_text":"Zydelig"},{"start":55,"end":62,"probability":0.3522,"type":"Person","normalized_text":"Xultophy"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"492630548809252864","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492593352584732672","created_at":"2014-07-25T08:53:01.000Z","possibly_sensitive":false,"author_id":"228895521","referenced_tweets":[{"type":"replied_to","id":"492591772338782208"}],"text":"A decision based on almost no evidence, and that may ultimately cause harm to people who are prescribed methadone/OST  @EMA_News","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":119,"end":128,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"492591772338782208","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"nl","id":"492328371146477568","created_at":"2014-07-24T15:20:05.000Z","possibly_sensitive":false,"author_id":"210934369","referenced_tweets":[{"type":"replied_to","id":"492265745049329664"}],"text":"Belangrijk nieuws! “@EMA_News: LNG &amp; ULI remain suitable emergency contraceptives regardless of weight http://t.co/wYVeKJgFqY #medicine”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":20,"end":29,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/wYVeKJgFqY","expanded_url":"http://bit.ly/1njSTiJ","display_url":"bit.ly/1njSTiJ"}],"hashtags":[{"start":130,"end":139,"tag":"medicine"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"492265745049329664","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492303512273833984","created_at":"2014-07-24T13:41:18.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":[{"type":"replied_to","id":"492292556274036736"}],"text":"@EMA_News: #Martindale methadone ban http://t.co/b5gHoxzgGl could have wider impact on #pharma  - read my @scripnews article to see why.....","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":37,"end":59,"url":"http://t.co/b5gHoxzgGl","expanded_url":"http://bit.ly/WJhXpp","display_url":"bit.ly/WJhXpp"}],"hashtags":[{"start":11,"end":22,"tag":"Martindale"},{"start":87,"end":94,"tag":"pharma"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"492292556274036736","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492287577622589441","created_at":"2014-07-24T12:37:59.000Z","possibly_sensitive":false,"author_id":"20170584","referenced_tweets":{},"text":"@EMA_News Hepatitis causes more deaths than HIV/AIDS. Greater awareness desperately needed! Please sign Thunderclap http://t.co/UKJ7GFUdQo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/UKJ7GFUdQo","expanded_url":"http://goo.gl/cu9QZH","display_url":"goo.gl/cu9QZH"}],"hashtags":{},"annotations":[{"start":44,"end":46,"probability":0.598,"type":"Other","normalized_text":"HIV"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"492287577622589441","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492231317917270016","created_at":"2014-07-24T08:54:26.000Z","possibly_sensitive":false,"author_id":"594078260","referenced_tweets":{},"text":"@EMA_News Check out Merck lie to patients.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"492231317917270016","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"492217314444840960","created_at":"2014-07-24T07:58:47.000Z","possibly_sensitive":false,"author_id":"16947313","referenced_tweets":[{"type":"replied_to","id":"492216489802727425"}],"text":"MT“@EMA_News: 1 more week to comment on our guideline: #subgroup analyses in #clinicaltrials http://t.co/p3Nw8puoc2” http://t.co/0857nj27Mg","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/p3Nw8puoc2","expanded_url":"http://bit.ly/1lwSNEU","display_url":"bit.ly/1lwSNEU"},{"start":117,"end":139,"url":"http://t.co/0857nj27Mg","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500160523.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":55,"end":64,"tag":"subgroup"},{"start":77,"end":92,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"492216489802727425","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"491822699908325377","created_at":"2014-07-23T05:50:43.000Z","possibly_sensitive":false,"author_id":"633978297","referenced_tweets":[{"type":"replied_to","id":"491625423198240768"}],"text":"Check the agenda of this week's human #medicines committee (#CHMP): http://t.co/tZNIc1R3NC @EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":91,"end":100,"username":"EMA_News","id":"116716199"}],"urls":[{"start":68,"end":90,"url":"http://t.co/tZNIc1R3NC","expanded_url":"http://bit.ly/1jSWVin","display_url":"bit.ly/1jSWVin"}],"hashtags":[{"start":38,"end":48,"tag":"medicines"},{"start":60,"end":65,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"491625423198240768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"491149387234418688","created_at":"2014-07-21T09:15:13.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News details the agency's recommendations for drug-marketing authorizations for the first half of 2014. http://t.co/zjCBnG1Ie8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/zjCBnG1Ie8","expanded_url":"http://bit.ly/1raQz09","display_url":"bit.ly/1raQz09"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"491149387234418688","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"491130719612436480","created_at":"2014-07-21T08:01:02.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Recommends 39 Drugs in First Half of 2014. http://t.co/CfmntMItod","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/CfmntMItod","expanded_url":"http://bit.ly/1jI0Dvp","display_url":"bit.ly/1jI0Dvp"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"491130719612436480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"490405882405326848","created_at":"2014-07-19T08:00:48.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Recommends 39 Drugs in First Half of 2014. http://t.co/CcB3V7pBJe","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/CcB3V7pBJe","expanded_url":"http://bit.ly/1raQz09","display_url":"bit.ly/1raQz09"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"490405882405326848","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"490266059707269120","created_at":"2014-07-18T22:45:12.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Recommends 39 Drugs in First Half of 2014. http://t.co/CfmntMItod","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/CfmntMItod","expanded_url":"http://bit.ly/1jI0Dvp","display_url":"bit.ly/1jI0Dvp"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"490266059707269120","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"490092108473057280","created_at":"2014-07-18T11:13:58.000Z","possibly_sensitive":false,"author_id":"2568609577","referenced_tweets":[{"type":"replied_to","id":"490087159752589315"}],"text":"@EMA_News Warning of drugs w most horrible side effects like Metoclopramide should be written on drug box saves lives http://t.co/72REus8cVJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/72REus8cVJ","expanded_url":"http://fatalhospitalerrors.blogspot.com","display_url":"fatalhospitalerrors.blogspot.com"}],"hashtags":{},"annotations":[{"start":61,"end":74,"probability":0.4428,"type":"Person","normalized_text":"Metoclopramide"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"490087159752589315","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"489771196779884544","created_at":"2014-07-17T13:58:47.000Z","possibly_sensitive":false,"author_id":"2443530930","referenced_tweets":[{"type":"replied_to","id":"489764670925180928"}],"text":"@EMA_News @Tweet_Ha T sorry,  ANSM is not planning to publish english version of these documents http://t.co/7oXPb4zciP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"Tweet_Ha","id":"254489074"}],"urls":[{"start":97,"end":119,"url":"http://t.co/7oXPb4zciP","expanded_url":"http://ow.ly/zgFOr","display_url":"ow.ly/zgFOr"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"489757897337741313","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"489758293019992064","created_at":"2014-07-17T13:07:30.000Z","possibly_sensitive":false,"author_id":"254489074","referenced_tweets":[{"type":"replied_to","id":"489757897337741313"}],"text":"@EMA_News @ansm how can I get English version of it? \nThanks","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":15,"username":"ansm","id":"2443530930"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Tweetbot for iΟS","conversation_id":"489757897337741313","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"489507466028515328","created_at":"2014-07-16T20:30:49.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News details the agency's recommendations for drug-marketing authorizations for the first half of 2014. http://t.co/CcB3V7pBJe","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/CcB3V7pBJe","expanded_url":"http://bit.ly/1raQz09","display_url":"bit.ly/1raQz09"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"489507466028515328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"489405409053388800","created_at":"2014-07-16T13:45:16.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News details the agency's recommendations for drug-marketing authorizations for the first half of 2014. http://t.co/CfmntMItod","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/CfmntMItod","expanded_url":"http://bit.ly/1jI0Dvp","display_url":"bit.ly/1jI0Dvp"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"489405409053388800","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"pt","id":"489116019831873536","created_at":"2014-07-15T18:35:21.000Z","possibly_sensitive":false,"author_id":"2219915250","referenced_tweets":{},"text":"@EMA_News  recomenda suspensão da comercialização das soluções orais de #metadona. Vía @RCMPharma   http://t.co/tYDNhLZibv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":87,"end":97,"username":"RCMPharma","id":"36047099"}],"urls":[{"start":100,"end":122,"url":"http://t.co/tYDNhLZibv","expanded_url":"http://ow.ly/zao3g","display_url":"ow.ly/zao3g"}],"hashtags":[{"start":72,"end":81,"tag":"metadona"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"489116019831873536","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"488771283761778688","created_at":"2014-07-14T19:45:29.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Recommends 39 Drugs in First Half of 2014. http://t.co/CcB3V7pBJe","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":53,"end":75,"url":"http://t.co/CcB3V7pBJe","expanded_url":"http://bit.ly/1raQz09","display_url":"bit.ly/1raQz09"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"488771283761778688","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"488710898950082560","created_at":"2014-07-14T15:45:32.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Revises Guidance on Advanced Therapies. http://t.co/7MJNWghXbs","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":50,"end":72,"url":"http://t.co/7MJNWghXbs","expanded_url":"http://bit.ly/1oWPT9K","display_url":"bit.ly/1oWPT9K"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"488710898950082560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"488581823652691968","created_at":"2014-07-14T07:12:38.000Z","possibly_sensitive":false,"author_id":"77694098","referenced_tweets":{},"text":"@EMA_News @US_FDA Why regulatory obsession with responder analysis is fooling them and costing millions http://t.co/GGvMcfosqR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"urls":[{"start":104,"end":126,"url":"http://t.co/GGvMcfosqR","expanded_url":"http://www.tandfonline.com/doi/abs/10.1080/19466315.2012.754726#.U8OCxbFAXv8","display_url":"tandfonline.com/doi/abs/10.108…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"488581823652691968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487605124601511936","created_at":"2014-07-11T14:31:35.000Z","possibly_sensitive":false,"author_id":"2364198660","referenced_tweets":[{"type":"replied_to","id":"487604704655183874"}],"text":"@EMA_News thank you","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487600229186019328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487600229186019328","created_at":"2014-07-11T14:12:08.000Z","possibly_sensitive":false,"author_id":"2364198660","referenced_tweets":{},"text":"@EMA_News Writing a blog post for a client about why businesses love working in Canary Wharf - may I email you a few q's?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":80,"end":91,"probability":0.8724,"type":"Place","normalized_text":"Canary Wharf"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487600229186019328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487580898158997504","created_at":"2014-07-11T12:55:19.000Z","possibly_sensitive":false,"author_id":"614450788","referenced_tweets":[{"type":"replied_to","id":"487240367495208960"}],"text":"@EMA_News Great. One important item didn't make the highlights.  3.3.2. Ponatinib - ICLUSIG (CAP).  How can I learn more about the outcome?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487238733213995008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487556023784574977","created_at":"2014-07-11T11:16:29.000Z","possibly_sensitive":false,"author_id":"1976092548","referenced_tweets":[{"type":"replied_to","id":"487553753495916544"}],"text":"@EMA_News PRAC issues recommendation for oral methadone products containing povidone…","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487553753495916544","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487509725106700288","created_at":"2014-07-11T08:12:30.000Z","possibly_sensitive":false,"author_id":"1495122764","referenced_tweets":{},"text":"@EMA_News fails to agree on transparency of #clinicaltrials data http://t.co/YeVt6zSRZe though crucial for #Doctors decision 4 prescription!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":65,"end":87,"url":"http://t.co/YeVt6zSRZe","expanded_url":"http://ow.ly/z28Zq","display_url":"ow.ly/z28Zq"}],"hashtags":[{"start":44,"end":59,"tag":"clinicaltrials"},{"start":107,"end":115,"tag":"Doctors"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487509725106700288","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487241248085143552","created_at":"2014-07-10T14:25:40.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News @Oncpall @ICU_Management @cancernurseEU @BrandcastHealth @Endo_Editor @Stef_Lav_Meds @HRK_ @wild_diva tx for yr RTs!","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"Oncpall","id":"1412760096"},{"start":19,"end":34,"username":"ICU_Management","id":"1253793494"},{"start":35,"end":49,"username":"cancernurseEU","id":"439224883"},{"start":50,"end":66,"username":"BrandcastHealth","id":"2306341848"},{"start":67,"end":79,"username":"Endo_Editor","id":"293682889"},{"start":101,"end":111,"username":"wild_diva","id":"65461631"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"487241248085143552","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487238733213995008","created_at":"2014-07-10T14:15:41.000Z","possibly_sensitive":false,"author_id":"614450788","referenced_tweets":{},"text":"@EMA_News when is the PRAC meeting highlights due out?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487238733213995008","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"487154060660056064","created_at":"2014-07-10T08:39:13.000Z","possibly_sensitive":false,"author_id":"1965354864","referenced_tweets":{},"text":"@EMA_News Guidance on #AdvancedTherapies revised http://t.co/K5ZTQe6PcI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":49,"end":71,"url":"http://t.co/K5ZTQe6PcI","expanded_url":"http://goo.gl/pCG266","display_url":"goo.gl/pCG266"}],"hashtags":[{"start":22,"end":40,"tag":"AdvancedTherapies"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"487154060660056064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"486953295182041088","created_at":"2014-07-09T19:21:27.000Z","possibly_sensitive":false,"author_id":"633978297","referenced_tweets":[{"type":"replied_to","id":"486874207050272768"}],"text":"We've published the assessment report for #Mekinist (#trametinib), a new #medicine for #melanoma: http://t.co/Wkksj5TJWO @EMA_News #EPAR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":121,"end":130,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/Wkksj5TJWO","expanded_url":"http://bit.ly/1qVhj4D","display_url":"bit.ly/1qVhj4D"}],"hashtags":[{"start":42,"end":51,"tag":"Mekinist"},{"start":53,"end":64,"tag":"trametinib"},{"start":73,"end":82,"tag":"medicine"},{"start":87,"end":96,"tag":"melanoma"},{"start":131,"end":136,"tag":"EPAR"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"486874207050272768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"486907558708662273","created_at":"2014-07-09T16:19:42.000Z","possibly_sensitive":false,"author_id":"18483956","referenced_tweets":{},"text":"@EMA_News no decision on #transparency. Wants \"balance\" between public health disclosure of data vs Pharma interests! http://t.co/uh8eU1e5d5","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/uh8eU1e5d5","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002138.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":25,"end":38,"tag":"transparency"}],"annotations":[{"start":100,"end":105,"probability":0.5914,"type":"Organization","normalized_text":"Pharma"}],"cashtags":{}},"source":"TweetDeck","conversation_id":"486907558708662273","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"486906288019111936","created_at":"2014-07-09T16:14:40.000Z","possibly_sensitive":false,"author_id":"741404372","referenced_tweets":{},"text":"@EMA_News does NOT respond to the questions asked by @EUombudsman http://t.co/86XZkT6XM4. The shroud of secrecy continues #AllTrials","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":53,"end":65,"username":"EUombudsman","id":"873777758"}],"urls":[{"start":66,"end":88,"url":"http://t.co/86XZkT6XM4","expanded_url":"http://bit.ly/1w1lhqa","display_url":"bit.ly/1w1lhqa"}],"hashtags":[{"start":122,"end":132,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android Tablets","conversation_id":"486906288019111936","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"486896758971047937","created_at":"2014-07-09T15:36:48.000Z","possibly_sensitive":false,"author_id":"83424009","referenced_tweets":{},"text":"@EMA_News announces delay in adoption of new publishing of clinical trial data http://t.co/kdJHUCiDZk was topic at #lnlm14","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/kdJHUCiDZk","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002138.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":115,"end":122,"tag":"lnlm14"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"486896758971047937","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"484569575720513536","created_at":"2014-07-03T05:29:24.000Z","possibly_sensitive":false,"author_id":"2192533356","referenced_tweets":{},"text":"@EMA_News Hi.We're building a twitter feed for St Gallen Prostate Cancer Conference.Please follow us&amp;retweet http://t.co/XYoDgpK8BS txs!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":135,"url":"http://t.co/XYoDgpK8BS","expanded_url":"http://prostatecancerconsensus.org","display_url":"prostatecancerconsensus.org"}],"hashtags":{},"annotations":[{"start":47,"end":82,"probability":0.4992,"type":"Other","normalized_text":"St Gallen Prostate Cancer Conference"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"484569575720513536","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"483940843079077889","created_at":"2014-07-01T11:51:02.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News #CHMP pushes EU approval of @GEHealthcare Vizamyl flutemetamol F18 Injection for #PET imaging of beta #amyloid plaque #alzheimers","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":38,"end":51,"username":"GEHealthcare","id":"15383592"}],"urls":{},"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":91,"end":95,"tag":"PET"},{"start":112,"end":120,"tag":"amyloid"},{"start":128,"end":139,"tag":"alzheimers"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"483940843079077889","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"483891665544151040","created_at":"2014-07-01T08:35:38.000Z","possibly_sensitive":false,"author_id":"183177433","referenced_tweets":[{"type":"replied_to","id":"483878078276718592"}],"text":"Impt for device combis“@EMA_News: We've revised guidance on classifying advanced therapies: #consultation now open: http://t.co/KpxXOMSebp”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":23,"end":32,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/KpxXOMSebp","expanded_url":"http://bit.ly/1mddpC9","display_url":"bit.ly/1mddpC9"}],"hashtags":[{"start":92,"end":105,"tag":"consultation"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"483878078276718592","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"483446356397154304","created_at":"2014-06-30T03:06:08.000Z","possibly_sensitive":false,"author_id":"1607376014","referenced_tweets":[{"type":"replied_to","id":"482444539672944641"}],"text":"@EMA_News Thank you for your information. :)","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482360323584716800","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482548289846640640","created_at":"2014-06-27T15:37:32.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":{},"text":"@EMA_News @Emma4facs thank you for the discussions today into #valproateinpregnancy #muchachieved","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"}],"urls":{},"hashtags":[{"start":62,"end":83,"tag":"valproateinpregnancy"},{"start":84,"end":97,"tag":"muchachieved"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"482548289846640640","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482506055390593024","created_at":"2014-06-27T12:49:42.000Z","possibly_sensitive":false,"author_id":"14525315","referenced_tweets":{},"text":"@EMA_News I would be honored if you could follow me back","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482506055390593024","attachments":{"media_keys":{}},"geo":{"place_id":"0659ef300999cb2f","coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482497618829131777","created_at":"2014-06-27T12:16:11.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"482497427124269056"}],"text":"@BettinaRyll However, we can't release specifics on the medicines we have selected to take part in the pilot yet.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":12,"username":"BettinaRyll","id":"810969654"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"482433901571633152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482491846602784768","created_at":"2014-06-27T11:53:15.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":[{"type":"replied_to","id":"482473466298662912"}],"text":"@EMA_News Certainly the method by which a drug is developed needs to be publicly available? Will this be released later?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482433901571633152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482485363995197442","created_at":"2014-06-27T11:27:29.000Z","possibly_sensitive":false,"author_id":"1606025952","referenced_tweets":{},"text":"@EMA_News Thanks for the recent RTs - have a great weekend!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"482485363995197442","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"482480374954881024","created_at":"2014-06-27T11:07:40.000Z","possibly_sensitive":false,"author_id":"25357774","referenced_tweets":[{"type":"replied_to","id":"482479807713005568"}],"text":"@EMA_News @japoco85","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"japoco85","id":"1369351747"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"482479807713005568","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482469322791845888","created_at":"2014-06-27T10:23:45.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":[{"type":"replied_to","id":"482436808241074177"}],"text":"@EMA_News Great! Any chance you could find out which drugs got selected for the Adaptive pilot and why?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482433901571633152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482441443190272000","created_at":"2014-06-27T08:32:58.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":{},"text":"@EMA_News @Emma4facs #review on #valproateinpregnancy today #INFACT looking forward to attending &amp; giving patients views #lackofinfo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"}],"urls":{},"hashtags":[{"start":21,"end":28,"tag":"review"},{"start":32,"end":53,"tag":"valproateinpregnancy"},{"start":60,"end":67,"tag":"INFACT"},{"start":125,"end":136,"tag":"lackofinfo"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"482441443190272000","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482433901571633152","created_at":"2014-06-27T08:02:59.000Z","possibly_sensitive":false,"author_id":"810969654","referenced_tweets":{},"text":"@EMA_News just tried to tweet from EMA website but links too long! http://t.co/CjwFAO4aMc","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":67,"end":89,"url":"http://t.co/CjwFAO4aMc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/06/news_detail_002119.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":[{"start":35,"end":37,"probability":0.5563,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482433901571633152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"482223600586735616","created_at":"2014-06-26T18:07:20.000Z","possibly_sensitive":false,"author_id":"839987330","referenced_tweets":{},"text":"@EMA_News  agreed on a policy to publish clinical trials data of the drugsitapproves.   http://t.co/M9QbCqvImi  http://t.co/9tbQawfzz8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/M9QbCqvImi","expanded_url":"http://tmblr.co/ZaTq4o1D2AcUK","display_url":"tmblr.co/ZaTq4o1D2AcUK"},{"start":112,"end":134,"url":"http://t.co/9tbQawfzz8","expanded_url":"http://ecoti.ms/cVIDfb","display_url":"ecoti.ms/cVIDfb"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"482223600586735616","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"481802727065128960","created_at":"2014-06-25T14:14:56.000Z","possibly_sensitive":false,"author_id":"2273387166","referenced_tweets":{},"text":"@EMA_News EU CTD revised and effective 2016. Serious Breach in GCP requirements included!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"481802727065128960","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"481802424047263745","created_at":"2014-06-25T14:13:44.000Z","possibly_sensitive":false,"author_id":"2273387166","referenced_tweets":{},"text":"@EMA_News EU CTD revised &amp; effective 2016. Serious Breach in GCP included!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"481802424047263745","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"481732399739707392","created_at":"2014-06-25T09:35:28.000Z","possibly_sensitive":false,"author_id":"949437734","referenced_tweets":[{"type":"replied_to","id":"476317925666979840"}],"text":"“@EMA_News: We've selected the first two medicines for our #adaptivelicensing pilot project: http://t.co/7CihfL9cp4”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/7CihfL9cp4","expanded_url":"http://bit.ly/SApXGS","display_url":"bit.ly/SApXGS"}],"hashtags":[{"start":59,"end":77,"tag":"adaptivelicensing"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"476317925666979840","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"481722295489421312","created_at":"2014-06-25T08:55:19.000Z","possibly_sensitive":false,"author_id":"16947313","referenced_tweets":[{"type":"replied_to","id":"481715079592050689"}],"text":"MT “@EMA_News: improving collaboration between EU regulators and HTA organisations http://t.co/uP6zofWI6E” paper http://t.co/UOTnO6hXoM","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":4,"end":13,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/uP6zofWI6E","expanded_url":"http://bit.ly/1pAdT3c","display_url":"bit.ly/1pAdT3c"},{"start":113,"end":135,"url":"http://t.co/UOTnO6hXoM","expanded_url":"http://www.valueinhealthjournal.com/webfiles/images/journals/jval/JVAL_940_final.pdf","display_url":"valueinhealthjournal.com/webfiles/image…"}],"hashtags":{},"annotations":[{"start":47,"end":48,"probability":0.601,"type":"Organization","normalized_text":"EU"},{"start":65,"end":67,"probability":0.573,"type":"Organization","normalized_text":"HTA"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"481715079592050689","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"481019171573346304","created_at":"2014-06-23T10:21:22.000Z","possibly_sensitive":false,"author_id":"2568609577","referenced_tweets":[{"type":"replied_to","id":"481009141000204288"}],"text":"@EMA_News Estonian hospital killed Oliver Rõigas(26) to cover up mistakes starting from Metoclopramide complications  http://t.co/L6MPJy1EPz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/L6MPJy1EPz","expanded_url":"http://fatalhospitalerrors.blogspot.com/2014/06/estonian-hospital-killed-26-year-old.html","display_url":"fatalhospitalerrors.blogspot.com/2014/06/estoni…"}],"hashtags":{},"annotations":[{"start":35,"end":47,"probability":0.9931,"type":"Person","normalized_text":"Oliver Rõigas"},{"start":88,"end":101,"probability":0.2488,"type":"Person","normalized_text":"Metoclopramide"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"481009141000204288","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"481010302822383616","created_at":"2014-06-23T09:46:07.000Z","possibly_sensitive":false,"author_id":"518392980","referenced_tweets":{},"text":"@EMA_News Bolsas de #empleo en la Agencia Europea del Medicamento para científicos, auditores y asistentes http://t.co/netEn62OM0","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/netEn62OM0","expanded_url":"http://ow.ly/ykD48","display_url":"ow.ly/ykD48"}],"hashtags":[{"start":20,"end":27,"tag":"empleo"}],"annotations":[{"start":34,"end":64,"probability":0.3197,"type":"Other","normalized_text":"Agencia Europea del Medicamento"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"481010302822383616","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"480992010044989440","created_at":"2014-06-23T08:33:26.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News @3NT @recnac1 @thoracic @MacriPaolo @CRCTU @drol007 @Galenia_cat @Oncoinfo_it @BreastOncology @SEEDpublisher Tx for RTs/MTs!","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":5,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"3NT","id":"228845995"},{"start":15,"end":23,"username":"recnac1","id":"237468540"},{"start":24,"end":33,"username":"thoracic","id":"619347326"},{"start":34,"end":45,"username":"MacriPaolo","id":"447381343"},{"start":46,"end":52,"username":"CRCTU","id":"1193633406"},{"start":53,"end":61,"username":"drol007","id":"333495548"},{"start":62,"end":74,"username":"Galenia_cat","id":"200027043"},{"start":75,"end":87,"username":"Oncoinfo_it","id":"1565672671"},{"start":88,"end":103,"username":"BreastOncology","id":"719804523208974336"},{"start":104,"end":118,"username":"SEEdPublisher","id":"197376024"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"480992010044989440","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"480595104038924288","created_at":"2014-06-22T06:16:16.000Z","possibly_sensitive":false,"author_id":"1057811264","referenced_tweets":[{"type":"replied_to","id":"479571991616577536"}],"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"479571991616577536","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"479586117100904448","created_at":"2014-06-19T11:26:55.000Z","possibly_sensitive":false,"author_id":"318743706","referenced_tweets":{},"text":"@EMA_News: Comments open on EMA viewpoint of patient-reported outcomes in #cancer studies. Deadline 30 Nov: http://t.co/4sq8McjhZ9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/4sq8McjhZ9","expanded_url":"http://bit.ly/1qomEAO","display_url":"bit.ly/1qomEAO"}],"hashtags":[{"start":74,"end":81,"tag":"cancer"}],"annotations":{},"cashtags":{}},"source":"LinkedIn","conversation_id":"479586117100904448","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"479323281162387456","created_at":"2014-06-18T18:02:30.000Z","possibly_sensitive":false,"author_id":"163225697","referenced_tweets":{},"text":"@EMA_News presents at #DIA2014 a new vision of the role of regulators in enabling innovation for the benefit of patients and economic growth","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":22,"end":30,"tag":"DIA2014"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"479323281162387456","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"479036266961727488","created_at":"2014-06-17T23:02:00.000Z","possibly_sensitive":false,"author_id":"204845213","referenced_tweets":[{"type":"replied_to","id":"477449755094949888"}],"text":"@EMA_News La risposta del diretto interessato a Luca Pani http://t.co/0jCltqnOah Molto informativa","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":58,"end":80,"url":"http://t.co/0jCltqnOah","expanded_url":"http://sorianablu.blogspot.it/2014/06/padre-di-federico-risponde-luca-pani.html","display_url":"sorianablu.blogspot.it/2014/06/padre-…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"477449755094949888","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"478831140233826304","created_at":"2014-06-17T09:26:54.000Z","possibly_sensitive":false,"author_id":"2175782167","referenced_tweets":[{"type":"replied_to","id":"478826046356467712"}],"text":"“@EMA_News: The EPAR for #Jardiance (#empagliflozin), a #medicine for type-2 #diabetes: http://t.co/eiCWAYzWlG” Otra GLIFLOZINA para la DM2.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/eiCWAYzWlG","expanded_url":"http://bit.ly/1qUKDFb","display_url":"bit.ly/1qUKDFb"}],"hashtags":[{"start":25,"end":35,"tag":"Jardiance"},{"start":37,"end":51,"tag":"empagliflozin"},{"start":56,"end":65,"tag":"medicine"},{"start":77,"end":86,"tag":"diabetes"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"478826046356467712","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"478797967097626624","created_at":"2014-06-17T07:15:05.000Z","possibly_sensitive":false,"author_id":"914462377","referenced_tweets":{},"text":"@EMA_News comienza revisión de riesgos cardiovasculares de ibuprofeno a dosis altas durante largos periodos http://t.co/jicIqZCjVV","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/jicIqZCjVV","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/06/WC500168436.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"478797967097626624","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"478463282454732800","created_at":"2014-06-16T09:05:10.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":[{"type":"replied_to","id":"478449787881410560"}],"text":"@EMA_News @Emma4facs #PRACinfo &amp; news of Review on #valproate please..!!! only 12 days away..!!","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"}],"urls":{},"hashtags":[{"start":21,"end":30,"tag":"PRACinfo"},{"start":55,"end":65,"tag":"valproate"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"478449787881410560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"478450906296770560","created_at":"2014-06-16T08:15:59.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News #PRAC starts a review to evaluate cardiovascular risks with systemic #ibuprofen medicines: http://t.co/6yGFL2lpRR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":101,"end":123,"url":"http://t.co/6yGFL2lpRR","expanded_url":"http://bit.ly/1oXj0vQ","display_url":"bit.ly/1oXj0vQ"}],"hashtags":[{"start":10,"end":15,"tag":"PRAC"},{"start":79,"end":89,"tag":"ibuprofen"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"478450906296770560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"478314823382728705","created_at":"2014-06-15T23:15:15.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes New Guidance for Qualified Person's Declaration on GMP Compliance of API. http://t.co/0vOEO4lQ2F","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/0vOEO4lQ2F","expanded_url":"http://bit.ly/SGDpZl","display_url":"bit.ly/SGDpZl"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"478314823382728705","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"478118552181149696","created_at":"2014-06-15T10:15:20.000Z","possibly_sensitive":false,"author_id":"2568609577","referenced_tweets":{},"text":"@EMA_News  Thanku for Cerucal study+warning. My son Oliver given Cerucal got horrible complications next day, hospital covered up killed him","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":22,"end":28,"probability":0.6912,"type":"Person","normalized_text":"Cerucal"},{"start":52,"end":57,"probability":0.9881,"type":"Person","normalized_text":"Oliver"},{"start":65,"end":71,"probability":0.8997,"type":"Person","normalized_text":"Cerucal"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"478118552181149696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477639319935791104","created_at":"2014-06-14T02:31:02.000Z","possibly_sensitive":false,"author_id":"37982988","referenced_tweets":{},"text":"@EMA_News has reversed its on-screen restrictions following researcher and citizen protest http://t.co/5nouXVjale","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/5nouXVjale","expanded_url":"http://www.alltrials.net/news/ema-has-reversed-its-on-screen-restrictions-following-researcher-and-citizen-protest/","display_url":"alltrials.net/news/ema-has-r…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"477639319935791104","attachments":{"media_keys":{}},"geo":{"place_id":"bcefc8dab1ed2c04","coordinates":{"type":"Point","coordinates":[5.9996,58.4495]}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477526927180562432","created_at":"2014-06-13T19:04:26.000Z","possibly_sensitive":false,"author_id":"1186490732","referenced_tweets":{},"text":"@EMA_News   EMA agrees policy on disclosure of clinical trial data - expected to start October 2014 #clinicaltrials #bigdatamed #bigdata","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":100,"end":115,"tag":"clinicaltrials"},{"start":116,"end":127,"tag":"bigdatamed"},{"start":128,"end":136,"tag":"bigdata"}],"annotations":{},"cashtags":{}},"source":"Twitter Web App","conversation_id":"477526927180562432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477499841191620608","created_at":"2014-06-13T17:16:48.000Z","possibly_sensitive":false,"author_id":"1527563420","referenced_tweets":{},"text":"@EMA_News relaxes data-sharing rules, but @alltrials &amp; @EUombudsman are still concerned. My story @ScienceNews http://t.co/dkC5oQrwgR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":42,"end":52,"username":"alltrials","id":"908693395"},{"start":59,"end":71,"username":"EUombudsman","id":"873777758"},{"start":102,"end":114,"username":"ScienceNews","id":"19402238"}],"urls":[{"start":115,"end":137,"url":"http://t.co/dkC5oQrwgR","expanded_url":"http://bit.ly/UzGnAP","display_url":"bit.ly/UzGnAP"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"477499841191620608","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477463525179531265","created_at":"2014-06-13T14:52:29.000Z","possibly_sensitive":false,"author_id":"140587674","referenced_tweets":[{"type":"replied_to","id":"477457405253394432"}],"text":"“@EMA_News: #PRAC has started a review to evaluate the cardiovascular risks with systemic #ibuprofen medicines: http://t.co/xThFoz5WE1”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/xThFoz5WE1","expanded_url":"http://bit.ly/1oXj0vQ","display_url":"bit.ly/1oXj0vQ"}],"hashtags":[{"start":12,"end":17,"tag":"PRAC"},{"start":90,"end":100,"tag":"ibuprofen"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"477457405253394432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477441095933366272","created_at":"2014-06-13T13:23:22.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":{},"text":"@EMA_News @GlenisWillmott @awood44 #FACSA &amp; #INFACT information booklet given to #mhra for safer preg if taking AEDs #necessity Pls RT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"GlenisWillmott","id":"106110469"},{"start":26,"end":34,"username":"awood44","id":"2605564837"}],"urls":{},"hashtags":[{"start":35,"end":41,"tag":"FACSA"},{"start":48,"end":55,"tag":"INFACT"},{"start":85,"end":90,"tag":"mhra"},{"start":121,"end":131,"tag":"necessity"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"477441095933366272","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477344711745617921","created_at":"2014-06-13T07:00:22.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes New Guidance for Qualified Person's Declaration on GMP Compliance of API. http://t.co/yGNvKLB77E","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/yGNvKLB77E","expanded_url":"http://bit.ly/1pNKzqY","display_url":"bit.ly/1pNKzqY"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"477344711745617921","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477152006646136833","created_at":"2014-06-12T18:14:38.000Z","possibly_sensitive":false,"author_id":"1892014616","referenced_tweets":{},"text":"@EMA_News Agency update on Publication of Clinical Trial Data  http://t.co/3KrOL9MDij","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":63,"end":85,"url":"http://t.co/3KrOL9MDij","expanded_url":"http://bit.ly/TOQUHv","display_url":"bit.ly/TOQUHv"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"477152006646136833","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477144243166015488","created_at":"2014-06-12T17:43:47.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":[{"type":"replied_to","id":"477141807021977600"}],"text":"@EMA_News has agreed its policy on publication of #ctdata with more user-friendly amendments: http://t.co/1PeX6xpguS","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/1PeX6xpguS","expanded_url":"http://bit.ly/SQReVn","display_url":"bit.ly/SQReVn"}],"hashtags":[{"start":50,"end":57,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"477141807021977600","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"477142621954252800","created_at":"2014-06-12T17:37:20.000Z","possibly_sensitive":false,"author_id":"16947313","referenced_tweets":[{"type":"replied_to","id":"477141807021977600"}],"text":"“@EMA_News: We've agreed our policy on publication of #ctdata with more user-friendly amendments: http://t.co/Jy3h4Yc1hX” Not #screenonly !","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/Jy3h4Yc1hX","expanded_url":"http://bit.ly/SQReVn","display_url":"bit.ly/SQReVn"}],"hashtags":[{"start":54,"end":61,"tag":"ctdata"},{"start":126,"end":137,"tag":"screenonly"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"477141807021977600","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476730662729568256","created_at":"2014-06-11T14:20:21.000Z","possibly_sensitive":false,"author_id":"713848298","referenced_tweets":{},"text":"@EMA_News picks pilots for early licensing - http://t.co/LJNDbhTvlu @EuroBiotechNews @EuropaBio #biotech #pharma #drugs #medicine","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":68,"end":84,"username":"EuroBiotechNews","id":"973770902"},{"start":85,"end":95,"username":"EuropaBio","id":"19642657"}],"urls":[{"start":45,"end":67,"url":"http://t.co/LJNDbhTvlu","expanded_url":"http://bit.ly/1s4PUhM","display_url":"bit.ly/1s4PUhM"}],"hashtags":[{"start":96,"end":104,"tag":"biotech"},{"start":105,"end":112,"tag":"pharma"},{"start":113,"end":119,"tag":"drugs"},{"start":120,"end":129,"tag":"medicine"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"476730662729568256","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476713487440568320","created_at":"2014-06-11T13:12:06.000Z","possibly_sensitive":false,"author_id":"167132484","referenced_tweets":[{"type":"replied_to","id":"374467745188163584"}],"text":"@EMA_News @Aifa_ufficiale http://t.co/vJdZ0WozTz T r a c k  m e","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":26,"end":48,"url":"http://t.co/vJdZ0WozTz","expanded_url":"http://drbipolardisorder.com","display_url":"drbipolardisorder.com"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"374467745188163584","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476684823919341569","created_at":"2014-06-11T11:18:13.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":[{"type":"replied_to","id":"476683752341790721"}],"text":"@EMA_News has published a response to concerns on its publication of clinical trial data policy: http://t.co/gdVHkdhpDa #ctdata","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":97,"end":119,"url":"http://t.co/gdVHkdhpDa","expanded_url":"http://bit.ly/1pjfz4k","display_url":"bit.ly/1pjfz4k"}],"hashtags":[{"start":120,"end":127,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"476683752341790721","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476653877887254529","created_at":"2014-06-11T09:15:14.000Z","possibly_sensitive":false,"author_id":"372715566","referenced_tweets":{},"text":"@ema_news Can't find the agenda for the #PRAC meeting 10-13 June? Look no further: http://t.co/Y9oEFgZF4T","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/Y9oEFgZF4T","expanded_url":"http://ow.ly/xRZpE","display_url":"ow.ly/xRZpE"}],"hashtags":[{"start":40,"end":45,"tag":"PRAC"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"476653877887254529","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476446355456819200","created_at":"2014-06-10T19:30:37.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News publishes revised guideline on the acceptability of names for drugs. http://t.co/2kDdQcnhxE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/2kDdQcnhxE","expanded_url":"http://bit.ly/TA5lPE","display_url":"bit.ly/TA5lPE"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"476446355456819200","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"476389010000973825","created_at":"2014-06-10T15:42:45.000Z","possibly_sensitive":false,"author_id":"442309682","referenced_tweets":[{"type":"replied_to","id":"476387202734497792"}],"text":"@EMA_News @Aifa_ufficiale","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"476387202734497792","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476383568026165248","created_at":"2014-06-10T15:21:08.000Z","possibly_sensitive":false,"author_id":"237222584","referenced_tweets":{},"text":"@EMA_News must not roll back clinical trial transparency policy http://t.co/refI6x6UjY #Alltrials","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/refI6x6UjY","expanded_url":"http://bit.ly/1hEIBZM","display_url":"bit.ly/1hEIBZM"}],"hashtags":[{"start":87,"end":97,"tag":"Alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"476383568026165248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"476287919062544384","created_at":"2014-06-10T09:01:03.000Z","possibly_sensitive":false,"author_id":"2354558196","referenced_tweets":[{"type":"replied_to","id":"476278204421140480"}],"text":"“@EMA_News: RT @Aifa_ufficiale: #Exceptional #responders from anecdotes of clinical trials to allies in the ...  http://t.co/UEuLKFTuXf”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":30,"username":"Aifa_ufficiale","id":"441940097"}],"urls":[{"start":113,"end":135,"url":"http://t.co/UEuLKFTuXf","expanded_url":"http://bit.ly/1jhokEO","display_url":"bit.ly/1jhokEO"}],"hashtags":[{"start":32,"end":44,"tag":"Exceptional"},{"start":45,"end":56,"tag":"responders"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"476278204421140480","attachments":{"media_keys":{}},"geo":{"place_id":"4eadd1e7f63c4eaa","coordinates":{"type":"Point","coordinates":[16.8654,41.1261]}}},{"in_reply_to_user_id":"116716199","lang":"ro","id":"476257663266082818","created_at":"2014-06-10T07:00:50.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Reinstates GMP Certificate for Ranbaxy Toansa Facility. http://t.co/P23bpn2zIJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":66,"end":88,"url":"http://t.co/P23bpn2zIJ","expanded_url":"http://bit.ly/1liiGWQ","display_url":"bit.ly/1liiGWQ"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"476257663266082818","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"475982713363898369","created_at":"2014-06-09T12:48:16.000Z","possibly_sensitive":false,"author_id":"190227425","referenced_tweets":{},"text":"@EMA_News - PLEASE SHARE #stepforward4pd #eurounitywalk &amp; b part of our amazing film. Help us reach 500: http://t.co/Qnp9AzPNLH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/Qnp9AzPNLH","expanded_url":"http://bit.ly/1pc8NNQ","display_url":"bit.ly/1pc8NNQ","status":200,"unwound_url":"https://www.youtube.com/watch?v=0XzQMP0zDhA&feature=youtu.be"}],"hashtags":[{"start":25,"end":40,"tag":"stepforward4pd"},{"start":41,"end":55,"tag":"eurounitywalk"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"475982713363898369","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"475759431008157697","created_at":"2014-06-08T22:01:02.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News publishes revised guideline on the acceptability of names for drugs. http://t.co/TE20tyDkz9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":79,"end":101,"url":"http://t.co/TE20tyDkz9","expanded_url":"http://bit.ly/1pacBfS","display_url":"bit.ly/1pacBfS"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"475759431008157697","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"474834914672922624","created_at":"2014-06-06T08:47:20.000Z","possibly_sensitive":false,"author_id":"914462377","referenced_tweets":[{"type":"replied_to","id":"474481291736666112"}],"text":"@EMA_News \"Publicado el EPAR de #Olysio (#simeprevir), a #medicine for chronic #hepatitisC: http://t.co/S4HEMeRWAZ\"","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":92,"end":114,"url":"http://t.co/S4HEMeRWAZ","expanded_url":"http://bit.ly/UbuKQs","display_url":"bit.ly/UbuKQs"}],"hashtags":[{"start":32,"end":39,"tag":"Olysio"},{"start":41,"end":52,"tag":"simeprevir"},{"start":57,"end":66,"tag":"medicine"},{"start":79,"end":90,"tag":"hepatitisC"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"474481291736666112","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474823281116450816","created_at":"2014-06-06T08:01:06.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Changes Guideline on Drug Name Acceptability. http://t.co/TE20tyDkz9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":56,"end":78,"url":"http://t.co/TE20tyDkz9","expanded_url":"http://bit.ly/1pacBfS","display_url":"bit.ly/1pacBfS"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"474823281116450816","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"474644080098811904","created_at":"2014-06-05T20:09:01.000Z","possibly_sensitive":false,"author_id":"2555875318","referenced_tweets":[{"type":"replied_to","id":"470926621281886208"}],"text":"@EMA_News @Aifa_ufficiale","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"470926621281886208","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"474638087453417476","created_at":"2014-06-05T19:45:13.000Z","possibly_sensitive":false,"author_id":"2409703312","referenced_tweets":{},"text":"@EMA_News admón conjunta prevenar13+infanrix hexa incrementa riesgo de convulsiones e hipotonia-hiporespuesta http://t.co/th5sf5nImb","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":110,"end":132,"url":"http://t.co/th5sf5nImb","expanded_url":"http://goo.gl/p1tySw","display_url":"goo.gl/p1tySw"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"474638087453417476","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474507115751829504","created_at":"2014-06-05T11:04:46.000Z","possibly_sensitive":false,"author_id":"18483956","referenced_tweets":[{"type":"replied_to","id":"474480731709009920"}],"text":"@EMA_News While @EUombudsman inquiry into your new anti-transparency policy is open, is it proper to vote on it next week? #AllTrials","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":28,"username":"EUombudsman","id":"873777758"}],"urls":{},"hashtags":[{"start":123,"end":133,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"474203684906471426","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474277159356624896","created_at":"2014-06-04T19:51:01.000Z","possibly_sensitive":false,"author_id":"18483956","referenced_tweets":[{"type":"replied_to","id":"474203684906471426"}],"text":"@EMA_News Why are you now retreating on the right to know the real efficacy and safety of our medicines? #transparency #alltrials","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":105,"end":118,"tag":"transparency"},{"start":119,"end":129,"tag":"alltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"474203684906471426","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474218090805616640","created_at":"2014-06-04T15:56:18.000Z","possibly_sensitive":false,"author_id":"2547774333","referenced_tweets":[{"type":"replied_to","id":"474205053105217536"}],"text":"@EMA_News: We've published the assessment report for #Olysio (#simeprevir), a new #medicine for chronic #hepatitisC: http://t.co/SPPGy6k1qW","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/SPPGy6k1qW","expanded_url":"http://bit.ly/UbuKQs","display_url":"bit.ly/UbuKQs"}],"hashtags":[{"start":53,"end":60,"tag":"Olysio"},{"start":62,"end":73,"tag":"simeprevir"},{"start":82,"end":91,"tag":"medicine"},{"start":104,"end":115,"tag":"hepatitisC"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"474205053105217536","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474203898920861696","created_at":"2014-06-04T14:59:54.000Z","possibly_sensitive":false,"author_id":"18483956","referenced_tweets":{},"text":"@EMA_News You should act on it to defend the fundamental right to public health #transparency over so-called \"commercial confidentiality\".","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":80,"end":93,"tag":"transparency"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"474203898920861696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474202093755322368","created_at":"2014-06-04T14:52:44.000Z","possibly_sensitive":false,"author_id":"2347362492","referenced_tweets":{},"text":"@EMA_News Can head of EMA legal service work for common good on #Transparency if he worked for Big Pharma til 8 months ago? #alltrials","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":64,"end":77,"tag":"Transparency"},{"start":124,"end":134,"tag":"alltrials"}],"annotations":[{"start":22,"end":24,"probability":0.4215,"type":"Organization","normalized_text":"EMA"},{"start":95,"end":104,"probability":0.76,"type":"Organization","normalized_text":"Big Pharma"}],"cashtags":{}},"source":"TweetDeck","conversation_id":"474202093755322368","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"474178706978926592","created_at":"2014-06-04T13:19:48.000Z","possibly_sensitive":false,"author_id":"96123346","referenced_tweets":[{"type":"replied_to","id":"474174692061106176"}],"text":"@EMA_News @LV_MPA Wrong link?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"LV_MPA","id":"77047226"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"474174692061106176","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473780639289053185","created_at":"2014-06-03T10:58:01.000Z","possibly_sensitive":false,"author_id":"284748226","referenced_tweets":[{"type":"replied_to","id":"473747875638550528"}],"text":"@EMA_News tu 4 ur info! i read that but no sign of nivolumab (BMS) or MK-3475 (Merck). in USA they will be approved this summer,octo at last","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":90,"end":92,"probability":0.9667,"type":"Place","normalized_text":"USA"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"473747875638550528","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473555477083983872","created_at":"2014-06-02T20:03:18.000Z","possibly_sensitive":false,"author_id":"284748226","referenced_tweets":{},"text":"@EMA_News is there any news on the approval for anti-pd1 for melanoma??!!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"473555477083983872","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473466458799095808","created_at":"2014-06-02T14:09:35.000Z","possibly_sensitive":false,"author_id":"18483956","referenced_tweets":{},"text":"@EMA_News caves in to #Badpharma on #transparency placing profits before public health. Shame! http://t.co/Qshu5gmd8C","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":95,"end":117,"url":"http://t.co/Qshu5gmd8C","expanded_url":"http://blogs.bmj.com/bmj/2014/06/02/jim-murray-policy-making-behind-closed-doors/?g=widget_default","display_url":"blogs.bmj.com/bmj/2014/06/02…"}],"hashtags":[{"start":22,"end":32,"tag":"Badpharma"},{"start":36,"end":49,"tag":"transparency"}],"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"473466458799095808","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473433692900450305","created_at":"2014-06-02T11:59:23.000Z","possibly_sensitive":false,"author_id":"1282932415","referenced_tweets":[{"type":"replied_to","id":"473424650958286848"}],"text":"@EMA_News Excellent news for patients","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Windows Phone","conversation_id":"473424650958286848","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473433620510953472","created_at":"2014-06-02T11:59:05.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News adopts change to an Indication for Eribulin: locally-adv. or metastatic #breastcancer #bcsm http://t.co/SPD9Il6Wdt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/SPD9Il6Wdt","expanded_url":"http://ow.ly/xw7pU","display_url":"ow.ly/xw7pU"}],"hashtags":[{"start":82,"end":95,"tag":"breastcancer"},{"start":96,"end":101,"tag":"bcsm"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"473433620510953472","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"473429418724306944","created_at":"2014-06-02T11:42:23.000Z","possibly_sensitive":false,"author_id":"16947313","referenced_tweets":[{"type":"replied_to","id":"473424650958286848"}],"text":"“@EMA_News: We welcome the Clinical Trials Regulation published last wk in Official Journal of the EU: http://t.co/IgVA83ifLe” &amp; clause 68?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":103,"end":125,"url":"http://t.co/IgVA83ifLe","expanded_url":"http://bit.ly/Sf4hzU","display_url":"bit.ly/Sf4hzU"}],"hashtags":{},"annotations":[{"start":27,"end":52,"probability":0.3086,"type":"Organization","normalized_text":"Clinical Trials Regulation"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"473424650958286848","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"472417392081899520","created_at":"2014-05-30T16:40:58.000Z","possibly_sensitive":false,"author_id":"28824136","referenced_tweets":{},"text":"@EMA_News 's Proposed Data Release Policy:Promotng Transparenc or Expndng Pharma Control over Data? http://t.co/YNiVKSqiOR via @TrudoLemmens","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":140,"username":"TrudoLemmens","id":"2440319112"}],"urls":[{"start":100,"end":122,"url":"http://t.co/YNiVKSqiOR","expanded_url":"http://bit.ly/1mz54om","display_url":"bit.ly/1mz54om"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"472417392081899520","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"472406853042044928","created_at":"2014-05-30T15:59:05.000Z","possibly_sensitive":false,"author_id":"9307672","referenced_tweets":{},"text":"@EMA_News Proposed Data Release Policy: Promoting Transparency or Expanding Pharma Control over Data?\nhttp://t.co/xsUcIhBPhq","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":102,"end":124,"url":"http://t.co/xsUcIhBPhq","expanded_url":"http://blogs.plos.org/speakingofmedicine/2014/05/30/emas-new-data-release-policy-promoting-transparency-expanding-pharma-control-data/","display_url":"blogs.plos.org/speakingofmedi…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"472406853042044928","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"472290274031308801","created_at":"2014-05-30T08:15:50.000Z","possibly_sensitive":false,"author_id":"470919035","referenced_tweets":[{"type":"replied_to","id":"471659842625863680"}],"text":"@EMA_News: And now a huge task for European researchers: to look at how new Clinical Trials Regulation will be implemented across EU States!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"471659842625863680","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"472143039604203520","created_at":"2014-05-29T22:30:47.000Z","possibly_sensitive":false,"author_id":"594965796","referenced_tweets":{},"text":"@EMA_News #Annex11 and Integrity of Erecs http://t.co/zaLhB46sX3 #dataintegrity","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":42,"end":64,"url":"http://t.co/zaLhB46sX3","expanded_url":"http://bit.ly/ScDROZ","display_url":"bit.ly/ScDROZ"}],"hashtags":[{"start":10,"end":18,"tag":"Annex11"},{"start":65,"end":79,"tag":"dataintegrity"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"472143039604203520","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"471728835386703873","created_at":"2014-05-28T19:04:53.000Z","possibly_sensitive":false,"author_id":"54546724","referenced_tweets":[{"type":"replied_to","id":"471659842625863680"}],"text":"@EMA_News So you welcome processing thousands of pages with (redacted) data on #screenonly ? You must be joking. https://t.co/iJgEl9Ghjv","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":113,"end":136,"url":"https://t.co/iJgEl9Ghjv","expanded_url":"https://www.iqwig.de/en/press/ema_use_of_study_data.6118.html","display_url":"iqwig.de/en/press/ema_u…"}],"hashtags":[{"start":79,"end":90,"tag":"screenonly"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"471659842625863680","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"fr","id":"471687268332478464","created_at":"2014-05-28T16:19:42.000Z","possibly_sensitive":false,"author_id":"2443530930","referenced_tweets":{},"text":"@EMA_News publie la nouvelle #réglementation des #essaiclinique http://t.co/Vj70cBVvdD","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":64,"end":86,"url":"http://t.co/Vj70cBVvdD","expanded_url":"http://ow.ly/xlT2p","display_url":"ow.ly/xlT2p"}],"hashtags":[{"start":29,"end":44,"tag":"réglementation"},{"start":49,"end":63,"tag":"essaiclinique"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"471687268332478464","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"471661654456172544","created_at":"2014-05-28T14:37:56.000Z","possibly_sensitive":false,"author_id":"250163834","referenced_tweets":[{"type":"replied_to","id":"471657872557092864"}],"text":"@EMA_News @Aifa_ufficiale @Emma4facs interesting &amp; good to see leading up to Euro Review on #valproateinpregnancy...","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"},{"start":26,"end":36,"username":"Emma4facs","id":"277466861"}],"urls":{},"hashtags":[{"start":96,"end":117,"tag":"valproateinpregnancy"}],"annotations":[{"start":77,"end":87,"probability":0.398,"type":"Other","normalized_text":"Euro Review"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"471657872557092864","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"471598042769268736","created_at":"2014-05-28T10:25:09.000Z","possibly_sensitive":false,"author_id":"594965796","referenced_tweets":{},"text":"@EMA_News #Annex11 and Integrity of Erecs http://t.co/zaLhB46sX3 #dataintegrity","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":42,"end":64,"url":"http://t.co/zaLhB46sX3","expanded_url":"http://bit.ly/ScDROZ","display_url":"bit.ly/ScDROZ"}],"hashtags":[{"start":10,"end":18,"tag":"Annex11"},{"start":65,"end":79,"tag":"dataintegrity"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"471598042769268736","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"471546579589935104","created_at":"2014-05-28T07:00:40.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Opens Registration for European Network of Paediatric Research Workshop. http://t.co/4geEYkorEO","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/4geEYkorEO","expanded_url":"http://bit.ly/1sA74yO","display_url":"bit.ly/1sA74yO"}],"hashtags":{},"annotations":[{"start":33,"end":80,"probability":0.4512,"type":"Other","normalized_text":"European Network of Paediatric Research Workshop"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"471546579589935104","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"470911291495051264","created_at":"2014-05-26T12:56:15.000Z","possibly_sensitive":false,"author_id":"2354558196","referenced_tweets":[{"type":"replied_to","id":"470908061256003584"}],"text":"“@EMA_News: Last Friday we published the #CHMP meeting highlights: http://t.co/6pSjEiFKpG”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":67,"end":89,"url":"http://t.co/6pSjEiFKpG","expanded_url":"http://bit.ly/1nj8y3y","display_url":"bit.ly/1nj8y3y"}],"hashtags":[{"start":41,"end":46,"tag":"CHMP"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"470908061256003584","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"470911280627613696","created_at":"2014-05-26T12:56:13.000Z","possibly_sensitive":false,"author_id":"2354558196","referenced_tweets":[{"type":"replied_to","id":"470908458574032896"}],"text":"“@EMA_News: We recommended #Translarna for treatment of #Duchenne muscular dystrophy: http://t.co/fx2RG9OUh3”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":86,"end":108,"url":"http://t.co/fx2RG9OUh3","expanded_url":"http://bit.ly/1gWcRPJ","display_url":"bit.ly/1gWcRPJ"}],"hashtags":[{"start":27,"end":38,"tag":"Translarna"},{"start":56,"end":65,"tag":"Duchenne"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"470908458574032896","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"470887641282789376","created_at":"2014-05-26T11:22:17.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News recommends granting marketing authorisation for Obinutuzumab #CLL #leusm http://t.co/Eai2rysMgJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/Eai2rysMgJ","expanded_url":"http://ow.ly/xfXiD","display_url":"ow.ly/xfXiD"}],"hashtags":[{"start":71,"end":75,"tag":"CLL"},{"start":76,"end":82,"tag":"leusm"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"470887641282789376","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469859650385768452","created_at":"2014-05-23T15:17:24.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News transparency policy on clinical trials should not be diluted\" #AllTrials http://t.co/LrQ3JDmbCh","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/LrQ3JDmbCh","expanded_url":"http://bit.ly/1gp9T5K","display_url":"bit.ly/1gp9T5K"}],"hashtags":[{"start":72,"end":82,"tag":"AllTrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"469859650385768452","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469831215378624512","created_at":"2014-05-23T13:24:25.000Z","possibly_sensitive":false,"author_id":"2547774333","referenced_tweets":[{"type":"replied_to","id":"469811476761694209"}],"text":"“@EMA_News: We've recommended #Translarna for treatment of #Duchenne muscular dystrophy: http://t.co/0lDznXI64a”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/0lDznXI64a","expanded_url":"http://bit.ly/1gWcRPJ","display_url":"bit.ly/1gWcRPJ"}],"hashtags":[{"start":30,"end":41,"tag":"Translarna"},{"start":59,"end":68,"tag":"Duchenne"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"469811476761694209","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469811649411821568","created_at":"2014-05-23T12:06:40.000Z","possibly_sensitive":false,"author_id":"554667907","referenced_tweets":{},"text":"@EMA_News recommends first-in-class medicine from $PTCT for treatment of DMD #Nonsensemutation #Ataluren  http://t.co/osRePJgV4i","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":106,"end":128,"url":"http://t.co/osRePJgV4i","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/05/WC500167540.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"hashtags":[{"start":77,"end":94,"tag":"Nonsensemutation"},{"start":95,"end":104,"tag":"Ataluren"}],"annotations":[{"start":50,"end":54,"probability":0.4869,"type":"Organization","normalized_text":"$PTCT"}],"cashtags":[{"start":50,"end":55,"tag":"PTCT"}]},"source":"Twitter Web Client","conversation_id":"469811649411821568","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469806048388583424","created_at":"2014-05-23T11:44:25.000Z","possibly_sensitive":false,"author_id":"594516236","referenced_tweets":{},"text":"@EMA_News @PharmaTimes CHMP backs six meds, incl Gazyvaro for CLL, Duchenne's drug Translarna and Plegridy for MS http://t.co/gTtuQbdLJp","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"PharmaTimes","id":"52354784"}],"urls":[{"start":114,"end":136,"url":"http://t.co/gTtuQbdLJp","expanded_url":"http://bit.ly/1mdvptD","display_url":"bit.ly/1mdvptD"}],"hashtags":{},"annotations":[{"start":49,"end":56,"probability":0.3565,"type":"Organization","normalized_text":"Gazyvaro"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"469806048388583424","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469576164152201216","created_at":"2014-05-22T20:30:56.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Opens Registration for European Network of Paediatric Research Workshop. http://t.co/G4J1mZuo69","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/G4J1mZuo69","expanded_url":"http://bit.ly/1sA74yO","display_url":"bit.ly/1sA74yO"}],"hashtags":{},"annotations":[{"start":33,"end":80,"probability":0.4512,"type":"Other","normalized_text":"European Network of Paediatric Research Workshop"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"469576164152201216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469503958273523713","created_at":"2014-05-22T15:44:01.000Z","possibly_sensitive":false,"author_id":"185653786","referenced_tweets":{},"text":"@EMA_News poised to make major U-turn on transparency initiative, terrible for @openscience http://t.co/DUfZ8k1cL2","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":79,"end":91,"username":"openscience","id":"53560219"}],"urls":[{"start":92,"end":114,"url":"http://t.co/DUfZ8k1cL2","expanded_url":"http://bit.ly/1lZsRza","display_url":"bit.ly/1lZsRza"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"469503958273523713","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"469145083238162432","created_at":"2014-05-21T15:57:58.000Z","possibly_sensitive":false,"author_id":"784869524","referenced_tweets":{},"text":"@EMA_News Backpedalling on EMA’s “proactive publicat ion of #clinical-data” draft policy: what is the EMA afraid of? http://t.co/I8LscgyIeF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/I8LscgyIeF","expanded_url":"http://urlz.fr/oxf","display_url":"urlz.fr/oxf"}],"hashtags":[{"start":60,"end":69,"tag":"clinical"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"469145083238162432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468922939434631168","created_at":"2014-05-21T01:15:15.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News opens registration for it's sixth annual workshop on pediatric drug research and development. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":104,"end":126,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"468922939434631168","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468904452817440768","created_at":"2014-05-21T00:01:48.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News opens registration for it's sixth annual workshop on pediatric drug research and development. http://t.co/G4J1mZuo69","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":104,"end":126,"url":"http://t.co/G4J1mZuo69","expanded_url":"http://bit.ly/1sA74yO","display_url":"bit.ly/1sA74yO"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"468904452817440768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468889196909043714","created_at":"2014-05-20T23:01:10.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News and ECHA sign agreement to share information and work together on risk assessments. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":[{"start":14,"end":17,"probability":0.4922,"type":"Organization","normalized_text":"ECHA"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"468889196909043714","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"468856751002255360","created_at":"2014-05-20T20:52:15.000Z","possibly_sensitive":false,"author_id":"2273512710","referenced_tweets":{},"text":"@EMA_News in corso studio su Ivabradina per aumentato rischio CV quando usata a 10mg x 2 http://t.co/lZc1edP0yk","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":89,"end":111,"url":"http://t.co/lZc1edP0yk","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/05/news_detail_002099.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468856751002255360","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468725404057214976","created_at":"2014-05-20T12:10:19.000Z","possibly_sensitive":false,"author_id":"313427304","referenced_tweets":[{"type":"replied_to","id":"468719818364170240"}],"text":"@EMA_News I will do, thanks for being so helpful. I think I found it though- http://t.co/gAHtkjjw0A","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":77,"end":99,"url":"http://t.co/gAHtkjjw0A","expanded_url":"http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Product_Information/PhVWP_Recommendations/Antidepressants/PAR_suicidal_thoughts.pdf","display_url":"hma.eu/fileadmin/date…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468709423352147968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468718313670205441","created_at":"2014-05-20T11:42:09.000Z","possibly_sensitive":false,"author_id":"313427304","referenced_tweets":[{"type":"replied_to","id":"468717260354617344"}],"text":"@EMA_News Thanks for that. Can you show me the report which upped the SSRI suicide warning to 24?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468709423352147968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468715378181668864","created_at":"2014-05-20T11:30:29.000Z","possibly_sensitive":false,"author_id":"313427304","referenced_tweets":[{"type":"replied_to","id":"468714475861078016"}],"text":"@EMA_News Thank you very much! Can you clarify whether this warning was upped to age 25? Not clear..","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468709423352147968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468712536385531904","created_at":"2014-05-20T11:19:11.000Z","possibly_sensitive":false,"author_id":"313427304","referenced_tweets":[{"type":"replied_to","id":"468709423352147968"}],"text":"@EMA_News Seriously? Any chance you could publish your assessment on SSRIs in humans? Irish Psychiatry seem to have little idea of dangers.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468709423352147968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468414784560713729","created_at":"2014-05-19T15:36:02.000Z","possibly_sensitive":false,"author_id":"420282116","referenced_tweets":{},"text":"@EMA_News #MIHealthForum is about to start! Join us in the conversation!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":10,"end":24,"tag":"MIHealthForum"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468414784560713729","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468402058010574849","created_at":"2014-05-19T14:45:27.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News and ECHA sign agreement to share information and work together on risk assessments. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":94,"end":116,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":[{"start":14,"end":17,"probability":0.4922,"type":"Organization","normalized_text":"ECHA"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"468402058010574849","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"hy","id":"468379576687554560","created_at":"2014-05-19T13:16:07.000Z","possibly_sensitive":false,"author_id":"339561626","referenced_tweets":{},"text":"@EMA_News Էէըթժի Ռտվսռջ Հհկփւցր Իիժթըէ Եեդգբա Ֆևֆօքփ Ծծխցրտվս Ժժթը Ռռջպչո Շշնյմ Գգդեէըթ Սսվրցպչո Ռռցծխլիժթը Էէզեդգ Ռցւփք Տտվսռջ Էէզեդգ Սսվռթ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"468379576687554560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468334088974524416","created_at":"2014-05-19T10:15:22.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News opens registration for it's sixth annual workshop on pediatric drug research and development. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":104,"end":126,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"468334088974524416","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"468321921718030336","created_at":"2014-05-19T09:27:01.000Z","possibly_sensitive":false,"author_id":"382690046","referenced_tweets":[{"type":"replied_to","id":"468312373980573696"}],"text":"@EMA_News @Aifa_ufficiale unica srada possibile la tracciatura con 2D, alcuni paesi lo impongono accelleriamo anche noi su questa strada .","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"Aifa_ufficiale","id":"441940097"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"468312373980573696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"468318949822967808","created_at":"2014-05-19T09:15:13.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"468318949822967808","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467990588349243392","created_at":"2014-05-18T11:30:25.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News and European Chemicals Agency Strengthen Collaboration. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":66,"end":88,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"467990588349243392","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467971641428168705","created_at":"2014-05-18T10:15:08.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Opens Registration for European Network of Paediatric Research Workshop. http://t.co/G4J1mZuo69","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/G4J1mZuo69","expanded_url":"http://bit.ly/1sA74yO","display_url":"bit.ly/1sA74yO"}],"hashtags":{},"annotations":[{"start":33,"end":80,"probability":0.4512,"type":"Other","normalized_text":"European Network of Paediatric Research Workshop"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"467971641428168705","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467956545905770496","created_at":"2014-05-18T09:15:09.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Opens Registration for European Network of Paediatric Research Workshop. http://t.co/U3Cf4QqpbX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/U3Cf4QqpbX","expanded_url":"http://bit.ly/1jPCXDb","display_url":"bit.ly/1jPCXDb"}],"hashtags":{},"annotations":[{"start":33,"end":80,"probability":0.4512,"type":"Other","normalized_text":"European Network of Paediatric Research Workshop"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"467956545905770496","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467280327011237889","created_at":"2014-05-16T12:28:06.000Z","possibly_sensitive":false,"author_id":"524685920","referenced_tweets":{},"text":"@EMA_News and @EU_ECHA enhance cooperation http://t.co/A4lWdCPtTI #drugdevelopment","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":22,"username":"EU_ECHA","id":"331604970"}],"urls":[{"start":43,"end":65,"url":"http://t.co/A4lWdCPtTI","expanded_url":"http://j.mp/1lvN5xp","display_url":"j.mp/1lvN5xp"}],"hashtags":[{"start":66,"end":82,"tag":"drugdevelopment"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"467280327011237889","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467246634922180608","created_at":"2014-05-16T10:14:13.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News #AllTrials Ombudsman concerned about change of policy at EMA as regards clinical trial data transparency http://t.co/X95NHBzMqO","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/X95NHBzMqO","expanded_url":"http://www.ombudsman.europa.eu/en/press/release.faces/en/54348/html.bookmark","display_url":"ombudsman.europa.eu/en/press/relea…"}],"hashtags":[{"start":10,"end":20,"tag":"AllTrials"}],"annotations":[{"start":67,"end":69,"probability":0.5769,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"467246634922180608","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"467220537161154560","created_at":"2014-05-16T08:30:31.000Z","possibly_sensitive":false,"author_id":"1106659014","referenced_tweets":{},"text":"@EMA_News #AllTrials Ombudsman concerned about change of policy at EMA as regards clinical trial data transparency http://t.co/kvri1YORVT","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":115,"end":137,"url":"http://t.co/kvri1YORVT","expanded_url":"http://www.ombudsman.europa.eu/press/release.faces/en/54348/html.bookmark","display_url":"ombudsman.europa.eu/press/release.…"}],"hashtags":[{"start":10,"end":20,"tag":"AllTrials"}],"annotations":[{"start":67,"end":69,"probability":0.5769,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"source":"Twitter for Websites","conversation_id":"467220537161154560","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"466978474285367296","created_at":"2014-05-15T16:28:39.000Z","possibly_sensitive":false,"author_id":"554667907","referenced_tweets":[{"type":"replied_to","id":"466977010896887808"}],"text":"@EMA_News Thank you We have filled out the form and submitted our questions. We look forward to hearing back from you shortly @alljoinjack","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":138,"username":"alljoinjack","id":"554667907"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"466909578588725248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"466856543292760064","created_at":"2014-05-15T08:24:08.000Z","possibly_sensitive":false,"author_id":"331604970","referenced_tweets":{},"text":"@EMA_News and ECHA: two EU Agencies agreed to strengthen their scientific dialogue http://t.co/mCRYT64c6f","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":83,"end":105,"url":"http://t.co/mCRYT64c6f","expanded_url":"http://bit.ly/1sOkwkC","display_url":"bit.ly/1sOkwkC"}],"hashtags":{},"annotations":[{"start":24,"end":34,"probability":0.8151,"type":"Organization","normalized_text":"EU Agencies"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"466856543292760064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"466745092267847682","created_at":"2014-05-15T01:01:16.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"466745092267847682","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"466676987097272321","created_at":"2014-05-14T20:30:38.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/wBhWDg5qfj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/wBhWDg5qfj","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"466676987097272321","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"466285590439559168","created_at":"2014-05-13T18:35:22.000Z","possibly_sensitive":false,"author_id":"1588972196","referenced_tweets":{},"text":"@EMA_News best practice guidance on scientific advice w/ #HTA bodies is open for comments: http://t.co/mood51afxG","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":91,"end":113,"url":"http://t.co/mood51afxG","expanded_url":"http://bit.ly/1otvMAs","display_url":"bit.ly/1otvMAs"}],"hashtags":[{"start":57,"end":61,"tag":"HTA"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"466285590439559168","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"465986128047505408","created_at":"2014-05-12T22:45:25.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/wBhWDg5qfj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/wBhWDg5qfj","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"465986128047505408","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"465899626747674624","created_at":"2014-05-12T17:01:41.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"465899626747674624","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"465072558275313664","created_at":"2014-05-10T10:15:13.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/wBhWDg5qfj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/wBhWDg5qfj","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"465072558275313664","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"464951734872592385","created_at":"2014-05-10T02:15:06.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"464951734872592385","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"464400144713408512","created_at":"2014-05-08T13:43:17.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News draft guide on parallel advice with #HTA bodies. Big step forward for drug development and patient access. http://t.co/CdXNWUn2Zz","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/CdXNWUn2Zz","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/05/news_detail_002097.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":46,"end":50,"tag":"HTA"}],"annotations":{},"cashtags":{}},"source":"iOS","conversation_id":"464400144713408512","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"464193154657550336","created_at":"2014-05-08T00:00:47.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"464193154657550336","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"464069012628832256","created_at":"2014-05-07T15:47:29.000Z","possibly_sensitive":false,"author_id":"1319836640","referenced_tweets":[{"type":"replied_to","id":"464068470666043392"}],"text":"@EMA_News  Thanks! Waiting @INFARMED_IP reply...","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":27,"end":39,"username":"INFARMED_IP","id":"1392501529"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"464067906062794752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"464067906062794752","created_at":"2014-05-07T15:43:05.000Z","possibly_sensitive":false,"author_id":"1319836640","referenced_tweets":{},"text":"@EMA_News @INFARMED_IP  What happened with Infanrix Tetra in #Portugal? Was it just a contaminated lot?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"INFARMED_IP","id":"1392501529"}],"urls":{},"hashtags":[{"start":61,"end":70,"tag":"Portugal"}],"annotations":[{"start":43,"end":56,"probability":0.6805,"type":"Person","normalized_text":"Infanrix Tetra"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"464067906062794752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"463279680414810112","created_at":"2014-05-05T11:30:57.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/wBhWDg5qfj","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/wBhWDg5qfj","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"463279680414810112","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"463265711084044288","created_at":"2014-05-05T10:35:27.000Z","possibly_sensitive":false,"author_id":"216314816","referenced_tweets":{},"text":"@EMA_News presents @EU_Health with first report on #safety of #medicines following new legislation http://t.co/MCsfBSNWqo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":19,"end":29,"username":"EU_Health","id":"606325697"}],"urls":[{"start":99,"end":121,"url":"http://t.co/MCsfBSNWqo","expanded_url":"http://goo.gl/L51W2C","display_url":"goo.gl/L51W2C"}],"hashtags":[{"start":51,"end":58,"tag":"safety"},{"start":62,"end":72,"tag":"medicines"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"463265711084044288","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"462978774544711680","created_at":"2014-05-04T15:35:16.000Z","possibly_sensitive":false,"author_id":"914462377","referenced_tweets":{},"text":"@EMA_News: informe anual 2013 diaponible en http://t.co/QW3b0W8ZdK","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":44,"end":66,"url":"http://t.co/QW3b0W8ZdK","expanded_url":"http://bit.ly/QZE1Jn","display_url":"bit.ly/QZE1Jn"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"462978774544711680","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"462263681288769536","created_at":"2014-05-02T16:13:44.000Z","possibly_sensitive":false,"author_id":"15536425","referenced_tweets":[{"type":"replied_to","id":"462254689225289728"}],"text":"RT @EMA_News: presented the 1st report on the implementation of the #pharmacovigilance legislation to @EU_Commission http://t.co/ij4e4M0gDg","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":102,"end":116,"username":"EU_Commission","id":"157981564"}],"urls":[{"start":117,"end":139,"url":"http://t.co/ij4e4M0gDg","expanded_url":"http://bit.ly/1rMBwFu","display_url":"bit.ly/1rMBwFu"}],"hashtags":[{"start":68,"end":86,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"462254689225289728","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"462256610203951104","created_at":"2014-05-02T15:45:38.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"462256610203951104","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"462241414152073216","created_at":"2014-05-02T14:45:15.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News releases annual report detailing 2013 drug approvals and initiatives. http://t.co/KvA9ErUKcw","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":80,"end":102,"url":"http://t.co/KvA9ErUKcw","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"462241414152073216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"462227818735480832","created_at":"2014-05-02T13:51:14.000Z","possibly_sensitive":false,"author_id":"633978297","referenced_tweets":[{"type":"replied_to","id":"462142694241079296"}],"text":"Our 2013 annual report is now available: http://t.co/62dyfWvTEl @EMA_News http://t.co/3IxUHyYeRz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":64,"end":73,"username":"EMA_News","id":"116716199"}],"urls":[{"start":41,"end":63,"url":"http://t.co/62dyfWvTEl","expanded_url":"http://bit.ly/QZE1Jn","display_url":"bit.ly/QZE1Jn"},{"start":74,"end":96,"url":"http://t.co/3IxUHyYeRz","expanded_url":"https://twitter.com/jagasquet/status/462227818735480832/photo/1","display_url":"pic.twitter.com/3IxUHyYeRz"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"462142694241079296","attachments":{"media_keys":["3_462227814314680320"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"462148208224141312","created_at":"2014-05-02T08:34:53.000Z","possibly_sensitive":false,"author_id":"1548804618","referenced_tweets":[{"type":"replied_to","id":"462138293451509760"}],"text":"@EMA_News Start with the basics (taxonomy): S. boulardii doesn't exist: http://t.co/uACSZqENmD","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":72,"end":94,"url":"http://t.co/uACSZqENmD","expanded_url":"http://www.ntvg.nl/publicatie/nieuwe-mogelijkheden-bij-clostridium-difficile-infecties","display_url":"ntvg.nl/publicatie/nie…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"462138293451509760","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461965953707040768","created_at":"2014-05-01T20:30:40.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/wBhWDg5qfj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/wBhWDg5qfj","expanded_url":"http://bit.ly/1u5be5f","display_url":"bit.ly/1u5be5f"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"461965953707040768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461947034871037952","created_at":"2014-05-01T19:15:30.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Publishes Annual Report. http://t.co/9SBCF00bmP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":35,"end":57,"url":"http://t.co/9SBCF00bmP","expanded_url":"http://bit.ly/PRmC4o","display_url":"bit.ly/PRmC4o"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"461947034871037952","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"de","id":"461684393233235968","created_at":"2014-05-01T01:51:51.000Z","possibly_sensitive":false,"author_id":"339561626","referenced_tweets":{},"text":"@EMA_News ẞÜüßöäÄ Tencolole alphabet line medicine type word morning freshness body X., eight proof.Solucious Prime German gophabetto.,","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"461684393233235968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461628637310365696","created_at":"2014-04-30T22:10:18.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/cdasGcNbib","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/cdasGcNbib","expanded_url":"http://bit.ly/QCA0Ki","display_url":"bit.ly/QCA0Ki"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"461628637310365696","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"461506983464423424","created_at":"2014-04-30T14:06:53.000Z","possibly_sensitive":false,"author_id":"339561626","referenced_tweets":{},"text":"@EMA_News بتثجغ حفقخدكلد ذلٱأإة هويصصصضء قفغعظ ططبات ٨٦٩٣؟١؛٤،٦ـــ صولار.،Pرووف.،Mيياكي@ى.،V\nChaos Computer Club.,E.v.,Medicine Team sign in","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"461506983464423424","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461394531586691072","created_at":"2014-04-30T06:40:03.000Z","possibly_sensitive":false,"author_id":"134450541","referenced_tweets":[{"type":"replied_to","id":"460791162031599616"}],"text":"@EMA_News thanks so much for sharing. Just added it here: http://t.co/KSKlNHWh1y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":58,"end":80,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"RebelMouse Application","conversation_id":"460791162031599616","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461241394057986049","created_at":"2014-04-29T20:31:32.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/cdasGcNbib","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/cdasGcNbib","expanded_url":"http://bit.ly/QCA0Ki","display_url":"bit.ly/QCA0Ki"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"461241394057986049","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461164448838082560","created_at":"2014-04-29T15:25:47.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"461163233291018241"}],"text":"@FrankPointfr For information on the release date in France, you will need to contact the national health authorities in France.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":13,"username":"FrankPointfr","id":"103437676"}],"urls":{},"hashtags":{},"annotations":[{"start":53,"end":58,"probability":0.9986,"type":"Place","normalized_text":"France"},{"start":121,"end":126,"probability":0.9972,"type":"Place","normalized_text":"France"}],"cashtags":{}},"source":"TweetDeck","conversation_id":"461104014978215936","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"461104014978215936","created_at":"2014-04-29T11:25:38.000Z","possibly_sensitive":false,"author_id":"103437676","referenced_tweets":{},"text":"@EMA_News is there a date of reviewing by EC planned for posaconazole tablets, and \"release\" in e.g. France? http://t.co/vCAGpMvl90","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":109,"end":131,"url":"http://t.co/vCAGpMvl90","expanded_url":"http://www.europeanpharmaceuticalreview.com/24321/news/industry-news/chmp-issues-positive-opinion-tablet-formulation-mercks-noxafil-posaconazole/#.U1-Jo5WKDs0","display_url":"europeanpharmaceuticalreview.com/24321/news/ind…"}],"hashtags":{},"annotations":[{"start":101,"end":106,"probability":0.8296,"type":"Place","normalized_text":"France"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"461104014978215936","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"460801373630910466","created_at":"2014-04-28T15:23:03.000Z","possibly_sensitive":false,"author_id":"315331799","referenced_tweets":[{"type":"replied_to","id":"459720540006408192"}],"text":"@EMA_News you're live on my @RebelMouse http://t.co/enPVuakmJT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":39,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":40,"end":62,"url":"http://t.co/enPVuakmJT","expanded_url":"http://rbl.ms/1m1GdOD","display_url":"rbl.ms/1m1GdOD"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"RebelMouse Application","conversation_id":"459720540006408192","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"460740749290930176","created_at":"2014-04-28T11:22:09.000Z","possibly_sensitive":false,"author_id":"104871547","referenced_tweets":[{"type":"replied_to","id":"460739520234004480"}],"text":"@EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"460739520234004480","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"460702721772118017","created_at":"2014-04-28T08:51:02.000Z","possibly_sensitive":false,"author_id":"134450541","referenced_tweets":[{"type":"replied_to","id":"460700484106723328"}],"text":"@EMA_News That tweet deserves to be featured! Check it out: http://t.co/KSKlNHWh1y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":60,"end":82,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"RebelMouse Application","conversation_id":"460700484106723328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"460346440251105280","created_at":"2014-04-27T09:15:18.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Sends Roche Findings to European Commission. http://t.co/y4s6Xlv5P4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/y4s6Xlv5P4","expanded_url":"http://bit.ly/1rjTQpj","display_url":"bit.ly/1rjTQpj"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"460346440251105280","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"460063485280657408","created_at":"2014-04-26T14:30:57.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Sends Roche Findings to European Commission. http://t.co/akRk00wzpV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/akRk00wzpV","expanded_url":"http://bit.ly/1jDFVHP","display_url":"bit.ly/1jDFVHP"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"460063485280657408","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"460046994791485440","created_at":"2014-04-26T13:25:25.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/cdasGcNbib","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/cdasGcNbib","expanded_url":"http://bit.ly/QCA0Ki","display_url":"bit.ly/QCA0Ki"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"460046994791485440","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"459876854401609728","created_at":"2014-04-26T02:09:20.000Z","possibly_sensitive":false,"author_id":"543802399","referenced_tweets":[{"type":"replied_to","id":"459649895755157504"}],"text":"We've published our guideline on good #pharmacovigilance practices:  – risk minimisation measures: http://t.co/mcH4wMsChM” @EMA_News","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":123,"end":132,"username":"EMA_News","id":"116716199"}],"urls":[{"start":99,"end":121,"url":"http://t.co/mcH4wMsChM","expanded_url":"http://bit.ly/1ntxOTt","display_url":"bit.ly/1ntxOTt"}],"hashtags":[{"start":38,"end":56,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"459649895755157504","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"459716440615317504","created_at":"2014-04-25T15:31:55.000Z","possibly_sensitive":false,"author_id":"55586971","referenced_tweets":{},"text":"@EMA_News &amp; @US_FDA award orphan designation to @boehringerus's #drug to treat patients w/acute myeloid leukemia http://t.co/a397trFZzU","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":23,"username":"US_FDA","id":"208120290"},{"start":52,"end":65,"username":"boehringerus","id":"61008852"}],"urls":[{"start":117,"end":139,"url":"http://t.co/a397trFZzU","expanded_url":"http://bit.ly/QINEMf","display_url":"bit.ly/QINEMf"}],"hashtags":[{"start":68,"end":73,"tag":"drug"}],"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"459716440615317504","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"459707137024090112","created_at":"2014-04-25T14:54:57.000Z","possibly_sensitive":false,"author_id":"275269011","referenced_tweets":{},"text":"@EMA_News: We've recommended extending use of Nexavar to include treatment of differentiated thyroid cancer http://t.co/Urw3wIf3xl","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":108,"end":130,"url":"http://t.co/Urw3wIf3xl","expanded_url":"http://bit.ly/1ila6AU","display_url":"bit.ly/1ila6AU"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"459707137024090112","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"459078159313690624","created_at":"2014-04-23T21:15:37.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/cdasGcNbib","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/cdasGcNbib","expanded_url":"http://bit.ly/QCA0Ki","display_url":"bit.ly/QCA0Ki"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"459078159313690624","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"459027745247608832","created_at":"2014-04-23T17:55:17.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Sends Roche Findings to European Commission. http://t.co/akRk00wzpV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/akRk00wzpV","expanded_url":"http://bit.ly/1jDFVHP","display_url":"bit.ly/1jDFVHP"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"459027745247608832","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458916450489872384","created_at":"2014-04-23T10:33:02.000Z","possibly_sensitive":false,"author_id":"134450541","referenced_tweets":[{"type":"replied_to","id":"458912885650259968"}],"text":"@EMA_News you're live on my @RebelMouse http://t.co/KSKlNHWh1y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":39,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":40,"end":62,"url":"http://t.co/KSKlNHWh1y","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"RebelMouse Application","conversation_id":"458912885650259968","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458621647629877248","created_at":"2014-04-22T15:01:36.000Z","possibly_sensitive":false,"author_id":"2426498719","referenced_tweets":[{"type":"replied_to","id":"458602546169659392"}],"text":"MT @EMA_News: We've published an update on our recent meeting with @US_FDA and @EU_Health: http://t.co/AZ2jwB5sJz #FDA #EMA #RxRegA","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"},{"start":67,"end":74,"username":"US_FDA","id":"208120290"},{"start":79,"end":89,"username":"EU_Health","id":"606325697"}],"urls":[{"start":91,"end":113,"url":"http://t.co/AZ2jwB5sJz","expanded_url":"http://bit.ly/1hkIZps","display_url":"bit.ly/1hkIZps"}],"hashtags":[{"start":114,"end":118,"tag":"FDA"},{"start":119,"end":123,"tag":"EMA"},{"start":124,"end":131,"tag":"RxRegA"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"458602546169659392","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458609708434481152","created_at":"2014-04-22T14:14:09.000Z","possibly_sensitive":false,"author_id":"2254792730","referenced_tweets":{},"text":"@EMA_News Hi! Quick question : do you regulate Mobile apps in any way? Apps that were developed by pharma companies? Thank you!","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"458609708434481152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458569022083465217","created_at":"2014-04-22T11:32:29.000Z","possibly_sensitive":false,"author_id":"2426498719","referenced_tweets":[{"type":"replied_to","id":"458519260319715328"}],"text":"MT @EMA_News: #CHMP Agenda this week http://t.co/kFRgWElTp0 Highlights post Friday #RxRegA","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":37,"end":59,"url":"http://t.co/kFRgWElTp0","expanded_url":"http://bit.ly/1nbNj27","display_url":"bit.ly/1nbNj27"}],"hashtags":[{"start":14,"end":19,"tag":"CHMP"},{"start":83,"end":90,"tag":"RxRegA"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"458519260319715328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458546029710020608","created_at":"2014-04-22T10:01:07.000Z","possibly_sensitive":false,"author_id":"69232855","referenced_tweets":{},"text":"@EMA_News alerts EU Healthcare Professionals after idenfication of vials of falsified Anticancer Medicines http://t.co/gMEtHWvd4F","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/gMEtHWvd4F","expanded_url":"http://ow.ly/w1pSW","display_url":"ow.ly/w1pSW"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"458546029710020608","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458248922050613248","created_at":"2014-04-21T14:20:31.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News notifies EU healthcare professionals of the falsified cancer drug Herceptin. http://t.co/7FJznQtPx0","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":87,"end":109,"url":"http://t.co/7FJznQtPx0","expanded_url":"http://ow.ly/vVixT","display_url":"ow.ly/vVixT"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"458248922050613248","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"458149441384366080","created_at":"2014-04-21T07:45:13.000Z","possibly_sensitive":false,"author_id":"382590363","referenced_tweets":{},"text":"@EMA_News FollowTUFFY CervicalCancer/GardasilControversy\"LessonsMySisterTaughtMe\" http://t.co/jyvSxm6Dh3","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/jyvSxm6Dh3","expanded_url":"http://vimeo.com/m/63124327","display_url":"vimeo.com/m/63124327"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"458149441384366080","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"457972547364339712","created_at":"2014-04-20T20:02:18.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News notifies EU healthcare professionals of the falsified cancer drug Herceptin. http://t.co/Xm7EEuiEbQ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":87,"end":109,"url":"http://t.co/Xm7EEuiEbQ","expanded_url":"http://ow.ly/vVey2","display_url":"ow.ly/vVey2"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"457972547364339712","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"457461238944251904","created_at":"2014-04-19T10:10:33.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News notifies EU healthcare professionals of the falsified cancer drug Herceptin. http://t.co/wnjcIu65Ny","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":87,"end":109,"url":"http://t.co/wnjcIu65Ny","expanded_url":"http://ow.ly/vTgNH","display_url":"ow.ly/vTgNH"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"457461238944251904","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"457164828453662720","created_at":"2014-04-18T14:32:43.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Sends Roche Findings to European Commission. http://t.co/WKrWHKahOm","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/WKrWHKahOm","expanded_url":"http://ow.ly/vTaQ3","display_url":"ow.ly/vTaQ3"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"457164828453662720","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456936451817877504","created_at":"2014-04-17T23:25:14.000Z","possibly_sensitive":false,"author_id":"21880565","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/UqezM49YsY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/UqezM49YsY","expanded_url":"http://ow.ly/vTamt","display_url":"ow.ly/vTamt"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"456936451817877504","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456915754504691712","created_at":"2014-04-17T22:02:59.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Warns of Falsified Herceptin Vials. http://t.co/s9iiISL2Fp","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":46,"end":68,"url":"http://t.co/s9iiISL2Fp","expanded_url":"http://ow.ly/vTejQ","display_url":"ow.ly/vTejQ"}],"hashtags":{},"annotations":[{"start":19,"end":43,"probability":0.2504,"type":"Other","normalized_text":"Falsified Herceptin Vials"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"456915754504691712","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"fr","id":"456832176491753473","created_at":"2014-04-17T16:30:53.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News completes report on Roche pharmacovigilance non-compliance allegations. http://t.co/QB7JepPpZI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":82,"end":104,"url":"http://t.co/QB7JepPpZI","expanded_url":"http://ow.ly/vQHS8","display_url":"ow.ly/vQHS8"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"456832176491753473","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"456824674442153985","created_at":"2014-04-17T16:01:04.000Z","possibly_sensitive":false,"author_id":"917639060","referenced_tweets":[{"type":"replied_to","id":"456821554714648576"}],"text":"“@EMA_News update on stolen vials of #Herceptin http://t.co/5zSiJ4gpGy” nueva información, otros productos pueden estar afectados.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":48,"end":70,"url":"http://t.co/5zSiJ4gpGy","expanded_url":"http://bit.ly/QgZRrp","display_url":"bit.ly/QgZRrp"}],"hashtags":[{"start":37,"end":47,"tag":"Herceptin"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"456821554714648576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456824457638588416","created_at":"2014-04-17T16:00:12.000Z","possibly_sensitive":false,"author_id":"1704701516","referenced_tweets":[{"type":"replied_to","id":"456821554714648576"}],"text":"#EMA says Alimta (pemetrexed) &amp; Remicade (infliximab) were also part of theft MT @EMA_News update on stolen Herceptin http://t.co/pujEIsDUmr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":85,"end":94,"username":"EMA_News","id":"116716199"}],"urls":[{"start":122,"end":144,"url":"http://t.co/pujEIsDUmr","expanded_url":"http://bit.ly/QgZRrp","display_url":"bit.ly/QgZRrp"}],"hashtags":[{"start":0,"end":4,"tag":"EMA"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"456821554714648576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456821554714648576","created_at":"2014-04-17T15:48:40.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":{},"text":"@EMA_News update on stolen vials of #Herceptin http://t.co/zfd3rsN2ql","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":47,"end":69,"url":"http://t.co/zfd3rsN2ql","expanded_url":"http://bit.ly/QgZRrp","display_url":"bit.ly/QgZRrp"}],"hashtags":[{"start":36,"end":46,"tag":"Herceptin"}],"annotations":{},"cashtags":{}},"source":"bitly bitlink","conversation_id":"456821554714648576","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456401640359067648","created_at":"2014-04-16T12:00:05.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News alerts EU #healthcare professionals after vials of falsified #Herceptin identified @Roche #pharma #biotech","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":93,"end":99,"username":"Roche","id":"20815041"}],"urls":{},"hashtags":[{"start":20,"end":31,"tag":"healthcare"},{"start":71,"end":81,"tag":"Herceptin"},{"start":100,"end":107,"tag":"pharma"},{"start":108,"end":116,"tag":"biotech"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"456401640359067648","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456385026142109697","created_at":"2014-04-16T10:54:04.000Z","possibly_sensitive":false,"author_id":"134450541","referenced_tweets":[{"type":"replied_to","id":"456380716004028417"}],"text":"@EMA_News definitely adding that tweet to my @RebelMouse http://t.co/DoxMe8R7v4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":45,"end":56,"username":"RebelMouse","id":"341251022"}],"urls":[{"start":57,"end":79,"url":"http://t.co/DoxMe8R7v4","expanded_url":"http://rbl.ms/1dLrWwE","display_url":"rbl.ms/1dLrWwE"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"RebelMouse Application","conversation_id":"456380716004028417","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456192824623771649","created_at":"2014-04-15T22:10:19.000Z","possibly_sensitive":false,"author_id":"263819136","referenced_tweets":{},"text":"@EMA_News Sends Roche Findings to European Commission. http://t.co/p2AA9ASHbN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":55,"end":77,"url":"http://t.co/p2AA9ASHbN","expanded_url":"http://ow.ly/vOhzj","display_url":"ow.ly/vOhzj"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"456192824623771649","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"456178096404574208","created_at":"2014-04-15T21:11:48.000Z","possibly_sensitive":false,"author_id":"35511598","referenced_tweets":[{"type":"replied_to","id":"456031082295857152"}],"text":"RT @EMA_News: We've published the EPAR for #Rivastigmine 3M Health Care Ltd, a #generic of Exelon for #Alzheimer's: http://t.co/aQNK0TbJ1F","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":116,"end":138,"url":"http://t.co/aQNK0TbJ1F","expanded_url":"http://bit.ly/1qyAD4O","display_url":"bit.ly/1qyAD4O"}],"hashtags":[{"start":43,"end":56,"tag":"Rivastigmine"},{"start":79,"end":87,"tag":"generic"},{"start":102,"end":112,"tag":"Alzheimer"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"456031082295857152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"455972962219601920","created_at":"2014-04-15T07:36:40.000Z","possibly_sensitive":false,"author_id":"524685920","referenced_tweets":{},"text":"@EMA_News: Meeting highlights from the #PRAC 7-10 April 2014 http://t.co/mXpfpAnRcy #pharmacovigilance","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":61,"end":83,"url":"http://t.co/mXpfpAnRcy","expanded_url":"http://j.mp/1iPqL1D","display_url":"j.mp/1iPqL1D"}],"hashtags":[{"start":39,"end":44,"tag":"PRAC"},{"start":84,"end":102,"tag":"pharmacovigilance"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"455972962219601920","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"455733495554654208","created_at":"2014-04-14T15:45:07.000Z","possibly_sensitive":false,"author_id":"243228907","referenced_tweets":{},"text":"@EMA_News ends inquiry into alleged non-compliance by @Roche Registration of pharmacovigilance obligations &amp; sent report to @EU_Commission","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":54,"end":60,"username":"Roche","id":"20815041"},{"start":128,"end":142,"username":"EU_Commission","id":"157981564"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"455733495554654208","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"455638059389042688","created_at":"2014-04-14T09:25:53.000Z","possibly_sensitive":false,"author_id":"35511598","referenced_tweets":[{"type":"replied_to","id":"455628380063670272"}],"text":"RT @EMA_News: We're holding a workshop on clinical investigation of #medicines for #Alzheimer’s disease in November. http://t.co/NAk7tKxSGo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":117,"end":139,"url":"http://t.co/NAk7tKxSGo","expanded_url":"http://bit.ly/1i8IseP","display_url":"bit.ly/1i8IseP"}],"hashtags":[{"start":68,"end":78,"tag":"medicines"},{"start":83,"end":93,"tag":"Alzheimer"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"455628380063670272","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"454596258129522688","created_at":"2014-04-11T12:26:08.000Z","possibly_sensitive":false,"author_id":"2426498719","referenced_tweets":[{"type":"replied_to","id":"454583590744260608"}],"text":"MT @EMA_News #PRAC recommends against combined use of medicines affecting the #reninangiotensin (#RAS) system #RxRegA http://t.co/KuV4fc7zBP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":118,"end":140,"url":"http://t.co/KuV4fc7zBP","expanded_url":"http://bit.ly/1nbILpU","display_url":"bit.ly/1nbILpU"}],"hashtags":[{"start":13,"end":18,"tag":"PRAC"},{"start":78,"end":95,"tag":"reninangiotensin"},{"start":97,"end":101,"tag":"RAS"},{"start":110,"end":117,"tag":"RxRegA"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"454583590744260608","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"454281908969799681","created_at":"2014-04-10T15:37:01.000Z","possibly_sensitive":false,"author_id":"2426498719","referenced_tweets":[{"type":"replied_to","id":"454278896478089216"}],"text":"MT @EMA_News: We've published the #EPAR for #Eperzan (#albiglutide), a new #medicine for type-2 #diabetes: http://t.co/ZG9UUmuAhz #RxRegA","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"urls":[{"start":107,"end":129,"url":"http://t.co/ZG9UUmuAhz","expanded_url":"http://bit.ly/Q9znb2","display_url":"bit.ly/Q9znb2"}],"hashtags":[{"start":34,"end":39,"tag":"EPAR"},{"start":44,"end":52,"tag":"Eperzan"},{"start":54,"end":66,"tag":"albiglutide"},{"start":75,"end":84,"tag":"medicine"},{"start":96,"end":105,"tag":"diabetes"},{"start":130,"end":137,"tag":"RxRegA"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"454278896478089216","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"454260363551576064","created_at":"2014-04-10T14:11:25.000Z","possibly_sensitive":false,"author_id":"1606025952","referenced_tweets":{},"text":"@EMA_News @MCBazacoPhD Thanks for the RTs!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"MCBazacoPhD","id":"2313950822"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Hootsuite","conversation_id":"454260363551576064","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"es","id":"454219271522877443","created_at":"2014-04-10T11:28:07.000Z","possibly_sensitive":false,"author_id":"231439755","referenced_tweets":{},"text":"@EMA_News y @US_FDA consolidan su cooperación regulatoria en favor del medicamento | @ElGlobalnet http://t.co/4T4n2l8ZeT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":19,"username":"US_FDA","id":"208120290"}],"urls":[{"start":98,"end":120,"url":"http://t.co/4T4n2l8ZeT","expanded_url":"http://www.elglobal.net/noticias-medicamento/2014-04-05/industria-farmaceutica/la-ema-y-la-fda-consolidan-su-cooperacion-regulatoria-en-favor-del-medicamento/pagina.aspx?idart=828977","display_url":"elglobal.net/noticias-medic…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Websites","conversation_id":"454219271522877443","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"453964551487508480","created_at":"2014-04-09T18:35:57.000Z","possibly_sensitive":false,"author_id":"214119379","referenced_tweets":{},"text":"@EMA_News guido rasi agli #StatiGeneraliSalute http://t.co/QM3Mx4zgEi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":47,"end":69,"url":"http://t.co/QM3Mx4zgEi","expanded_url":"https://twitter.com/voglioibaffi/status/453964551487508480/photo/1","display_url":"pic.twitter.com/QM3Mx4zgEi"}],"hashtags":[{"start":26,"end":46,"tag":"StatiGeneraliSalute"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"453964551487508480","attachments":{"media_keys":["3_453964546827644928"]},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453681991171309569","created_at":"2014-04-08T23:53:10.000Z","possibly_sensitive":false,"author_id":"2198604157","referenced_tweets":[{"type":"replied_to","id":"453210787352678400"}],"text":"@EMA_News TGA and EMA increase collaboration on orphan medicines to accelerate access to patients.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPad","conversation_id":"453210787352678400","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453571764107640832","created_at":"2014-04-08T16:35:10.000Z","possibly_sensitive":false,"author_id":"2426498719","referenced_tweets":[{"type":"replied_to","id":"453570629745516544"}],"text":".@EMA_News announces the final steps for their clinical trial data policy http://t.co/0yz7wJX6IB #ctdata  #EU #EMA #transparecy #RxRegA","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":[{"start":74,"end":96,"url":"http://t.co/0yz7wJX6IB","expanded_url":"http://bit.ly/PZuAss","display_url":"bit.ly/PZuAss"}],"hashtags":[{"start":97,"end":104,"tag":"ctdata"},{"start":106,"end":109,"tag":"EU"},{"start":110,"end":114,"tag":"EMA"},{"start":115,"end":127,"tag":"transparecy"},{"start":128,"end":135,"tag":"RxRegA"}],"annotations":{},"cashtags":{}},"source":"Twitter for Mac","conversation_id":"453570629745516544","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453525904967626752","created_at":"2014-04-08T13:32:56.000Z","possibly_sensitive":false,"author_id":"524685920","referenced_tweets":{},"text":"@EMA_News and #Australian regulator strengthen collaboration in the area of #orphanmedicines http://t.co/71olggh00x #regulatory #raredisease","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":93,"end":115,"url":"http://t.co/71olggh00x","expanded_url":"http://j.mp/1iq14Vc","display_url":"j.mp/1iq14Vc"}],"hashtags":[{"start":14,"end":25,"tag":"Australian"},{"start":76,"end":92,"tag":"orphanmedicines"},{"start":116,"end":127,"tag":"regulatory"},{"start":128,"end":140,"tag":"raredisease"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"453525904967626752","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453438631500193792","created_at":"2014-04-08T07:46:08.000Z","possibly_sensitive":false,"author_id":"2198604157","referenced_tweets":[{"type":"replied_to","id":"451279170614878208"}],"text":"@EMA_News  EMA's fees increase by 1.5%","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for Android","conversation_id":"451279170614878208","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453261226739761152","created_at":"2014-04-07T20:01:12.000Z","possibly_sensitive":false,"author_id":"71542880","referenced_tweets":{},"text":"@EMA_News and Australia’s TGA collaborate in the area of orphan medicines http://t.co/cJMuq8jwb7 #pharma","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":74,"end":96,"url":"http://t.co/cJMuq8jwb7","expanded_url":"http://bit.ly/1elr81w","display_url":"bit.ly/1elr81w"}],"hashtags":[{"start":97,"end":104,"tag":"pharma"}],"annotations":[{"start":14,"end":22,"probability":0.95,"type":"Place","normalized_text":"Australia"}],"cashtags":{}},"source":"Hootsuite","conversation_id":"453261226739761152","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"453123782849597440","created_at":"2014-04-07T10:55:03.000Z","possibly_sensitive":false,"author_id":"308356449","referenced_tweets":{},"text":"@EMA_News: strengthened collaboration on orphan medicines with the Australian medicine regulator: http://t.co/xYimm6pLNG #raredisease","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":98,"end":120,"url":"http://t.co/xYimm6pLNG","expanded_url":"http://bit.ly/1hkwNe2","display_url":"bit.ly/1hkwNe2"}],"hashtags":[{"start":121,"end":133,"tag":"raredisease"}],"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"453123782849597440","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"452113235874172929","created_at":"2014-04-04T15:59:29.000Z","possibly_sensitive":false,"author_id":"2176193576","referenced_tweets":{},"text":"@EMA_News: We confirm that @AbbVie has withdrawn its court cases against us concerning access to clinical-trial data: http://t.co/OJYsDN7d4u","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":27,"end":34,"username":"abbvie","id":"531892451"}],"urls":[{"start":118,"end":140,"url":"http://t.co/OJYsDN7d4u","expanded_url":"http://bit.ly/1fEHHJm","display_url":"bit.ly/1fEHHJm"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter for iPhone","conversation_id":"452113235874172929","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451781956213411840","created_at":"2014-04-03T18:03:06.000Z","possibly_sensitive":false,"author_id":"113148426","referenced_tweets":{},"text":"@EMA_News confirms that #AbbVie has withdrawn both its court cases on access to #ctdata http://t.co/jAIDpqiCDO","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":88,"end":110,"url":"http://t.co/jAIDpqiCDO","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/04/news_detail_002060.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"hashtags":[{"start":24,"end":31,"tag":"AbbVie"},{"start":80,"end":87,"tag":"ctdata"}],"annotations":{},"cashtags":{}},"source":"iOS","conversation_id":"451781956213411840","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451779601011048448","created_at":"2014-04-03T17:53:45.000Z","possibly_sensitive":false,"author_id":"552617924","referenced_tweets":{},"text":"@EMA_News confirms @AbbVie withdrawal of court cases on access to clinical trial data http://t.co/ALADyYSDhq Will InterMune follow suit?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":19,"end":26,"username":"abbvie","id":"531892451"}],"urls":[{"start":86,"end":108,"url":"http://t.co/ALADyYSDhq","expanded_url":"http://bit.ly/1mNchoq","display_url":"bit.ly/1mNchoq"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"451779601011048448","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451659824686972928","created_at":"2014-04-03T09:57:48.000Z","possibly_sensitive":false,"author_id":"1017044760","referenced_tweets":{},"text":"@EMA_News @AnimalTaskFrc @FVEurope @epruma1 @COPACOGECA - Mark your diary- @FIDIN_DGM Conf, 1 Oct 2014: http://t.co/75ezQedOP6  #FIDIN50CONF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"AnimalTaskFrc","id":"971640636"},{"start":25,"end":34,"username":"FVEurope","id":"1549866445"},{"start":35,"end":43,"username":"epruma1","id":"2386927416"},{"start":44,"end":55,"username":"COPACOGECA","id":"475624182"},{"start":75,"end":85,"username":"FIDIN_DGM","id":"281540837"}],"urls":[{"start":104,"end":126,"url":"http://t.co/75ezQedOP6","expanded_url":"http://bit.ly/1mHxbVP","display_url":"bit.ly/1mHxbVP"}],"hashtags":[{"start":128,"end":140,"tag":"FIDIN50CONF"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"451659824686972928","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"it","id":"451621707481378816","created_at":"2014-04-03T07:26:20.000Z","possibly_sensitive":false,"author_id":"441940097","referenced_tweets":{},"text":"@EMA_News Management Board: l’impegno della Commissione Europea contro lo sviluppo delle antibiotico resistenze http://t.co/WiId9vajDa","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":112,"end":134,"url":"http://t.co/WiId9vajDa","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-management-board-l%E2%80%99impegno-della-commissione-europea-contro-lo-sviluppo-delle-antibiotic","display_url":"agenziafarmaco.gov.it/it/content/ema…"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"TweetDeck","conversation_id":"451621707481378816","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451617730752704512","created_at":"2014-04-03T07:10:32.000Z","possibly_sensitive":false,"author_id":"524685920","referenced_tweets":{},"text":"@EMA_News: Increased fees coming into effect on 1 April 2014 http://t.co/lBnuRhofYZ #regulatory","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":61,"end":83,"url":"http://t.co/lBnuRhofYZ","expanded_url":"http://j.mp/1lCtUXD","display_url":"j.mp/1lCtUXD"}],"hashtags":[{"start":84,"end":95,"tag":"regulatory"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"451617730752704512","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451308062130073600","created_at":"2014-04-02T10:40:01.000Z","possibly_sensitive":false,"author_id":"116716199","referenced_tweets":[{"type":"replied_to","id":"451284064738484224"}],"text":"Apologies, the deadline to apply for this job is 2 May, not 14 May. We've corrected it on our website: http://t.co/hCvn8Uqhel","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":{},"urls":[{"start":103,"end":125,"url":"http://t.co/hCvn8Uqhel","expanded_url":"http://bit.ly/1dQus9R","display_url":"bit.ly/1dQus9R"}],"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"451284064738484224","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"451023111929208832","created_at":"2014-04-01T15:47:44.000Z","possibly_sensitive":false,"author_id":"380500399","referenced_tweets":[{"type":"replied_to","id":"451022866054930432"}],"text":".@EMA_News I thought the EU is undergoing deflation right now","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":[{"start":25,"end":26,"probability":0.5983,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"451022866054930432","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"448920033503502336","created_at":"2014-03-26T20:30:51.000Z","possibly_sensitive":false,"author_id":"509110681","referenced_tweets":{},"text":"@EMA_News Can't wait for the expert content &amp; warm weather at Nuclear Cardiology in Orlando http://t.co/GlpVGXndfj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":[{"start":96,"end":118,"url":"http://t.co/GlpVGXndfj","expanded_url":"http://www.asnc.org/nctoday","display_url":"asnc.org/nctoday"}],"hashtags":{},"annotations":[{"start":62,"end":79,"probability":0.4231,"type":"Organization","normalized_text":"Nuclear Cardiology"},{"start":84,"end":90,"probability":0.9985,"type":"Place","normalized_text":"Orlando"}],"cashtags":{}},"source":"Twitter Web Client","conversation_id":"448920033503502336","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"448903539029733376","created_at":"2014-03-26T19:25:18.000Z","possibly_sensitive":false,"author_id":"21746310","referenced_tweets":[{"type":"replied_to","id":"448881179077664768"}],"text":"give feedback + show power of social media =&gt; “@EMA_News: Tell us what you think of our Twitter feed by completing: http://t.co/ebhMHBBcwV”","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":50,"end":59,"username":"EMA_News","id":"116716199"}],"urls":[{"start":119,"end":141,"url":"http://t.co/ebhMHBBcwV","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"annotations":[{"start":88,"end":94,"probability":0.7371,"type":"Product","normalized_text":"Twitter"}],"cashtags":{}},"source":"Twitter for iPad","conversation_id":"448881179077664768","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"und","id":"448858832488640512","created_at":"2014-03-26T16:27:39.000Z","possibly_sensitive":false,"author_id":"30285991","referenced_tweets":[{"type":"replied_to","id":"447065616072327168"}],"text":"@EMA_News @sanofipasteur yes","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":{},"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"447065616072327168","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"in_reply_to_user_id":"116716199","lang":"en","id":"448465987281891328","created_at":"2014-03-25T14:26:38.000Z","possibly_sensitive":false,"author_id":"1186490732","referenced_tweets":{},"text":"@EMA_News EMA's final policy on access to clinical trial data and an implementation plan expected in June. #transparency #clinicaltrials","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"urls":{},"hashtags":[{"start":107,"end":120,"tag":"transparency"},{"start":121,"end":136,"tag":"clinicaltrials"}],"annotations":{},"cashtags":{}},"source":"Twitter Web Client","conversation_id":"448465987281891328","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}}]
